id	sid	tid	token	lemma	pos
aji-170	1	1	_	_	PUNCT
aji-170	2	1	_	_	PUNCT
aji-170	3	1	_	_	PUNCT
aji-170	4	1	_	_	PUNCT
aji-170	5	1	_	_	PUNCT
aji-170	6	1	_	_	PUNCT
aji-170	7	1	_	_	PUNCT
aji-170	8	1	_	_	PUNCT
aji-170	9	1	_	_	PUNCT
aji-170	10	1	_	_	PUNCT
aji-170	11	1	_	_	PUNCT
aji-170	12	1	_	_	PUNCT
aji-170	13	1	_	_	PUNCT
aji-170	14	1	_	_	PUNCT
aji-170	15	1	_	_	PUNCT
aji-170	16	1	_	_	PUNCT
aji-170	17	1	_	_	PUNCT
aji-170	18	1	_	_	PUNCT
aji-170	19	1	_	_	PUNCT
aji-170	20	1	_	_	PUNCT
aji-170	21	1	_	_	PUNCT
aji-170	22	1	_	_	PUNCT
aji-170	23	1	_	_	PUNCT
aji-170	24	1	_	_	PUNCT
aji-170	25	1	_	_	PUNCT
aji-170	26	1	_	_	PUNCT
aji-170	27	1	_	_	PUNCT
aji-170	28	1	_	_	PUNCT
aji-170	29	1	_	_	PUNCT
aji-170	30	1	_	_	PUNCT
aji-170	31	1	_	_	PUNCT
aji-170	32	1	_	_	PUNCT
aji-170	33	1	_	_	PUNCT
aji-170	34	1	_	_	PUNCT
aji-170	35	1	_	_	PUNCT
aji-170	36	1	_	_	PUNCT
aji-170	37	1	_	_	PUNCT
aji-170	38	1	_	_	PUNCT
aji-170	39	1	_	_	PUNCT
aji-170	40	1	_	_	PUNCT
aji-170	41	1	_	_	PUNCT
aji-170	42	1	_	_	PUNCT
aji-170	43	1	_	_	PUNCT
aji-170	44	1	_	_	PUNCT
aji-170	45	1	_	_	PUNCT
aji-170	46	1	_	_	PUNCT
aji-170	47	1	_	_	PUNCT
aji-170	48	1	_	_	PUNCT
aji-170	49	1	_	_	PUNCT
aji-170	50	1	_	_	PUNCT
aji-170	51	1	_	_	PUNCT
aji-170	52	1	_	_	PUNCT
aji-170	53	1	_	_	PUNCT
aji-170	54	1	_	_	PUNCT
aji-170	55	1	_	_	PUNCT
aji-170	56	1	_	_	PUNCT
aji-170	57	1	_	_	PUNCT
aji-170	58	1	_	_	PUNCT
aji-170	59	1	_	_	PUNCT
aji-170	60	1	_	_	PUNCT
aji-170	61	1	_	_	PUNCT
aji-170	62	1	_	_	PUNCT
aji-170	63	1	_	_	PUNCT
aji-170	64	1	_	_	PUNCT
aji-170	65	1	_	_	PUNCT
aji-170	66	1	_	_	PUNCT
aji-170	67	1	_	_	PUNCT
aji-170	68	1	_	_	PUNCT
aji-170	69	1	_	_	PUNCT
aji-170	70	1	_	_	PUNCT
aji-170	71	1	_	_	PUNCT
aji-170	72	1	_	_	PUNCT
aji-170	73	1	_	_	PUNCT
aji-170	74	1	_	_	PUNCT
aji-170	75	1	_	_	PUNCT
aji-170	76	1	_	_	PUNCT
aji-170	77	1	_	_	PUNCT
aji-170	78	1	_	_	PUNCT
aji-170	79	1	_	_	PUNCT
aji-170	80	1	_	_	PUNCT
aji-170	81	1	_	_	PUNCT
aji-170	82	1	_	_	PUNCT
aji-170	83	1	_	_	PUNCT
aji-170	84	1	_	_	PUNCT
aji-170	85	1	_	_	PUNCT
aji-170	86	1	_	_	PUNCT
aji-170	87	1	_	_	PUNCT
aji-170	88	1	_	_	PUNCT
aji-170	89	1	_	_	PUNCT
aji-170	90	1	_	_	PUNCT
aji-170	91	1	_	_	PUNCT
aji-170	92	1	_	_	PUNCT
aji-170	93	1	_	_	PUNCT
aji-170	94	1	_	_	PUNCT
aji-170	95	1	_	_	PUNCT
aji-170	96	1	_	_	PUNCT
aji-170	97	1	_	_	PUNCT
aji-170	98	1	_	_	PUNCT
aji-170	99	1	_	_	PUNCT
aji-170	100	1	_	_	PUNCT
aji-170	101	1	_	_	PUNCT
aji-170	102	1	*	*	PUNCT
aji-170	102	2	corresponding	correspond	VERB
aji-170	102	3	author	author	NOUN
aji-170	102	4	:	:	PUNCT
aji-170	102	5	e	e	NOUN
aji-170	102	6	-	-	NOUN
aji-170	102	7	mail	mail	NOUN
aji-170	102	8	:	:	PUNCT
aji-170	102	9	wwalana@uds.edu.gh	wwalana@uds.edu.gh	NOUN
aji-170	102	10	;	;	PUNCT
aji-170	102	11	cite	cite	VERB
aji-170	102	12	as	as	ADP
aji-170	102	13	:	:	PUNCT
aji-170	102	14	walana	walana	PROPN
aji-170	102	15	,	,	PUNCT
aji-170	102	16	williams	williams	PROPN
aji-170	102	17	,	,	PUNCT
aji-170	102	18	george	george	PROPN
aji-170	102	19	billak	billak	PROPN
aji-170	102	20	,	,	PUNCT
aji-170	102	21	jennifer	jennifer	PROPN
aji-170	102	22	suurbaar	suurbaar	PROPN
aji-170	102	23	,	,	PUNCT
aji-170	102	24	and	and	CCONJ
aji-170	102	25	hawa	hawa	PROPN
aji-170	102	26	malechi	malechi	PROPN
aji-170	102	27	.	.	PUNCT
aji-170	103	1	2025	2025	NUM
aji-170	103	2	.	.	PUNCT
aji-170	104	1	“	"	PUNCT
aji-170	104	2	t	t	NOUN
aji-170	104	3	cell	cell	NOUN
aji-170	104	4	exhaustion	exhaustion	NOUN
aji-170	104	5	and	and	CCONJ
aji-170	104	6	immune	immune	ADJ
aji-170	104	7	dysfunction	dysfunction	NOUN
aji-170	104	8	in	in	ADP
aji-170	104	9	spontaneous	spontaneous	ADJ
aji-170	104	10	abortion	abortion	NOUN
aji-170	104	11	:	:	PUNCT
aji-170	104	12	a	a	DET
aji-170	104	13	targeted	target	VERB
aji-170	104	14	review	review	NOUN
aji-170	104	15	”	"	PUNCT
aji-170	104	16	.	.	PUNCT
aji-170	105	1	asian	asian	ADJ
aji-170	105	2	journal	journal	NOUN
aji-170	105	3	of	of	ADP
aji-170	105	4	immunology	immunology	NOUN
aji-170	105	5	8	8	NUM
aji-170	105	6	(	(	PUNCT
aji-170	105	7	1):179	1):179	NUM
aji-170	105	8	-	-	SYM
aji-170	105	9	89	89	NUM
aji-170	105	10	.	.	PUNCT
aji-170	106	1	https://doi.org/10.9734/aji/2025/v8i1170	https://doi.org/10.9734/aji/2025/v8i1170	PROPN
aji-170	106	2	.	.	PUNCT
aji-170	107	1	asian	asian	PROPN
aji-170	107	2	journal	journal	PROPN
aji-170	107	3	of	of	ADP
aji-170	107	4	immunology	immunology	NOUN
aji-170	107	5	volume	volume	NOUN
aji-170	107	6	8	8	NUM
aji-170	107	7	,	,	PUNCT
aji-170	107	8	issue	issue	NOUN
aji-170	107	9	1	1	NUM
aji-170	107	10	,	,	PUNCT
aji-170	107	11	page	page	NOUN
aji-170	107	12	179	179	NUM
aji-170	107	13	-	-	SYM
aji-170	107	14	189	189	NUM
aji-170	107	15	,	,	PUNCT
aji-170	107	16	2025	2025	NUM
aji-170	107	17	;	;	PUNCT
aji-170	107	18	article	article	NOUN
aji-170	107	19	no.aji.139815	no.aji.139815	PROPN
aji-170	107	20	t	t	PROPN
aji-170	107	21	cell	cell	NOUN
aji-170	107	22	exhaustion	exhaustion	NOUN
aji-170	107	23	and	and	CCONJ
aji-170	107	24	immune	immune	ADJ
aji-170	107	25	dysfunction	dysfunction	NOUN
aji-170	107	26	in	in	ADP
aji-170	107	27	spontaneous	spontaneous	ADJ
aji-170	107	28	abortion	abortion	NOUN
aji-170	107	29	:	:	PUNCT
aji-170	107	30	a	a	DET
aji-170	107	31	targeted	target	VERB
aji-170	107	32	review	review	NOUN
aji-170	107	33	williams	williams	PROPN
aji-170	107	34	walana	walana	PROPN
aji-170	108	1	a	a	PROPN
aji-170	108	2	*	*	PROPN
aji-170	108	3	,	,	PUNCT
aji-170	108	4	george	george	PROPN
aji-170	108	5	billak	billak	PROPN
aji-170	108	6	b	b	PROPN
aji-170	108	7	,	,	PUNCT
aji-170	108	8	jennifer	jennifer	PROPN
aji-170	108	9	suurbaar	suurbaar	PROPN
aji-170	108	10	b	b	PROPN
aji-170	108	11	and	and	CCONJ
aji-170	108	12	hawa	hawa	PROPN
aji-170	108	13	malechi	malechi	PROPN
aji-170	108	14	c	c	PROPN
aji-170	108	15	,	,	PUNCT
aji-170	108	16	d	d	PROPN
aji-170	108	17	a	a	DET
aji-170	108	18	department	department	NOUN
aji-170	108	19	of	of	ADP
aji-170	108	20	clinical	clinical	ADJ
aji-170	108	21	microbiology	microbiology	NOUN
aji-170	108	22	,	,	PUNCT
aji-170	108	23	school	school	NOUN
aji-170	108	24	of	of	ADP
aji-170	108	25	medicine	medicine	NOUN
aji-170	108	26	,	,	PUNCT
aji-170	108	27	university	university	NOUN
aji-170	108	28	for	for	ADP
aji-170	108	29	development	development	NOUN
aji-170	108	30	studies	study	NOUN
aji-170	108	31	,	,	PUNCT
aji-170	108	32	tamale	tamale	NOUN
aji-170	108	33	,	,	PUNCT
aji-170	108	34	ghana	ghana	PROPN
aji-170	108	35	.	.	PUNCT
aji-170	109	1	b	b	X
aji-170	109	2	department	department	PROPN
aji-170	109	3	of	of	ADP
aji-170	109	4	biochemistry	biochemistry	NOUN
aji-170	109	5	and	and	CCONJ
aji-170	109	6	molecular	molecular	ADJ
aji-170	109	7	medicine	medicine	NOUN
aji-170	109	8	,	,	PUNCT
aji-170	109	9	school	school	NOUN
aji-170	109	10	of	of	ADP
aji-170	109	11	medicine	medicine	NOUN
aji-170	109	12	,	,	PUNCT
aji-170	109	13	university	university	NOUN
aji-170	109	14	for	for	ADP
aji-170	109	15	development	development	NOUN
aji-170	109	16	studies	study	NOUN
aji-170	109	17	,	,	PUNCT
aji-170	109	18	tamale	tamale	NOUN
aji-170	109	19	,	,	PUNCT
aji-170	109	20	ghana	ghana	PROPN
aji-170	109	21	.	.	PUNCT
aji-170	110	1	c	c	PROPN
aji-170	110	2	department	department	NOUN
aji-170	110	3	of	of	ADP
aji-170	110	4	obstetrics	obstetric	NOUN
aji-170	110	5	and	and	CCONJ
aji-170	110	6	gynaecology	gynaecology	NOUN
aji-170	110	7	,	,	PUNCT
aji-170	110	8	school	school	NOUN
aji-170	110	9	of	of	ADP
aji-170	110	10	medicine	medicine	NOUN
aji-170	110	11	,	,	PUNCT
aji-170	110	12	university	university	NOUN
aji-170	110	13	for	for	ADP
aji-170	110	14	development	development	NOUN
aji-170	110	15	studies	study	NOUN
aji-170	110	16	,	,	PUNCT
aji-170	110	17	tamale	tamale	NOUN
aji-170	110	18	,	,	PUNCT
aji-170	110	19	ghana	ghana	PROPN
aji-170	110	20	.	.	PUNCT
aji-170	111	1	d	d	DET
aji-170	111	2	department	department	NOUN
aji-170	111	3	of	of	ADP
aji-170	111	4	obstetrics	obstetric	NOUN
aji-170	111	5	and	and	CCONJ
aji-170	111	6	gynaecology	gynaecology	NOUN
aji-170	111	7	,	,	PUNCT
aji-170	111	8	tamale	tamale	NOUN
aji-170	111	9	teaching	teaching	NOUN
aji-170	111	10	hospital	hospital	NOUN
aji-170	111	11	,	,	PUNCT
aji-170	111	12	northern	northern	ADJ
aji-170	111	13	region	region	NOUN
aji-170	111	14	,	,	PUNCT
aji-170	111	15	tamale	tamale	NOUN
aji-170	111	16	,	,	PUNCT
aji-170	111	17	ghana	ghana	PROPN
aji-170	111	18	.	.	PUNCT
aji-170	112	1	authors	author	NOUN
aji-170	112	2	’	'	PUNCT
aji-170	112	3	contributions	contribution	NOUN
aji-170	112	4	this	this	DET
aji-170	112	5	work	work	NOUN
aji-170	112	6	was	be	AUX
aji-170	112	7	carried	carry	VERB
aji-170	112	8	out	out	ADP
aji-170	112	9	in	in	ADP
aji-170	112	10	collaboration	collaboration	NOUN
aji-170	112	11	among	among	ADP
aji-170	112	12	all	all	DET
aji-170	112	13	authors	author	NOUN
aji-170	112	14	.	.	PUNCT
aji-170	113	1	authors	author	NOUN
aji-170	113	2	ww	ww	PROPN
aji-170	113	3	and	and	CCONJ
aji-170	113	4	gb	gb	PROPN
aji-170	113	5	conceived	conceive	VERB
aji-170	113	6	the	the	DET
aji-170	113	7	idea	idea	NOUN
aji-170	113	8	.	.	PUNCT
aji-170	114	1	authors	author	NOUN
aji-170	114	2	ww	ww	PROPN
aji-170	114	3	,	,	PUNCT
aji-170	114	4	gb	gb	PROPN
aji-170	114	5	,	,	PUNCT
aji-170	114	6	js	js	PROPN
aji-170	114	7	and	and	CCONJ
aji-170	114	8	hm	hm	INTJ
aji-170	114	9	performed	perform	VERB
aji-170	114	10	a	a	DET
aji-170	114	11	literature	literature	NOUN
aji-170	114	12	search	search	NOUN
aji-170	114	13	.	.	PUNCT
aji-170	115	1	all	all	DET
aji-170	115	2	authors	author	NOUN
aji-170	115	3	reviewed	review	VERB
aji-170	115	4	and	and	CCONJ
aji-170	115	5	made	make	VERB
aji-170	115	6	significant	significant	ADJ
aji-170	115	7	contributions	contribution	NOUN
aji-170	115	8	to	to	PART
aji-170	115	9	finalise	finalise	VERB
aji-170	115	10	the	the	DET
aji-170	115	11	manuscript	manuscript	NOUN
aji-170	115	12	and	and	CCONJ
aji-170	115	13	agreed	agree	VERB
aji-170	115	14	to	to	ADP
aji-170	115	15	the	the	DET
aji-170	115	16	submission	submission	NOUN
aji-170	115	17	of	of	ADP
aji-170	115	18	this	this	DET
aji-170	115	19	manuscript	manuscript	NOUN
aji-170	115	20	for	for	ADP
aji-170	115	21	consideration	consideration	NOUN
aji-170	115	22	.	.	PUNCT
aji-170	116	1	all	all	DET
aji-170	116	2	authors	author	NOUN
aji-170	116	3	read	read	VERB
aji-170	116	4	and	and	CCONJ
aji-170	116	5	approved	approve	VERB
aji-170	116	6	the	the	DET
aji-170	116	7	final	final	ADJ
aji-170	116	8	manuscript	manuscript	NOUN
aji-170	116	9	.	.	PUNCT
aji-170	117	1	article	article	NOUN
aji-170	117	2	information	information	PROPN
aji-170	117	3	doi	doi	PROPN
aji-170	117	4	:	:	PUNCT
aji-170	117	5	https://doi.org/10.9734/aji/2025/v8i1170	https://doi.org/10.9734/aji/2025/v8i1170	PROPN
aji-170	117	6	open	open	ADJ
aji-170	117	7	peer	peer	NOUN
aji-170	117	8	review	review	NOUN
aji-170	117	9	history	history	NOUN
aji-170	117	10	:	:	PUNCT
aji-170	117	11	this	this	DET
aji-170	117	12	journal	journal	NOUN
aji-170	117	13	follows	follow	VERB
aji-170	117	14	the	the	DET
aji-170	117	15	advanced	advance	VERB
aji-170	117	16	open	open	ADJ
aji-170	117	17	peer	peer	NOUN
aji-170	117	18	review	review	NOUN
aji-170	117	19	policy	policy	NOUN
aji-170	117	20	.	.	PUNCT
aji-170	118	1	identity	identity	NOUN
aji-170	118	2	of	of	ADP
aji-170	118	3	the	the	DET
aji-170	118	4	reviewers	reviewer	NOUN
aji-170	118	5	,	,	PUNCT
aji-170	118	6	editor(s	editor(s	NOUN
aji-170	118	7	)	)	PUNCT
aji-170	118	8	and	and	CCONJ
aji-170	118	9	additional	additional	ADJ
aji-170	118	10	reviewers	reviewer	NOUN
aji-170	118	11	,	,	PUNCT
aji-170	118	12	peer	peer	NOUN
aji-170	118	13	review	review	NOUN
aji-170	118	14	comments	comment	NOUN
aji-170	118	15	,	,	PUNCT
aji-170	118	16	different	different	ADJ
aji-170	118	17	versions	version	NOUN
aji-170	118	18	of	of	ADP
aji-170	118	19	the	the	DET
aji-170	118	20	manuscript	manuscript	NOUN
aji-170	118	21	,	,	PUNCT
aji-170	118	22	comments	comment	NOUN
aji-170	118	23	of	of	ADP
aji-170	118	24	the	the	DET
aji-170	118	25	editors	editor	NOUN
aji-170	118	26	,	,	PUNCT
aji-170	118	27	etc	etc	X
aji-170	118	28	,	,	PUNCT
aji-170	118	29	are	be	AUX
aji-170	118	30	available	available	ADJ
aji-170	118	31	here	here	ADV
aji-170	118	32	:	:	PUNCT
aji-170	118	33	https://pr.sdiarticle5.com/review-history/139815	https://pr.sdiarticle5.com/review-history/139815	NOUN
aji-170	118	34	received	receive	VERB
aji-170	118	35	:	:	PUNCT
aji-170	118	36	10/05/2025	10/05/2025	NUM
aji-170	118	37	published	publish	VERB
aji-170	118	38	:	:	PUNCT
aji-170	118	39	15/07/2025	15/07/2025	NUM
aji-170	118	40	abstract	abstract	ADJ
aji-170	118	41	background	background	NOUN
aji-170	118	42	:	:	PUNCT
aji-170	118	43	immune	immune	ADJ
aji-170	118	44	tolerance	tolerance	NOUN
aji-170	118	45	is	be	AUX
aji-170	118	46	established	establish	VERB
aji-170	118	47	between	between	ADP
aji-170	118	48	the	the	DET
aji-170	118	49	foetus	foetus	NOUN
aji-170	118	50	and	and	CCONJ
aji-170	118	51	the	the	DET
aji-170	118	52	mother	mother	NOUN
aji-170	118	53	in	in	ADP
aji-170	118	54	normal	normal	ADJ
aji-170	118	55	pregnancies	pregnancy	NOUN
aji-170	118	56	.	.	PUNCT
aji-170	119	1	however	however	ADV
aji-170	119	2	,	,	PUNCT
aji-170	119	3	this	this	DET
aji-170	119	4	tolerance	tolerance	NOUN
aji-170	119	5	may	may	AUX
aji-170	119	6	be	be	AUX
aji-170	119	7	breached	breach	VERB
aji-170	119	8	,	,	PUNCT
aji-170	119	9	resulting	result	VERB
aji-170	119	10	in	in	ADP
aji-170	119	11	undesired	undesired	ADJ
aji-170	119	12	pregnancy	pregnancy	NOUN
aji-170	119	13	outcomes	outcome	NOUN
aji-170	119	14	such	such	ADJ
aji-170	119	15	as	as	ADP
aji-170	119	16	spontaneous	spontaneous	ADJ
aji-170	119	17	abortion	abortion	NOUN
aji-170	119	18	,	,	PUNCT
aji-170	119	19	foetal	foetal	ADJ
aji-170	119	20	anomalies	anomaly	NOUN
aji-170	119	21	,	,	PUNCT
aji-170	119	22	and	and	CCONJ
aji-170	119	23	maternal	maternal	ADJ
aji-170	119	24	complications	complication	NOUN
aji-170	119	25	.	.	PUNCT
aji-170	120	1	reported	report	VERB
aji-170	120	2	review	review	NOUN
aji-170	120	3	article	article	NOUN
aji-170	120	4	https://doi.org/10.9734/aji/2025/v8i1170	https://doi.org/10.9734/aji/2025/v8i1170	PROPN
aji-170	120	5	https://pr.sdiarticle5.com/review-history/139815	https://pr.sdiarticle5.com/review-history/139815	NOUN
aji-170	120	6	walana	walana	PROPN
aji-170	120	7	et	et	PROPN
aji-170	120	8	al	al	PROPN
aji-170	120	9	.	.	PROPN
aji-170	120	10	;	;	PUNCT
aji-170	120	11	asian	asian	PROPN
aji-170	120	12	j.	j.	PROPN
aji-170	120	13	immunol	immunol	PROPN
aji-170	120	14	.	.	PROPN
aji-170	120	15	,	,	PUNCT
aji-170	120	16	vol	vol	NOUN
aji-170	120	17	.	.	PROPN
aji-170	120	18	8	8	NUM
aji-170	120	19	,	,	PUNCT
aji-170	120	20	no	no	INTJ
aji-170	120	21	.	.	NOUN
aji-170	120	22	1	1	NUM
aji-170	120	23	,	,	PUNCT
aji-170	120	24	pp	pp	ADJ
aji-170	120	25	.	.	PUNCT
aji-170	121	1	179	179	NUM
aji-170	121	2	-	-	SYM
aji-170	121	3	189	189	NUM
aji-170	121	4	,	,	PUNCT
aji-170	121	5	2025	2025	NUM
aji-170	121	6	;	;	PUNCT
aji-170	121	7	article	article	NOUN
aji-170	121	8	no.aji.139815	no.aji.139815	VERB
aji-170	121	9	180	180	NUM
aji-170	121	10	studies	study	NOUN
aji-170	121	11	suggest	suggest	VERB
aji-170	121	12	a	a	DET
aji-170	121	13	potential	potential	ADJ
aji-170	121	14	link	link	NOUN
aji-170	121	15	between	between	ADP
aji-170	121	16	immune	immune	ADJ
aji-170	121	17	response	response	NOUN
aji-170	121	18	and	and	CCONJ
aji-170	121	19	unplanned	unplanned	ADJ
aji-170	121	20	pregnancy	pregnancy	NOUN
aji-170	121	21	termination	termination	NOUN
aji-170	121	22	.	.	PUNCT
aji-170	122	1	a	a	DET
aji-170	122	2	comprehensive	comprehensive	ADJ
aji-170	122	3	understanding	understanding	NOUN
aji-170	122	4	of	of	ADP
aji-170	122	5	immune	immune	ADJ
aji-170	122	6	responses	response	NOUN
aji-170	122	7	in	in	ADP
aji-170	122	8	pregnancy	pregnancy	NOUN
aji-170	122	9	loss	loss	NOUN
aji-170	122	10	harbours	harbour	VERB
aji-170	122	11	the	the	DET
aji-170	122	12	potential	potential	NOUN
aji-170	122	13	to	to	PART
aji-170	122	14	control	control	VERB
aji-170	122	15	the	the	DET
aji-170	122	16	associated	associated	ADJ
aji-170	122	17	mechanisms	mechanism	NOUN
aji-170	122	18	.	.	PUNCT
aji-170	123	1	objective	objective	NOUN
aji-170	123	2	:	:	PUNCT
aji-170	123	3	this	this	DET
aji-170	123	4	review	review	NOUN
aji-170	123	5	synthesised	synthesise	VERB
aji-170	123	6	existing	exist	VERB
aji-170	123	7	studies	study	NOUN
aji-170	123	8	on	on	ADP
aji-170	123	9	t	t	PROPN
aji-170	123	10	cell	cell	NOUN
aji-170	123	11	exhaustion	exhaustion	NOUN
aji-170	123	12	(	(	PUNCT
aji-170	123	13	tce	tce	PROPN
aji-170	123	14	)	)	PUNCT
aji-170	123	15	in	in	ADP
aji-170	123	16	spontaneous	spontaneous	ADJ
aji-170	123	17	abortion	abortion	NOUN
aji-170	123	18	and	and	CCONJ
aji-170	123	19	pregnancy	pregnancy	NOUN
aji-170	123	20	complications	complication	NOUN
aji-170	123	21	.	.	PUNCT
aji-170	124	1	methodology	methodology	NOUN
aji-170	124	2	:	:	PUNCT
aji-170	124	3	a	a	DET
aji-170	124	4	comprehensive	comprehensive	ADJ
aji-170	124	5	database	database	NOUN
aji-170	124	6	search	search	NOUN
aji-170	124	7	from	from	ADP
aji-170	124	8	scopus	scopus	PROPN
aji-170	124	9	,	,	PUNCT
aji-170	124	10	google	google	PROPN
aji-170	124	11	scholar	scholar	NOUN
aji-170	124	12	,	,	PUNCT
aji-170	124	13	pubmed	pubmed	PROPN
aji-170	124	14	,	,	PUNCT
aji-170	124	15	and	and	CCONJ
aji-170	124	16	web	web	NOUN
aji-170	124	17	of	of	ADP
aji-170	124	18	science	science	NOUN
aji-170	124	19	identified	identify	VERB
aji-170	124	20	21	21	NUM
aji-170	124	21	eligible	eligible	ADJ
aji-170	124	22	studies	study	NOUN
aji-170	124	23	that	that	PRON
aji-170	124	24	reported	report	VERB
aji-170	124	25	original	original	ADJ
aji-170	124	26	data	datum	NOUN
aji-170	124	27	on	on	ADP
aji-170	124	28	spontaneous	spontaneous	ADJ
aji-170	124	29	abortion	abortion	NOUN
aji-170	124	30	and	and	CCONJ
aji-170	124	31	pregnancy	pregnancy	NOUN
aji-170	124	32	complications	complication	NOUN
aji-170	124	33	and	and	CCONJ
aji-170	124	34	tce	tce	PROPN
aji-170	124	35	.	.	PROPN
aji-170	124	36	results	result	NOUN
aji-170	124	37	:	:	PUNCT
aji-170	124	38	the	the	DET
aji-170	124	39	review	review	NOUN
aji-170	124	40	has	have	AUX
aji-170	124	41	shown	show	VERB
aji-170	124	42	that	that	SCONJ
aji-170	124	43	tce	tce	PROPN
aji-170	124	44	is	be	AUX
aji-170	124	45	common	common	ADJ
aji-170	124	46	in	in	ADP
aji-170	124	47	spontaneous	spontaneous	ADJ
aji-170	124	48	abortion	abortion	NOUN
aji-170	124	49	,	,	PUNCT
aji-170	124	50	characterised	characterise	VERB
aji-170	124	51	by	by	ADP
aji-170	124	52	the	the	DET
aji-170	124	53	upregulation	upregulation	NOUN
aji-170	124	54	of	of	ADP
aji-170	124	55	inhibitory	inhibitory	ADJ
aji-170	124	56	receptors	receptor	NOUN
aji-170	124	57	and	and	CCONJ
aji-170	124	58	a	a	DET
aji-170	124	59	suboptimal	suboptimal	ADJ
aji-170	124	60	or	or	CCONJ
aji-170	124	61	lack	lack	NOUN
aji-170	124	62	of	of	ADP
aji-170	124	63	t	t	PROPN
aji-170	124	64	-	-	PUNCT
aji-170	124	65	cells	cell	NOUN
aji-170	124	66	to	to	PART
aji-170	124	67	perform	perform	VERB
aji-170	124	68	their	their	PRON
aji-170	124	69	normal	normal	ADJ
aji-170	124	70	functions	function	NOUN
aji-170	124	71	,	,	PUNCT
aji-170	124	72	such	such	ADJ
aji-170	124	73	as	as	ADP
aji-170	124	74	proliferation	proliferation	NOUN
aji-170	124	75	,	,	PUNCT
aji-170	124	76	cytokine	cytokine	ADJ
aji-170	124	77	production	production	NOUN
aji-170	124	78	,	,	PUNCT
aji-170	124	79	and	and	CCONJ
aji-170	124	80	cytotoxicity	cytotoxicity	NOUN
aji-170	124	81	.	.	PUNCT
aji-170	125	1	decreased	decrease	VERB
aji-170	125	2	expression	expression	NOUN
aji-170	125	3	of	of	ADP
aji-170	125	4	pd1	pd1	NOUN
aji-170	125	5	,	,	PUNCT
aji-170	125	6	lag-3	lag-3	PUNCT
aji-170	125	7	and	and	CCONJ
aji-170	125	8	tim-3	tim-3	X
aji-170	125	9	may	may	AUX
aji-170	125	10	contribute	contribute	VERB
aji-170	125	11	to	to	ADP
aji-170	125	12	an	an	DET
aji-170	125	13	enhanced	enhanced	ADJ
aji-170	125	14	inflammatory	inflammatory	ADJ
aji-170	125	15	response	response	NOUN
aji-170	125	16	.	.	PUNCT
aji-170	126	1	increased	increase	VERB
aji-170	126	2	proportions	proportion	NOUN
aji-170	126	3	of	of	ADP
aji-170	126	4	th1	th1	PROPN
aji-170	126	5	and	and	CCONJ
aji-170	126	6	th17	th17	PROPN
aji-170	126	7	cells	cell	NOUN
aji-170	126	8	are	be	AUX
aji-170	126	9	associated	associate	VERB
aji-170	126	10	with	with	ADP
aji-170	126	11	pro	pro	ADJ
aji-170	126	12	-	-	ADJ
aji-170	126	13	inflammatory	inflammatory	ADJ
aji-170	126	14	responses	response	NOUN
aji-170	126	15	and	and	CCONJ
aji-170	126	16	decreased	decrease	VERB
aji-170	126	17	immune	immune	ADJ
aji-170	126	18	regulatory	regulatory	ADJ
aji-170	126	19	function	function	NOUN
aji-170	126	20	,	,	PUNCT
aji-170	126	21	resulting	result	VERB
aji-170	126	22	from	from	ADP
aji-170	126	23	altered	altered	ADJ
aji-170	126	24	pd-1	pd-1	ADP
aji-170	126	25	/	/	SYM
aji-170	126	26	pd	pd	ADJ
aji-170	126	27	-	-	PUNCT
aji-170	126	28	l1	l1	PROPN
aji-170	126	29	expression	expression	NOUN
aji-170	126	30	,	,	PUNCT
aji-170	126	31	which	which	PRON
aji-170	126	32	may	may	AUX
aji-170	126	33	contribute	contribute	VERB
aji-170	126	34	to	to	ADP
aji-170	126	35	pregnancy	pregnancy	NOUN
aji-170	126	36	loss	loss	NOUN
aji-170	126	37	.	.	PUNCT
aji-170	127	1	decreased	decrease	VERB
aji-170	127	2	anti	anti	ADJ
aji-170	127	3	-	-	ADJ
aji-170	127	4	inflammatory	inflammatory	ADJ
aji-170	127	5	cytokines	cytokine	NOUN
aji-170	127	6	(	(	PUNCT
aji-170	127	7	tgf	tgf	NOUN
aji-170	127	8	-	-	PUNCT
aji-170	127	9	β1	β1	PROPN
aji-170	127	10	,	,	PUNCT
aji-170	127	11	il-10	il-10	PRON
aji-170	127	12	,	,	PUNCT
aji-170	127	13	and	and	CCONJ
aji-170	127	14	il-4	il-4	X
aji-170	127	15	)	)	PUNCT
aji-170	127	16	promote	promote	VERB
aji-170	127	17	an	an	DET
aji-170	127	18	imbalanced	imbalanced	ADJ
aji-170	127	19	homeostasis	homeostasis	NOUN
aji-170	127	20	,	,	PUNCT
aji-170	127	21	which	which	PRON
aji-170	127	22	can	can	AUX
aji-170	127	23	lead	lead	VERB
aji-170	127	24	to	to	ADP
aji-170	127	25	pregnancy	pregnancy	NOUN
aji-170	127	26	loss	loss	NOUN
aji-170	127	27	.	.	PUNCT
aji-170	128	1	these	these	DET
aji-170	128	2	anomalies	anomaly	NOUN
aji-170	128	3	are	be	AUX
aji-170	128	4	partly	partly	ADV
aji-170	128	5	anchored	anchor	VERB
aji-170	128	6	on	on	ADP
aji-170	128	7	chronic	chronic	ADJ
aji-170	128	8	antigen	antigen	NOUN
aji-170	128	9	exposure	exposure	NOUN
aji-170	128	10	,	,	PUNCT
aji-170	128	11	oxidative	oxidative	ADJ
aji-170	128	12	stress	stress	NOUN
aji-170	128	13	,	,	PUNCT
aji-170	128	14	and	and	CCONJ
aji-170	128	15	hormonal	hormonal	ADJ
aji-170	128	16	changes	change	NOUN
aji-170	128	17	,	,	PUNCT
aji-170	128	18	phenomena	phenomenon	NOUN
aji-170	128	19	frequently	frequently	ADV
aji-170	128	20	associated	associate	VERB
aji-170	128	21	with	with	ADP
aji-170	128	22	recurrent	recurrent	ADJ
aji-170	128	23	spontaneous	spontaneous	ADJ
aji-170	128	24	abortion	abortion	NOUN
aji-170	128	25	or	or	CCONJ
aji-170	128	26	poor	poor	ADJ
aji-170	128	27	pregnancy	pregnancy	NOUN
aji-170	128	28	outcomes	outcome	NOUN
aji-170	128	29	.	.	PUNCT
aji-170	129	1	conclusion	conclusion	NOUN
aji-170	129	2	:	:	PUNCT
aji-170	129	3	optimal	optimal	ADJ
aji-170	129	4	modulation	modulation	NOUN
aji-170	129	5	of	of	ADP
aji-170	129	6	immune	immune	ADJ
aji-170	129	7	response	response	NOUN
aji-170	129	8	to	to	PART
aji-170	129	9	control	control	VERB
aji-170	129	10	tce	tce	PROPN
aji-170	129	11	may	may	AUX
aji-170	129	12	prevent	prevent	VERB
aji-170	129	13	or	or	CCONJ
aji-170	129	14	minimise	minimise	VERB
aji-170	129	15	the	the	DET
aji-170	129	16	occurrence	occurrence	NOUN
aji-170	129	17	of	of	ADP
aji-170	129	18	spontaneous	spontaneous	ADJ
aji-170	129	19	abortion	abortion	NOUN
aji-170	129	20	and	and	CCONJ
aji-170	129	21	promote	promote	VERB
aji-170	129	22	successful	successful	ADJ
aji-170	129	23	pregnancies	pregnancy	NOUN
aji-170	129	24	.	.	PUNCT
aji-170	130	1	keywords	keyword	NOUN
aji-170	130	2	:	:	PUNCT
aji-170	130	3	t	t	NOUN
aji-170	130	4	cell	cell	NOUN
aji-170	130	5	exhaustion	exhaustion	NOUN
aji-170	130	6	;	;	PUNCT
aji-170	130	7	immune	immune	ADJ
aji-170	130	8	exhaustion	exhaustion	NOUN
aji-170	130	9	;	;	PUNCT
aji-170	130	10	spontaneous	spontaneous	ADJ
aji-170	130	11	abortion	abortion	NOUN
aji-170	130	12	;	;	PUNCT
aji-170	130	13	pregnancy	pregnancy	NOUN
aji-170	130	14	;	;	PUNCT
aji-170	130	15	immune	immune	ADJ
aji-170	130	16	regulation	regulation	NOUN
aji-170	130	17	;	;	PUNCT
aji-170	130	18	reproductive	reproductive	ADJ
aji-170	130	19	immunology	immunology	NOUN
aji-170	130	20	;	;	PUNCT
aji-170	130	21	systematic	systematic	ADJ
aji-170	130	22	review	review	NOUN
aji-170	130	23	.	.	PUNCT
aji-170	131	1	1	1	X
aji-170	131	2	.	.	X
aji-170	131	3	introduction	introduction	NOUN
aji-170	131	4	pregnancy	pregnancy	NOUN
aji-170	131	5	is	be	AUX
aji-170	131	6	a	a	DET
aji-170	131	7	complex	complex	ADJ
aji-170	131	8	immune	immune	ADJ
aji-170	131	9	state	state	NOUN
aji-170	131	10	where	where	SCONJ
aji-170	131	11	tolerance	tolerance	NOUN
aji-170	131	12	and	and	CCONJ
aji-170	131	13	immune	immune	ADJ
aji-170	131	14	activation	activation	NOUN
aji-170	131	15	coexist	coexist	NOUN
aji-170	131	16	(	(	PUNCT
aji-170	131	17	hu	hu	PROPN
aji-170	131	18	et	et	PROPN
aji-170	131	19	al	al	PROPN
aji-170	131	20	.	.	PROPN
aji-170	131	21	,	,	PUNCT
aji-170	131	22	2016	2016	NUM
aji-170	131	23	)	)	PUNCT
aji-170	131	24	.	.	PUNCT
aji-170	132	1	despite	despite	SCONJ
aji-170	132	2	its	its	PRON
aji-170	132	3	prevalence	prevalence	NOUN
aji-170	132	4	,	,	PUNCT
aji-170	132	5	the	the	DET
aji-170	132	6	mechanisms	mechanism	NOUN
aji-170	132	7	governing	govern	VERB
aji-170	132	8	maternal	maternal	ADJ
aji-170	132	9	-	-	PUNCT
aji-170	132	10	foetal	foetal	ADJ
aji-170	132	11	immune	immune	ADJ
aji-170	132	12	tolerance	tolerance	NOUN
aji-170	132	13	remain	remain	VERB
aji-170	132	14	unclear	unclear	ADJ
aji-170	132	15	.	.	PUNCT
aji-170	133	1	pregnancy	pregnancy	NOUN
aji-170	133	2	failure	failure	NOUN
aji-170	133	3	affects	affect	VERB
aji-170	133	4	approximately	approximately	ADV
aji-170	133	5	15	15	NUM
aji-170	133	6	%	%	NOUN
aji-170	133	7	of	of	ADP
aji-170	133	8	known	known	ADJ
aji-170	133	9	pregnancies	pregnancy	NOUN
aji-170	133	10	,	,	PUNCT
aji-170	133	11	with	with	ADP
aji-170	133	12	more	more	ADJ
aji-170	133	13	than	than	ADP
aji-170	133	14	50	50	NUM
aji-170	133	15	%	%	NOUN
aji-170	133	16	attributed	attribute	VERB
aji-170	133	17	to	to	ADP
aji-170	133	18	immune	immune	ADJ
aji-170	133	19	tolerance	tolerance	NOUN
aji-170	133	20	defects	defect	NOUN
aji-170	133	21	(	(	PUNCT
aji-170	133	22	kuon	kuon	PROPN
aji-170	133	23	et	et	PROPN
aji-170	133	24	al	al	PROPN
aji-170	133	25	.	.	PROPN
aji-170	133	26	,	,	PUNCT
aji-170	133	27	2015	2015	NUM
aji-170	133	28	)	)	PUNCT
aji-170	133	29	.	.	PUNCT
aji-170	134	1	research	research	NOUN
aji-170	134	2	has	have	AUX
aji-170	134	3	shown	show	VERB
aji-170	134	4	that	that	SCONJ
aji-170	134	5	natural	natural	ADJ
aji-170	134	6	killer	killer	NOUN
aji-170	134	7	cells	cell	NOUN
aji-170	134	8	expressing	express	VERB
aji-170	134	9	tim-3	tim-3	VERB
aji-170	134	10	play	play	VERB
aji-170	134	11	a	a	DET
aji-170	134	12	defensive	defensive	ADJ
aji-170	134	13	role	role	NOUN
aji-170	134	14	in	in	ADP
aji-170	134	15	the	the	DET
aji-170	134	16	early	early	ADJ
aji-170	134	17	stages	stage	NOUN
aji-170	134	18	of	of	ADP
aji-170	134	19	pregnancy	pregnancy	NOUN
aji-170	134	20	,	,	PUNCT
aji-170	134	21	promoting	promote	VERB
aji-170	134	22	immunosuppressive	immunosuppressive	ADJ
aji-170	134	23	activities	activity	NOUN
aji-170	134	24	and	and	CCONJ
aji-170	134	25	the	the	DET
aji-170	134	26	induction	induction	NOUN
aji-170	134	27	of	of	ADP
aji-170	134	28	regulatory	regulatory	ADJ
aji-170	134	29	t	t	NOUN
aji-170	134	30	cells	cell	NOUN
aji-170	134	31	(	(	PUNCT
aji-170	134	32	kuon	kuon	PROPN
aji-170	134	33	et	et	PROPN
aji-170	134	34	al	al	PROPN
aji-170	134	35	.	.	PROPN
aji-170	134	36	,	,	PUNCT
aji-170	134	37	2015	2015	NUM
aji-170	134	38	)	)	PUNCT
aji-170	134	39	.	.	PUNCT
aji-170	135	1	spontaneous	spontaneous	ADJ
aji-170	135	2	abortion	abortion	NOUN
aji-170	135	3	,	,	PUNCT
aji-170	135	4	also	also	ADV
aji-170	135	5	known	know	VERB
aji-170	135	6	as	as	ADP
aji-170	135	7	miscarriage	miscarriage	NOUN
aji-170	135	8	,	,	PUNCT
aji-170	135	9	is	be	AUX
aji-170	135	10	the	the	DET
aji-170	135	11	unplanned	unplanned	ADJ
aji-170	135	12	termination	termination	NOUN
aji-170	135	13	of	of	ADP
aji-170	135	14	a	a	DET
aji-170	135	15	pregnancy	pregnancy	NOUN
aji-170	135	16	before	before	SCONJ
aji-170	135	17	the	the	DET
aji-170	135	18	foetus	foetus	NOUN
aji-170	135	19	can	can	AUX
aji-170	135	20	survive	survive	VERB
aji-170	135	21	outside	outside	ADP
aji-170	135	22	the	the	DET
aji-170	135	23	womb	womb	NOUN
aji-170	135	24	,	,	PUNCT
aji-170	135	25	typically	typically	ADV
aji-170	135	26	before	before	ADP
aji-170	135	27	the	the	DET
aji-170	135	28	20th	20th	ADJ
aji-170	135	29	week	week	NOUN
aji-170	135	30	of	of	ADP
aji-170	135	31	gestation	gestation	NOUN
aji-170	135	32	(	(	PUNCT
aji-170	135	33	miller	miller	PROPN
aji-170	135	34	et	et	PROPN
aji-170	135	35	al	al	PROPN
aji-170	135	36	.	.	PROPN
aji-170	135	37	,	,	PUNCT
aji-170	135	38	2020	2020	NUM
aji-170	135	39	)	)	PUNCT
aji-170	135	40	.	.	PUNCT
aji-170	136	1	spontaneous	spontaneous	ADJ
aji-170	136	2	abortion	abortion	NOUN
aji-170	136	3	can	can	AUX
aji-170	136	4	occur	occur	VERB
aji-170	136	5	due	due	ADP
aji-170	136	6	to	to	ADP
aji-170	136	7	various	various	ADJ
aji-170	136	8	reasons	reason	NOUN
aji-170	136	9	,	,	PUNCT
aji-170	136	10	including	include	VERB
aji-170	136	11	chromosomal	chromosomal	ADJ
aji-170	136	12	abnormalities	abnormality	NOUN
aji-170	136	13	,	,	PUNCT
aji-170	136	14	hormonal	hormonal	ADJ
aji-170	136	15	imbalance	imbalance	NOUN
aji-170	136	16	,	,	PUNCT
aji-170	136	17	infections	infection	NOUN
aji-170	136	18	,	,	PUNCT
aji-170	136	19	immune	immune	ADJ
aji-170	136	20	system	system	NOUN
aji-170	136	21	disorders	disorder	NOUN
aji-170	136	22	,	,	PUNCT
aji-170	136	23	uterine	uterine	ADJ
aji-170	136	24	or	or	CCONJ
aji-170	136	25	cervical	cervical	ADJ
aji-170	136	26	abnormalities	abnormality	NOUN
aji-170	136	27	,	,	PUNCT
aji-170	136	28	and	and	CCONJ
aji-170	136	29	advanced	advanced	ADJ
aji-170	136	30	maternal	maternal	ADJ
aji-170	136	31	age	age	NOUN
aji-170	136	32	,	,	PUNCT
aji-170	136	33	among	among	ADP
aji-170	136	34	others	other	NOUN
aji-170	136	35	(	(	PUNCT
aji-170	136	36	miller	miller	PROPN
aji-170	136	37	et	et	PROPN
aji-170	136	38	al	al	PROPN
aji-170	136	39	.	.	PROPN
aji-170	136	40	,	,	PUNCT
aji-170	136	41	2020	2020	NUM
aji-170	136	42	)	)	PUNCT
aji-170	136	43	.	.	PUNCT
aji-170	137	1	spontaneous	spontaneous	ADJ
aji-170	137	2	abortion	abortion	NOUN
aji-170	137	3	,	,	PUNCT
aji-170	137	4	affecting	affect	VERB
aji-170	137	5	close	close	ADV
aji-170	137	6	to	to	PART
aji-170	137	7	30	30	NUM
aji-170	137	8	%	%	NOUN
aji-170	137	9	of	of	ADP
aji-170	137	10	pregnancies	pregnancy	NOUN
aji-170	137	11	,	,	PUNCT
aji-170	137	12	is	be	AUX
aji-170	137	13	a	a	DET
aji-170	137	14	common	common	ADJ
aji-170	137	15	complication	complication	NOUN
aji-170	137	16	,	,	PUNCT
aji-170	137	17	with	with	ADP
aji-170	137	18	recurrent	recurrent	ADJ
aji-170	137	19	pregnancy	pregnancy	NOUN
aji-170	137	20	loss	loss	NOUN
aji-170	137	21	affecting	affect	VERB
aji-170	137	22	1	1	NUM
aji-170	137	23	in	in	ADP
aji-170	137	24	100	100	NUM
aji-170	137	25	women	woman	NOUN
aji-170	137	26	(	(	PUNCT
aji-170	137	27	miller	miller	PROPN
aji-170	137	28	et	et	PROPN
aji-170	137	29	al	al	PROPN
aji-170	137	30	.	.	PROPN
aji-170	137	31	,	,	PUNCT
aji-170	137	32	2020	2020	NUM
aji-170	137	33	)	)	PUNCT
aji-170	137	34	.	.	PUNCT
aji-170	138	1	while	while	SCONJ
aji-170	138	2	chromosomal	chromosomal	ADJ
aji-170	138	3	abnormalities	abnormality	NOUN
aji-170	138	4	and	and	CCONJ
aji-170	138	5	thrombotic	thrombotic	ADJ
aji-170	138	6	complications	complication	NOUN
aji-170	138	7	are	be	AUX
aji-170	138	8	established	establish	VERB
aji-170	138	9	causes	cause	NOUN
aji-170	138	10	,	,	PUNCT
aji-170	138	11	immunologic	immunologic	ADJ
aji-170	138	12	factors	factor	NOUN
aji-170	138	13	,	,	PUNCT
aji-170	138	14	such	such	ADJ
aji-170	138	15	as	as	ADP
aji-170	138	16	t	t	NOUN
aji-170	138	17	-	-	PUNCT
aji-170	138	18	cell	cell	NOUN
aji-170	138	19	exhaustion	exhaustion	NOUN
aji-170	138	20	,	,	PUNCT
aji-170	138	21	have	have	AUX
aji-170	138	22	also	also	ADV
aji-170	138	23	been	be	AUX
aji-170	138	24	implicated	implicate	VERB
aji-170	138	25	(	(	PUNCT
aji-170	138	26	miller	miller	PROPN
aji-170	138	27	et	et	PROPN
aji-170	138	28	al	al	PROPN
aji-170	138	29	.	.	PROPN
aji-170	138	30	,	,	PUNCT
aji-170	138	31	2020	2020	NUM
aji-170	138	32	)	)	PUNCT
aji-170	138	33	.	.	PUNCT
aji-170	139	1	programmed	program	VERB
aji-170	139	2	cell	cell	NOUN
aji-170	139	3	death	death	NOUN
aji-170	139	4	protein	protein	NOUN
aji-170	139	5	1	1	NUM
aji-170	139	6	(	(	PUNCT
aji-170	139	7	pd-1	pd-1	NUM
aji-170	139	8	)	)	PUNCT
aji-170	139	9	,	,	PUNCT
aji-170	139	10	t	t	PROPN
aji-170	139	11	cell	cell	NOUN
aji-170	139	12	immunoglobulin	immunoglobulin	NOUN
aji-170	139	13	and	and	CCONJ
aji-170	139	14	mucin	mucin	NOUN
aji-170	139	15	-	-	PUNCT
aji-170	139	16	domain	domain	NOUN
aji-170	139	17	containing-3	containing-3	NOUN
aji-170	139	18	(	(	PUNCT
aji-170	139	19	tim-3	tim-3	NUM
aji-170	139	20	)	)	PUNCT
aji-170	139	21	,	,	PUNCT
aji-170	139	22	and	and	CCONJ
aji-170	139	23	cytotoxic	cytotoxic	ADJ
aji-170	139	24	t	t	PROPN
aji-170	139	25	-	-	PUNCT
aji-170	139	26	lymphocyte	lymphocyte	NOUN
aji-170	139	27	-	-	PUNCT
aji-170	139	28	associated	associate	VERB
aji-170	139	29	protein	protein	NOUN
aji-170	139	30	4	4	NUM
aji-170	139	31	(	(	PUNCT
aji-170	139	32	ctla-4	ctla-4	X
aji-170	139	33	)	)	PUNCT
aji-170	139	34	are	be	AUX
aji-170	139	35	critical	critical	ADJ
aji-170	139	36	immune	immune	ADJ
aji-170	139	37	checkpoint	checkpoint	NOUN
aji-170	139	38	receptors	receptor	NOUN
aji-170	139	39	(	(	PUNCT
aji-170	139	40	catakovic	catakovic	PROPN
aji-170	139	41	et	et	PROPN
aji-170	139	42	al	al	PROPN
aji-170	139	43	.	.	PROPN
aji-170	139	44	,	,	PUNCT
aji-170	139	45	2017	2017	NUM
aji-170	139	46	)	)	PUNCT
aji-170	139	47	.	.	PUNCT
aji-170	140	1	their	their	PRON
aji-170	140	2	dysregulation	dysregulation	NOUN
aji-170	140	3	can	can	AUX
aji-170	140	4	contribute	contribute	VERB
aji-170	140	5	to	to	ADP
aji-170	140	6	spontaneous	spontaneous	ADJ
aji-170	140	7	abortion	abortion	NOUN
aji-170	140	8	by	by	ADP
aji-170	140	9	disrupting	disrupt	VERB
aji-170	140	10	immune	immune	ADJ
aji-170	140	11	tolerance	tolerance	NOUN
aji-170	140	12	during	during	ADP
aji-170	140	13	pregnancy	pregnancy	NOUN
aji-170	140	14	.	.	PUNCT
aji-170	141	1	these	these	DET
aji-170	141	2	markers	marker	NOUN
aji-170	141	3	maintain	maintain	VERB
aji-170	141	4	a	a	DET
aji-170	141	5	balance	balance	NOUN
aji-170	141	6	of	of	ADP
aji-170	141	7	t	t	PROPN
aji-170	141	8	helper	helper	NOUN
aji-170	141	9	cells	cell	NOUN
aji-170	141	10	(	(	PUNCT
aji-170	141	11	th1	th1	PROPN
aji-170	141	12	/	/	SYM
aji-170	141	13	th2	th2	PROPN
aji-170	141	14	)	)	PUNCT
aji-170	141	15	and	and	CCONJ
aji-170	141	16	regulatory	regulatory	ADJ
aji-170	141	17	t	t	NOUN
aji-170	141	18	cells	cell	NOUN
aji-170	141	19	(	(	PUNCT
aji-170	141	20	tregs	treg	NOUN
aji-170	141	21	)	)	PUNCT
aji-170	141	22	,	,	PUNCT
aji-170	141	23	along	along	ADP
aji-170	141	24	with	with	ADP
aji-170	141	25	their	their	PRON
aji-170	141	26	respective	respective	ADJ
aji-170	141	27	cytokines	cytokine	NOUN
aji-170	141	28	,	,	PUNCT
aji-170	141	29	which	which	PRON
aji-170	141	30	are	be	AUX
aji-170	141	31	essential	essential	ADJ
aji-170	141	32	for	for	ADP
aji-170	141	33	pregnancy	pregnancy	NOUN
aji-170	141	34	success	success	NOUN
aji-170	141	35	(	(	PUNCT
aji-170	141	36	li	li	PROPN
aji-170	141	37	et	et	PROPN
aji-170	141	38	al	al	PROPN
aji-170	141	39	.	.	PROPN
aji-170	141	40	,	,	PUNCT
aji-170	141	41	2017	2017	NUM
aji-170	141	42	)	)	PUNCT
aji-170	141	43	.	.	PUNCT
aji-170	142	1	altered	alter	VERB
aji-170	142	2	expression	expression	NOUN
aji-170	142	3	of	of	ADP
aji-170	142	4	these	these	DET
aji-170	142	5	markers	marker	NOUN
aji-170	142	6	can	can	AUX
aji-170	142	7	lead	lead	VERB
aji-170	142	8	to	to	ADP
aji-170	142	9	t	t	NOUN
aji-170	142	10	-	-	PUNCT
aji-170	142	11	cell	cell	NOUN
aji-170	142	12	exhaustion	exhaustion	NOUN
aji-170	142	13	and	and	CCONJ
aji-170	142	14	recurrent	recurrent	ADJ
aji-170	142	15	miscarriages	miscarriage	NOUN
aji-170	142	16	,	,	PUNCT
aji-170	142	17	underscoring	underscore	VERB
aji-170	142	18	their	their	PRON
aji-170	142	19	importance	importance	NOUN
aji-170	142	20	in	in	ADP
aji-170	142	21	maintaining	maintain	VERB
aji-170	142	22	the	the	DET
aji-170	142	23	delicate	delicate	ADJ
aji-170	142	24	balance	balance	NOUN
aji-170	142	25	of	of	ADP
aji-170	142	26	the	the	DET
aji-170	142	27	maternal	maternal	ADJ
aji-170	142	28	-	-	PUNCT
aji-170	142	29	foetal	foetal	ADJ
aji-170	142	30	immune	immune	ADJ
aji-170	142	31	system	system	NOUN
aji-170	142	32	(	(	PUNCT
aji-170	142	33	li	li	PROPN
aji-170	142	34	et	et	PROPN
aji-170	142	35	al	al	PROPN
aji-170	142	36	.	.	PROPN
aji-170	142	37	,	,	PUNCT
aji-170	142	38	2020	2020	NUM
aji-170	142	39	)	)	PUNCT
aji-170	142	40	.	.	PUNCT
aji-170	143	1	this	this	DET
aji-170	143	2	systematic	systematic	ADJ
aji-170	143	3	review	review	NOUN
aji-170	143	4	synthesised	synthesise	VERB
aji-170	143	5	existing	exist	VERB
aji-170	143	6	literature	literature	NOUN
aji-170	143	7	on	on	ADP
aji-170	143	8	tce	tce	PROPN
aji-170	143	9	in	in	ADP
aji-170	143	10	spontaneous	spontaneous	ADJ
aji-170	143	11	abortion	abortion	NOUN
aji-170	143	12	and	and	CCONJ
aji-170	143	13	pregnancy	pregnancy	NOUN
aji-170	143	14	,	,	PUNCT
aji-170	143	15	exploring	explore	VERB
aji-170	143	16	its	its	PRON
aji-170	143	17	prevalence	prevalence	NOUN
aji-170	143	18	,	,	PUNCT
aji-170	143	19	mechanisms	mechanism	NOUN
aji-170	143	20	,	,	PUNCT
aji-170	143	21	and	and	CCONJ
aji-170	143	22	clinical	clinical	ADJ
aji-170	143	23	implications	implication	NOUN
aji-170	143	24	to	to	PART
aji-170	143	25	identify	identify	VERB
aji-170	143	26	knowledge	knowledge	NOUN
aji-170	143	27	gaps	gap	NOUN
aji-170	143	28	and	and	CCONJ
aji-170	143	29	areas	area	NOUN
aji-170	143	30	for	for	ADP
aji-170	143	31	future	future	ADJ
aji-170	143	32	research	research	NOUN
aji-170	143	33	.	.	PUNCT
aji-170	144	1	2	2	X
aji-170	144	2	.	.	X
aji-170	144	3	methodology	methodology	NOUN
aji-170	144	4	2.1	2.1	NUM
aji-170	144	5	study	study	NOUN
aji-170	144	6	design	design	NOUN
aji-170	144	7	this	this	DET
aji-170	144	8	systematic	systematic	ADJ
aji-170	144	9	review	review	NOUN
aji-170	144	10	spanned	span	VERB
aji-170	144	11	from	from	ADP
aji-170	144	12	january	january	PROPN
aji-170	144	13	2014	2014	NUM
aji-170	144	14	to	to	ADP
aji-170	144	15	march	march	PROPN
aji-170	144	16	2024	2024	NUM
aji-170	144	17	,	,	PUNCT
aji-170	144	18	adhering	adhere	VERB
aji-170	144	19	to	to	ADP
aji-170	144	20	the	the	DET
aji-170	144	21	prisma	prisma	PROPN
aji-170	144	22	walana	walana	PROPN
aji-170	144	23	et	et	PROPN
aji-170	144	24	al	al	PROPN
aji-170	144	25	.	.	PROPN
aji-170	144	26	;	;	PUNCT
aji-170	144	27	asian	asian	PROPN
aji-170	144	28	j.	j.	PROPN
aji-170	144	29	immunol	immunol	PROPN
aji-170	144	30	.	.	PROPN
aji-170	144	31	,	,	PUNCT
aji-170	144	32	vol	vol	NOUN
aji-170	144	33	.	.	PROPN
aji-170	144	34	8	8	NUM
aji-170	144	35	,	,	PUNCT
aji-170	144	36	no	no	INTJ
aji-170	144	37	.	.	NOUN
aji-170	144	38	1	1	NUM
aji-170	144	39	,	,	PUNCT
aji-170	144	40	pp	pp	ADJ
aji-170	144	41	.	.	PUNCT
aji-170	145	1	179	179	NUM
aji-170	145	2	-	-	SYM
aji-170	145	3	189	189	NUM
aji-170	145	4	,	,	PUNCT
aji-170	145	5	2025	2025	NUM
aji-170	145	6	;	;	PUNCT
aji-170	145	7	article	article	NOUN
aji-170	145	8	no.aji.139815	no.aji.139815	VERB
aji-170	145	9	181	181	NUM
aji-170	145	10	2020	2020	NUM
aji-170	145	11	guidelines	guideline	NOUN
aji-170	145	12	for	for	ADP
aji-170	145	13	a	a	DET
aji-170	145	14	comprehensive	comprehensive	ADJ
aji-170	145	15	and	and	CCONJ
aji-170	145	16	transparent	transparent	ADJ
aji-170	145	17	approach	approach	NOUN
aji-170	145	18	.	.	PUNCT
aji-170	146	1	the	the	DET
aji-170	146	2	research	research	NOUN
aji-170	146	3	process	process	NOUN
aji-170	146	4	involved	involve	VERB
aji-170	146	5	a	a	DET
aji-170	146	6	structured	structured	ADJ
aji-170	146	7	identification	identification	NOUN
aji-170	146	8	,	,	PUNCT
aji-170	146	9	screening	screening	NOUN
aji-170	146	10	,	,	PUNCT
aji-170	146	11	eligibility	eligibility	NOUN
aji-170	146	12	,	,	PUNCT
aji-170	146	13	and	and	CCONJ
aji-170	146	14	inclusion	inclusion	NOUN
aji-170	146	15	framework	framework	NOUN
aji-170	146	16	conducted	conduct	VERB
aji-170	146	17	independently	independently	ADV
aji-170	146	18	to	to	PART
aji-170	146	19	minimise	minimise	VERB
aji-170	146	20	errors	error	NOUN
aji-170	146	21	and	and	CCONJ
aji-170	146	22	bias	bias	NOUN
aji-170	146	23	.	.	PUNCT
aji-170	147	1	studies	study	NOUN
aji-170	147	2	were	be	AUX
aji-170	147	3	selected	select	VERB
aji-170	147	4	based	base	VERB
aji-170	147	5	on	on	ADP
aji-170	147	6	their	their	PRON
aji-170	147	7	relevance	relevance	NOUN
aji-170	147	8	to	to	ADP
aji-170	147	9	understanding	understand	VERB
aji-170	147	10	t	t	NOUN
aji-170	147	11	cell	cell	NOUN
aji-170	147	12	exhaustion	exhaustion	NOUN
aji-170	147	13	in	in	ADP
aji-170	147	14	pregnancy	pregnancy	NOUN
aji-170	147	15	,	,	PUNCT
aji-170	147	16	with	with	ADP
aji-170	147	17	a	a	DET
aji-170	147	18	focus	focus	NOUN
aji-170	147	19	on	on	ADP
aji-170	147	20	peer	peer	NOUN
aji-170	147	21	-	-	PUNCT
aji-170	147	22	reviewed	review	VERB
aji-170	147	23	journals	journal	NOUN
aji-170	147	24	.	.	PUNCT
aji-170	148	1	data	datum	NOUN
aji-170	148	2	extraction	extraction	NOUN
aji-170	148	3	encompassed	encompass	VERB
aji-170	148	4	t	t	NOUN
aji-170	148	5	cell	cell	NOUN
aji-170	148	6	functionality	functionality	NOUN
aji-170	148	7	,	,	PUNCT
aji-170	148	8	inhibitory	inhibitory	ADJ
aji-170	148	9	receptor	receptor	NOUN
aji-170	148	10	expression	expression	NOUN
aji-170	148	11	,	,	PUNCT
aji-170	148	12	cytokine	cytokine	ADJ
aji-170	148	13	profiles	profile	NOUN
aji-170	148	14	,	,	PUNCT
aji-170	148	15	and	and	CCONJ
aji-170	148	16	outcomes	outcome	NOUN
aji-170	148	17	related	relate	VERB
aji-170	148	18	to	to	ADP
aji-170	148	19	spontaneous	spontaneous	ADJ
aji-170	148	20	abortion	abortion	NOUN
aji-170	148	21	.	.	PUNCT
aji-170	149	1	furthermore	furthermore	ADV
aji-170	149	2	,	,	PUNCT
aji-170	149	3	a	a	DET
aji-170	149	4	comprehensive	comprehensive	ADJ
aji-170	149	5	review	review	NOUN
aji-170	149	6	of	of	ADP
aji-170	149	7	animal	animal	NOUN
aji-170	149	8	models	model	NOUN
aji-170	149	9	and	and	CCONJ
aji-170	149	10	clinical	clinical	ADJ
aji-170	149	11	studies	study	NOUN
aji-170	149	12	was	be	AUX
aji-170	149	13	conducted	conduct	VERB
aji-170	149	14	to	to	PART
aji-170	149	15	gain	gain	VERB
aji-170	149	16	a	a	DET
aji-170	149	17	deeper	deep	ADJ
aji-170	149	18	insight	insight	NOUN
aji-170	149	19	into	into	ADP
aji-170	149	20	the	the	DET
aji-170	149	21	role	role	NOUN
aji-170	149	22	of	of	ADP
aji-170	149	23	t	t	NOUN
aji-170	149	24	cell	cell	NOUN
aji-170	149	25	exhaustion	exhaustion	NOUN
aji-170	149	26	in	in	ADP
aji-170	149	27	spontaneous	spontaneous	ADJ
aji-170	149	28	abortion	abortion	NOUN
aji-170	149	29	and	and	CCONJ
aji-170	149	30	pregnancy	pregnancy	NOUN
aji-170	149	31	complications	complication	NOUN
aji-170	149	32	,	,	PUNCT
aji-170	149	33	providing	provide	VERB
aji-170	149	34	a	a	DET
aji-170	149	35	more	more	ADV
aji-170	149	36	complete	complete	ADJ
aji-170	149	37	understanding	understanding	NOUN
aji-170	149	38	of	of	ADP
aji-170	149	39	this	this	DET
aji-170	149	40	complex	complex	ADJ
aji-170	149	41	phenomenon	phenomenon	NOUN
aji-170	149	42	.	.	PUNCT
aji-170	150	1	2.2	2.2	NUM
aji-170	150	2	search	search	NOUN
aji-170	150	3	strategy	strategy	NOUN
aji-170	150	4	a	a	DET
aji-170	150	5	systematic	systematic	ADJ
aji-170	150	6	literature	literature	NOUN
aji-170	150	7	search	search	NOUN
aji-170	150	8	was	be	AUX
aji-170	150	9	conducted	conduct	VERB
aji-170	150	10	,	,	PUNCT
aji-170	150	11	encompassing	encompass	VERB
aji-170	150	12	a	a	DET
aji-170	150	13	range	range	NOUN
aji-170	150	14	of	of	ADP
aji-170	150	15	databases	database	NOUN
aji-170	150	16	,	,	PUNCT
aji-170	150	17	including	include	VERB
aji-170	150	18	scopus	scopus	NOUN
aji-170	150	19	,	,	PUNCT
aji-170	150	20	google	google	PROPN
aji-170	150	21	scholar	scholar	NOUN
aji-170	150	22	,	,	PUNCT
aji-170	150	23	pubmed	pubmed	PROPN
aji-170	150	24	,	,	PUNCT
aji-170	150	25	and	and	CCONJ
aji-170	150	26	web	web	NOUN
aji-170	150	27	of	of	ADP
aji-170	150	28	science	science	NOUN
aji-170	150	29	,	,	PUNCT
aji-170	150	30	to	to	PART
aji-170	150	31	identify	identify	VERB
aji-170	150	32	and	and	CCONJ
aji-170	150	33	synthesise	synthesise	VERB
aji-170	150	34	the	the	DET
aji-170	150	35	findings	finding	NOUN
aji-170	150	36	of	of	ADP
aji-170	150	37	previous	previous	ADJ
aji-170	150	38	studies	study	NOUN
aji-170	150	39	.	.	PUNCT
aji-170	151	1	applicable	applicable	ADJ
aji-170	151	2	keywords	keyword	NOUN
aji-170	151	3	,	,	PUNCT
aji-170	151	4	utilising	utilise	VERB
aji-170	151	5	medical	medical	ADJ
aji-170	151	6	subject	subject	NOUN
aji-170	151	7	headings	heading	NOUN
aji-170	151	8	(	(	PUNCT
aji-170	151	9	mesh	mesh	NOUN
aji-170	151	10	)	)	PUNCT
aji-170	151	11	for	for	ADP
aji-170	151	12	pubmed	pubmed	PROPN
aji-170	151	13	,	,	PUNCT
aji-170	151	14	were	be	AUX
aji-170	151	15	combined	combine	VERB
aji-170	151	16	using	use	VERB
aji-170	151	17	logical	logical	ADJ
aji-170	151	18	operators	operator	NOUN
aji-170	151	19	to	to	PART
aji-170	151	20	develop	develop	VERB
aji-170	151	21	a	a	DET
aji-170	151	22	comprehensive	comprehensive	ADJ
aji-170	151	23	search	search	NOUN
aji-170	151	24	strategy	strategy	NOUN
aji-170	151	25	.	.	PUNCT
aji-170	152	1	a	a	DET
aji-170	152	2	combination	combination	NOUN
aji-170	152	3	of	of	ADP
aji-170	152	4	keywords	keyword	NOUN
aji-170	152	5	from	from	ADP
aji-170	152	6	the	the	DET
aji-170	152	7	title	title	NOUN
aji-170	152	8	was	be	AUX
aji-170	152	9	used	use	VERB
aji-170	152	10	to	to	PART
aji-170	152	11	construct	construct	VERB
aji-170	152	12	boolean	boolean	ADJ
aji-170	152	13	search	search	NOUN
aji-170	152	14	strings	string	NOUN
aji-170	152	15	(	(	PUNCT
aji-170	152	16	“	"	PUNCT
aji-170	152	17	t	t	NOUN
aji-170	152	18	cell	cell	NOUN
aji-170	152	19	exhaustion	exhaustion	NOUN
aji-170	152	20	”	"	PUNCT
aji-170	152	21	)	)	PUNCT
aji-170	152	22	or	or	CCONJ
aji-170	152	23	(	(	PUNCT
aji-170	152	24	“	"	PUNCT
aji-170	152	25	immune	immune	ADJ
aji-170	152	26	exhaustion	exhaustion	NOUN
aji-170	152	27	”	"	PUNCT
aji-170	152	28	)	)	PUNCT
aji-170	152	29	and	and	CCONJ
aji-170	152	30	(	(	PUNCT
aji-170	152	31	“	"	PUNCT
aji-170	152	32	spontaneous	spontaneous	ADJ
aji-170	152	33	abortion	abortion	NOUN
aji-170	152	34	”	"	PUNCT
aji-170	152	35	)	)	PUNCT
aji-170	152	36	or	or	CCONJ
aji-170	152	37	(	(	PUNCT
aji-170	152	38	“	"	PUNCT
aji-170	152	39	miscarriage	miscarriage	NOUN
aji-170	152	40	”	"	PUNCT
aji-170	152	41	)	)	PUNCT
aji-170	152	42	and	and	CCONJ
aji-170	152	43	(	(	PUNCT
aji-170	152	44	“	"	PUNCT
aji-170	152	45	pregnancy	pregnancy	NOUN
aji-170	152	46	”	"	PUNCT
aji-170	152	47	)	)	PUNCT
aji-170	152	48	in	in	ADP
aji-170	152	49	order	order	NOUN
aji-170	152	50	to	to	PART
aji-170	152	51	search	search	VERB
aji-170	152	52	and	and	CCONJ
aji-170	152	53	identify	identify	VERB
aji-170	152	54	relevant	relevant	ADJ
aji-170	152	55	studies	study	NOUN
aji-170	152	56	.	.	PUNCT
aji-170	153	1	this	this	DET
aji-170	153	2	methodology	methodology	NOUN
aji-170	153	3	ensured	ensure	VERB
aji-170	153	4	a	a	DET
aji-170	153	5	rigorous	rigorous	ADJ
aji-170	153	6	and	and	CCONJ
aji-170	153	7	systematic	systematic	ADJ
aji-170	153	8	approach	approach	NOUN
aji-170	153	9	to	to	ADP
aji-170	153	10	understanding	understand	VERB
aji-170	153	11	t	t	NOUN
aji-170	153	12	cell	cell	NOUN
aji-170	153	13	exhaustion	exhaustion	NOUN
aji-170	153	14	in	in	ADP
aji-170	153	15	the	the	DET
aji-170	153	16	context	context	NOUN
aji-170	153	17	of	of	ADP
aji-170	153	18	spontaneous	spontaneous	ADJ
aji-170	153	19	abortion	abortion	NOUN
aji-170	153	20	and	and	CCONJ
aji-170	153	21	pregnancy	pregnancy	NOUN
aji-170	153	22	.	.	PUNCT
aji-170	154	1	2.3	2.3	NUM
aji-170	154	2	inclusion	inclusion	NOUN
aji-170	154	3	criteria	criterion	NOUN
aji-170	154	4	available	available	ADJ
aji-170	154	5	studies	study	NOUN
aji-170	154	6	and	and	CCONJ
aji-170	154	7	data	datum	NOUN
aji-170	154	8	were	be	AUX
aji-170	154	9	included	include	VERB
aji-170	154	10	based	base	VERB
aji-170	154	11	on	on	ADP
aji-170	154	12	the	the	DET
aji-170	154	13	following	following	ADJ
aji-170	154	14	predefined	predefine	VERB
aji-170	154	15	criteria	criterion	NOUN
aji-170	154	16	:	:	PUNCT
aji-170	154	17	(	(	PUNCT
aji-170	154	18	1	1	X
aji-170	154	19	)	)	PUNCT
aji-170	154	20	original	original	ADJ
aji-170	154	21	research	research	NOUN
aji-170	154	22	papers	paper	NOUN
aji-170	154	23	published	publish	VERB
aji-170	154	24	between	between	ADP
aji-170	154	25	january	january	PROPN
aji-170	154	26	2014	2014	NUM
aji-170	154	27	and	and	CCONJ
aji-170	154	28	march	march	PROPN
aji-170	154	29	2024	2024	NUM
aji-170	154	30	,	,	PUNCT
aji-170	154	31	(	(	PUNCT
aji-170	154	32	2	2	X
aji-170	154	33	)	)	PUNCT
aji-170	154	34	experimental	experimental	ADJ
aji-170	154	35	and	and	CCONJ
aji-170	154	36	observational	observational	ADJ
aji-170	154	37	studies	study	NOUN
aji-170	154	38	,	,	PUNCT
aji-170	154	39	(	(	PUNCT
aji-170	154	40	3	3	X
aji-170	154	41	)	)	PUNCT
aji-170	154	42	availability	availability	NOUN
aji-170	154	43	of	of	ADP
aji-170	154	44	full	full	ADJ
aji-170	154	45	text	text	NOUN
aji-170	154	46	,	,	PUNCT
aji-170	154	47	and	and	CCONJ
aji-170	154	48	(	(	PUNCT
aji-170	154	49	4	4	X
aji-170	154	50	)	)	PUNCT
aji-170	154	51	articles	article	NOUN
aji-170	154	52	written	write	VERB
aji-170	154	53	and	and	CCONJ
aji-170	154	54	published	publish	VERB
aji-170	154	55	in	in	ADP
aji-170	154	56	english	english	PROPN
aji-170	154	57	.	.	PUNCT
aji-170	155	1	fig	fig	NOUN
aji-170	155	2	.	.	PUNCT
aji-170	156	1	1	1	X
aji-170	156	2	.	.	X
aji-170	156	3	schematic	schematic	ADJ
aji-170	156	4	flow	flow	NOUN
aji-170	156	5	diagram	diagram	NOUN
aji-170	156	6	of	of	ADP
aji-170	156	7	the	the	DET
aji-170	156	8	study	study	NOUN
aji-170	156	9	retrieval	retrieval	NOUN
aji-170	156	10	process	process	NOUN
aji-170	156	11	walana	walana	PROPN
aji-170	156	12	et	et	PROPN
aji-170	156	13	al	al	PROPN
aji-170	156	14	.	.	PROPN
aji-170	156	15	;	;	PUNCT
aji-170	156	16	asian	asian	PROPN
aji-170	156	17	j.	j.	PROPN
aji-170	156	18	immunol	immunol	PROPN
aji-170	156	19	.	.	PROPN
aji-170	156	20	,	,	PUNCT
aji-170	156	21	vol	vol	NOUN
aji-170	156	22	.	.	PROPN
aji-170	156	23	8	8	NUM
aji-170	156	24	,	,	PUNCT
aji-170	156	25	no	no	INTJ
aji-170	156	26	.	.	NOUN
aji-170	156	27	1	1	NUM
aji-170	156	28	,	,	PUNCT
aji-170	156	29	pp	pp	ADJ
aji-170	156	30	.	.	PUNCT
aji-170	157	1	179	179	NUM
aji-170	157	2	-	-	SYM
aji-170	157	3	189	189	NUM
aji-170	157	4	,	,	PUNCT
aji-170	157	5	2025	2025	NUM
aji-170	157	6	;	;	PUNCT
aji-170	157	7	article	article	NOUN
aji-170	157	8	no.aji.139815	no.aji.139815	VERB
aji-170	157	9	182	182	NUM
aji-170	157	10	table	table	NOUN
aji-170	157	11	1	1	NUM
aji-170	157	12	.	.	PUNCT
aji-170	158	1	summary	summary	NOUN
aji-170	158	2	of	of	ADP
aji-170	158	3	included	include	VERB
aji-170	158	4	articles	article	NOUN
aji-170	158	5	.	.	PUNCT
aji-170	159	1	rsa	rsa	PROPN
aji-170	159	2	:	:	PUNCT
aji-170	159	3	recurrent	recurrent	VERB
aji-170	159	4	spontaneous	spontaneous	ADJ
aji-170	159	5	abortion	abortion	NOUN
aji-170	159	6	:	:	PUNCT
aji-170	159	7	rsa	rsa	PROPN
aji-170	159	8	is	be	AUX
aji-170	159	9	defined	define	VERB
aji-170	159	10	as	as	ADP
aji-170	159	11	three	three	NUM
aji-170	159	12	or	or	CCONJ
aji-170	159	13	more	more	ADV
aji-170	159	14	consecutive	consecutive	ADJ
aji-170	159	15	spontaneous	spontaneous	ADJ
aji-170	159	16	miscarriages	miscarriage	NOUN
aji-170	159	17	before	before	ADP
aji-170	159	18	the	the	DET
aji-170	159	19	22nd	22nd	ADJ
aji-170	159	20	week	week	NOUN
aji-170	159	21	of	of	ADP
aji-170	159	22	gestation	gestation	NOUN
aji-170	159	23	;	;	PUNCT
aji-170	159	24	wrsa	wrsa	NOUN
aji-170	159	25	:	:	PUNCT
aji-170	159	26	women	woman	NOUN
aji-170	159	27	with	with	ADP
aji-170	159	28	rsa	rsa	PROPN
aji-170	159	29	;	;	PUNCT
aji-170	159	30	ipl	ipl	PROPN
aji-170	159	31	:	:	PUNCT
aji-170	159	32	induced	induce	VERB
aji-170	159	33	pregnancy	pregnancy	NOUN
aji-170	159	34	loss	loss	NOUN
aji-170	159	35	;	;	PUNCT
aji-170	159	36	hc	hc	X
aji-170	159	37	-	-	PUNCT
aji-170	159	38	p	p	NOUN
aji-170	159	39	:	:	PUNCT
aji-170	159	40	healthy	healthy	ADJ
aji-170	159	41	control	control	NOUN
aji-170	159	42	pregnant	pregnant	ADJ
aji-170	159	43	;	;	PUNCT
aji-170	159	44	hc	hc	PROPN
aji-170	159	45	-	-	PUNCT
aji-170	159	46	np	np	NOUN
aji-170	159	47	:	:	PUNCT
aji-170	159	48	healthy	healthy	ADJ
aji-170	159	49	control	control	PROPN
aji-170	159	50	non	non	ADJ
aji-170	159	51	-	-	ADJ
aji-170	159	52	pregnant	pregnant	ADJ
aji-170	159	53	;	;	PUNCT
aji-170	159	54	decidual	decidual	ADJ
aji-170	159	55	macrophagesmφs	macrophagesmφs	NOUN
aji-170	159	56	;	;	PUNCT
aji-170	159	57	nk	nk	PROPN
aji-170	159	58	-	-	PUNCT
aji-170	159	59	cells	cell	NOUN
aji-170	159	60	:	:	PUNCT
aji-170	159	61	natural	natural	ADJ
aji-170	159	62	killer	killer	NOUN
aji-170	159	63	cells	cell	NOUN
aji-170	159	64	authors	author	NOUN
aji-170	159	65	;	;	PUNCT
aji-170	159	66	year	year	NOUN
aji-170	159	67	population	population	NOUN
aji-170	159	68	characteristics	characteristic	VERB
aji-170	159	69	t	t	PROPN
aji-170	159	70	-	-	PUNCT
aji-170	159	71	cells	cell	NOUN
aji-170	159	72	&	&	CCONJ
aji-170	159	73	exhaustion	exhaustion	NOUN
aji-170	159	74	markers	marker	NOUN
aji-170	159	75	practical	practical	ADJ
aji-170	159	76	implications	implication	NOUN
aji-170	159	77	observational	observational	ADJ
aji-170	159	78	(	(	PUNCT
aji-170	159	79	zych	zych	NOUN
aji-170	159	80	et	et	NOUN
aji-170	159	81	al	al	PROPN
aji-170	159	82	.	.	PROPN
aji-170	159	83	,	,	PUNCT
aji-170	159	84	2024	2024	NUM
aji-170	159	85	)	)	PUNCT
aji-170	159	86	n	n	NOUN
aji-170	159	87	=	=	SYM
aji-170	159	88	50	50	NUM
aji-170	159	89	;	;	PUNCT
aji-170	159	90	20	20	NUM
aji-170	159	91	=	=	SYM
aji-170	159	92	wrsa	wrsa	NOUN
aji-170	159	93	,	,	PUNCT
aji-170	159	94	20	20	NUM
aji-170	159	95	=	=	SYM
aji-170	159	96	hc	hc	PROPN
aji-170	159	97	-	-	PUNCT
aji-170	159	98	p	p	NOUN
aji-170	159	99	,	,	PUNCT
aji-170	159	100	and	and	CCONJ
aji-170	159	101	10	10	NUM
aji-170	159	102	=	=	NOUN
aji-170	159	103	hc	hc	PROPN
aji-170	159	104	-	-	PUNCT
aji-170	159	105	np	np	PROPN
aji-170	159	106	rsa	rsa	PROPN
aji-170	159	107	women	woman	NOUN
aji-170	159	108	exhibit	exhibit	VERB
aji-170	159	109	decreased	decrease	VERB
aji-170	159	110	expression	expression	NOUN
aji-170	159	111	of	of	ADP
aji-170	159	112	pd-1	pd-1	ADJ
aji-170	159	113	and	and	CCONJ
aji-170	159	114	lag-3	lag-3	PUNCT
aji-170	159	115	on	on	ADP
aji-170	159	116	various	various	ADJ
aji-170	159	117	t	t	NOUN
aji-170	159	118	cells	cell	NOUN
aji-170	159	119	and	and	CCONJ
aji-170	159	120	increased	increase	VERB
aji-170	159	121	expression	expression	NOUN
aji-170	159	122	of	of	ADP
aji-170	159	123	tigit	tigit	NOUN
aji-170	159	124	on	on	ADP
aji-170	159	125	nkt	nkt	NOUN
aji-170	159	126	cells	cell	NOUN
aji-170	159	127	.	.	PUNCT
aji-170	160	1	•	•	NUM
aji-170	160	2	the	the	DET
aji-170	160	3	decreased	decrease	VERB
aji-170	160	4	expression	expression	NOUN
aji-170	160	5	of	of	ADP
aji-170	160	6	pd-1	pd-1	ADJ
aji-170	160	7	and	and	CCONJ
aji-170	160	8	lag-3	lag-3	PUNCT
aji-170	160	9	may	may	AUX
aji-170	160	10	contribute	contribute	VERB
aji-170	160	11	to	to	ADP
aji-170	160	12	an	an	DET
aji-170	160	13	enhanced	enhanced	ADJ
aji-170	160	14	inflammatory	inflammatory	ADJ
aji-170	160	15	response	response	NOUN
aji-170	160	16	.	.	PUNCT
aji-170	161	1	•	•	NUM
aji-170	161	2	in	in	ADP
aji-170	161	3	women	woman	NOUN
aji-170	161	4	with	with	ADP
aji-170	161	5	rsa	rsa	PROPN
aji-170	161	6	,	,	PUNCT
aji-170	161	7	elevated	elevated	ADJ
aji-170	161	8	tigit	tigit	NOUN
aji-170	161	9	expression	expression	NOUN
aji-170	161	10	on	on	ADP
aji-170	161	11	nkt	nkt	NOUN
aji-170	161	12	cells	cell	NOUN
aji-170	161	13	compensates	compensate	VERB
aji-170	161	14	for	for	ADP
aji-170	161	15	reduced	reduce	VERB
aji-170	161	16	pd-1	pd-1	ADP
aji-170	161	17	and	and	CCONJ
aji-170	161	18	lag-3	lag-3	PUNCT
aji-170	161	19	expression	expression	NOUN
aji-170	161	20	.	.	PUNCT
aji-170	162	1	(	(	PUNCT
aji-170	162	2	zargar	zargar	NOUN
aji-170	162	3	et	et	NOUN
aji-170	162	4	al	al	PROPN
aji-170	162	5	.	.	PROPN
aji-170	162	6	,2024	,2024	PUNCT
aji-170	162	7	)	)	PUNCT
aji-170	163	1	n	n	NOUN
aji-170	163	2	=	=	SYM
aji-170	163	3	57	57	NUM
aji-170	163	4	;	;	PUNCT
aji-170	163	5	22	22	NUM
aji-170	163	6	=	=	SYM
aji-170	163	7	wrsa	wrsa	NOUN
aji-170	163	8	,	,	PUNCT
aji-170	163	9	18	18	NUM
aji-170	163	10	=	=	NOUN
aji-170	163	11	recurrent	recurrent	ADJ
aji-170	163	12	implantation	implantation	NOUN
aji-170	163	13	failure	failure	NOUN
aji-170	163	14	,	,	PUNCT
aji-170	163	15	and	and	CCONJ
aji-170	163	16	17	17	NUM
aji-170	163	17	=	=	SYM
aji-170	163	18	hc	hc	PROPN
aji-170	163	19	-	-	PUNCT
aji-170	163	20	p	p	NOUN
aji-170	163	21	the	the	DET
aji-170	163	22	mean	mean	ADJ
aji-170	163	23	numbers	number	NOUN
aji-170	163	24	of	of	ADP
aji-170	163	25	nk	nk	PROPN
aji-170	163	26	cells	cell	NOUN
aji-170	163	27	(	(	PUNCT
aji-170	163	28	cd16	cd16	PROPN
aji-170	163	29	+	+	NOUN
aji-170	163	30	and	and	CCONJ
aji-170	163	31	cd56	cd56	PROPN
aji-170	163	32	+	+	PROPN
aji-170	163	33	)	)	PUNCT
aji-170	163	34	and	and	CCONJ
aji-170	163	35	ifn	ifn	PROPN
aji-170	163	36	-	-	PUNCT
aji-170	163	37	γ	γ	NOUN
aji-170	163	38	levels	level	NOUN
aji-170	163	39	were	be	AUX
aji-170	163	40	significantly	significantly	ADV
aji-170	163	41	higher	high	ADJ
aji-170	163	42	in	in	ADP
aji-170	163	43	the	the	DET
aji-170	163	44	rsa	rsa	PROPN
aji-170	163	45	•	•	ADP
aji-170	163	46	a	a	DET
aji-170	163	47	significant	significant	ADJ
aji-170	163	48	correlation	correlation	NOUN
aji-170	163	49	was	be	AUX
aji-170	163	50	found	find	VERB
aji-170	163	51	between	between	ADP
aji-170	163	52	the	the	DET
aji-170	163	53	levels	level	NOUN
aji-170	163	54	of	of	ADP
aji-170	163	55	ifn	ifn	PROPN
aji-170	163	56	-	-	PUNCT
aji-170	163	57	γ	γ	X
aji-170	163	58	and	and	CCONJ
aji-170	163	59	nk	nk	PROPN
aji-170	163	60	cells	cell	NOUN
aji-170	163	61	in	in	ADP
aji-170	163	62	the	the	DET
aji-170	163	63	rpl	rpl	NOUN
aji-170	163	64	group	group	NOUN
aji-170	163	65	,	,	PUNCT
aji-170	163	66	indicating	indicate	VERB
aji-170	163	67	that	that	SCONJ
aji-170	163	68	immune	immune	ADJ
aji-170	163	69	dysfunction	dysfunction	NOUN
aji-170	163	70	and	and	CCONJ
aji-170	163	71	ifn	ifn	NOUN
aji-170	163	72	-	-	PUNCT
aji-170	163	73	related	relate	VERB
aji-170	163	74	cytotoxicity	cytotoxicity	NOUN
aji-170	163	75	may	may	AUX
aji-170	163	76	contribute	contribute	VERB
aji-170	163	77	to	to	ADP
aji-170	163	78	pregnancy	pregnancy	NOUN
aji-170	163	79	loss	loss	NOUN
aji-170	163	80	.	.	PUNCT
aji-170	164	1	(	(	PUNCT
aji-170	164	2	zhang	zhang	PROPN
aji-170	164	3	et	et	PROPN
aji-170	164	4	al	al	AUX
aji-170	164	5	.	.	PROPN
aji-170	164	6	,	,	PUNCT
aji-170	164	7	2022	2022	NUM
aji-170	164	8	)	)	PUNCT
aji-170	164	9	n=98	n=98	PROPN
aji-170	164	10	,	,	PUNCT
aji-170	164	11	17	17	NUM
aji-170	164	12	=	=	SYM
aji-170	164	13	wrsa	wrsa	NOUN
aji-170	164	14	,	,	PUNCT
aji-170	164	15	81	81	NUM
aji-170	164	16	hc	hc	PROPN
aji-170	164	17	-	-	PUNCT
aji-170	164	18	p	p	NOUN
aji-170	164	19	decreased	decrease	VERB
aji-170	164	20	levels	level	NOUN
aji-170	164	21	of	of	ADP
aji-170	164	22	tim-3	tim-3	VERB
aji-170	164	23	+	+	NUM
aji-170	164	24	peripheral	peripheral	ADJ
aji-170	164	25	nk	nk	NOUN
aji-170	164	26	-	-	PUNCT
aji-170	164	27	cells	cell	NOUN
aji-170	164	28	and	and	CCONJ
aji-170	164	29	pd-1	pd-1	ADV
aji-170	164	30	in	in	ADP
aji-170	164	31	women	woman	NOUN
aji-170	164	32	with	with	ADP
aji-170	164	33	miscarriage	miscarriage	NOUN
aji-170	164	34	•	•	ADP
aji-170	164	35	lower	low	ADJ
aji-170	164	36	tim-3	tim-3	PUNCT
aji-170	164	37	levels	level	NOUN
aji-170	164	38	in	in	ADP
aji-170	164	39	wrsa	wrsa	ADJ
aji-170	164	40	cases	case	NOUN
aji-170	164	41	may	may	AUX
aji-170	164	42	indicate	indicate	VERB
aji-170	164	43	poor	poor	ADJ
aji-170	164	44	immune	immune	ADJ
aji-170	164	45	adaptation	adaptation	NOUN
aji-170	164	46	to	to	ADP
aji-170	164	47	pregnancy	pregnancy	NOUN
aji-170	164	48	,	,	PUNCT
aji-170	164	49	suggesting	suggest	VERB
aji-170	164	50	tim-3	tim-3	VERB
aji-170	164	51	could	could	AUX
aji-170	164	52	be	be	AUX
aji-170	164	53	a	a	DET
aji-170	164	54	marker	marker	NOUN
aji-170	164	55	for	for	ADP
aji-170	164	56	predicting	predict	VERB
aji-170	164	57	miscarriage	miscarriage	NOUN
aji-170	164	58	risk	risk	NOUN
aji-170	164	59	.	.	PUNCT
aji-170	165	1	(	(	PUNCT
aji-170	165	2	talukdar	talukdar	NOUN
aji-170	165	3	et	et	PROPN
aji-170	165	4	al	al	PROPN
aji-170	165	5	.	.	PROPN
aji-170	165	6	,	,	PUNCT
aji-170	165	7	2018	2018	NUM
aji-170	165	8	)	)	PUNCT
aji-170	166	1	n	n	NOUN
aji-170	166	2	=	=	SYM
aji-170	166	3	43	43	NUM
aji-170	166	4	;	;	PUNCT
aji-170	166	5	26	26	NUM
aji-170	166	6	women	woman	NOUN
aji-170	166	7	with	with	ADP
aji-170	166	8	idiopathic	idiopathic	ADJ
aji-170	166	9	recurrent	recurrent	ADJ
aji-170	166	10	pregnancy	pregnancy	NOUN
aji-170	166	11	loss	loss	NOUN
aji-170	166	12	(	(	PUNCT
aji-170	166	13	rpl	rpl	NOUN
aji-170	166	14	)	)	PUNCT
aji-170	166	15	and	and	CCONJ
aji-170	166	16	17	17	NUM
aji-170	166	17	healthy	healthy	ADJ
aji-170	166	18	fertile	fertile	ADJ
aji-170	166	19	controls	control	NOUN
aji-170	166	20	significantly	significantly	ADV
aji-170	166	21	elevated	elevated	ADJ
aji-170	166	22	frequencies	frequency	NOUN
aji-170	166	23	of	of	ADP
aji-170	166	24	γδ	γδ	ADP
aji-170	166	25	t	t	PROPN
aji-170	166	26	cells	cell	NOUN
aji-170	166	27	correspond	correspond	VERB
aji-170	166	28	to	to	ADP
aji-170	166	29	elevated	elevate	VERB
aji-170	166	30	ifn	ifn	PROPN
aji-170	166	31	-	-	PUNCT
aji-170	166	32	γ	γ	X
aji-170	166	33	and	and	CCONJ
aji-170	166	34	tnf	tnf	PROPN
aji-170	166	35	-	-	PUNCT
aji-170	166	36	α	α	PROPN
aji-170	166	37	,	,	PUNCT
aji-170	166	38	but	but	CCONJ
aji-170	166	39	decreased	decrease	VERB
aji-170	166	40	il-10	il-10	PRON
aji-170	166	41	,	,	PUNCT
aji-170	166	42	in	in	ADP
aji-170	166	43	rpls	rpls	NOUN
aji-170	166	44	.	.	PUNCT
aji-170	167	1	•	•	NOUN
aji-170	167	2	these	these	DET
aji-170	167	3	findings	finding	NOUN
aji-170	167	4	suggest	suggest	VERB
aji-170	167	5	a	a	DET
aji-170	167	6	shift	shift	NOUN
aji-170	167	7	in	in	ADP
aji-170	167	8	γδ	γδ	ADP
aji-170	167	9	t	t	PROPN
aji-170	167	10	cell	cell	NOUN
aji-170	167	11	cytokine	cytokine	NOUN
aji-170	167	12	profile	profile	NOUN
aji-170	167	13	toward	toward	ADP
aji-170	167	14	a	a	DET
aji-170	167	15	pro	pro	ADJ
aji-170	167	16	-	-	ADJ
aji-170	167	17	inflammatory	inflammatory	ADJ
aji-170	167	18	phenotype	phenotype	NOUN
aji-170	167	19	,	,	PUNCT
aji-170	167	20	which	which	PRON
aji-170	167	21	may	may	AUX
aji-170	167	22	contribute	contribute	VERB
aji-170	167	23	to	to	ADP
aji-170	167	24	immune	immune	ADJ
aji-170	167	25	dysregulation	dysregulation	NOUN
aji-170	167	26	and	and	CCONJ
aji-170	167	27	pregnancy	pregnancy	NOUN
aji-170	167	28	failure	failure	NOUN
aji-170	167	29	in	in	ADP
aji-170	167	30	women	woman	NOUN
aji-170	167	31	with	with	ADP
aji-170	167	32	idiopathic	idiopathic	ADJ
aji-170	167	33	recurrent	recurrent	ADJ
aji-170	167	34	pregnancy	pregnancy	NOUN
aji-170	167	35	loss	loss	NOUN
aji-170	167	36	.	.	PUNCT
aji-170	168	1	(	(	PUNCT
aji-170	168	2	zych	zych	NOUN
aji-170	168	3	et	et	NOUN
aji-170	168	4	al	al	PROPN
aji-170	168	5	.	.	PROPN
aji-170	168	6	,	,	PUNCT
aji-170	168	7	2021	2021	NUM
aji-170	168	8	)	)	PUNCT
aji-170	169	1	n	n	NOUN
aji-170	169	2	=	=	SYM
aji-170	169	3	36	36	NUM
aji-170	169	4	,	,	PUNCT
aji-170	169	5	24	24	NUM
aji-170	169	6	=	=	SYM
aji-170	169	7	wrsa	wrsa	NOUN
aji-170	169	8	,	,	PUNCT
aji-170	169	9	12	12	NUM
aji-170	169	10	=	=	SYM
aji-170	169	11	hc	hc	PROPN
aji-170	169	12	-	-	PUNCT
aji-170	169	13	p	p	NOUN
aji-170	169	14	elevated	elevate	VERB
aji-170	169	15	pd-1	pd-1	ADP
aji-170	169	16	expression	expression	NOUN
aji-170	169	17	was	be	AUX
aji-170	169	18	observed	observe	VERB
aji-170	169	19	on	on	ADP
aji-170	169	20	t	t	PROPN
aji-170	169	21	helper	helper	NOUN
aji-170	169	22	(	(	PUNCT
aji-170	169	23	cd4	cd4	PROPN
aji-170	169	24	+	+	NOUN
aji-170	169	25	)	)	PUNCT
aji-170	169	26	cells	cell	NOUN
aji-170	169	27	in	in	ADP
aji-170	169	28	wrsa	wrsa	NOUN
aji-170	169	29	,	,	PUNCT
aji-170	169	30	while	while	SCONJ
aji-170	169	31	tim-3	tim-3	VERB
aji-170	169	32	expression	expression	NOUN
aji-170	169	33	was	be	AUX
aji-170	169	34	decreased	decrease	VERB
aji-170	169	35	on	on	ADP
aji-170	169	36	t	t	PROPN
aji-170	169	37	cytotoxic	cytotoxic	NOUN
aji-170	169	38	(	(	PUNCT
aji-170	169	39	cd8	cd8	PROPN
aji-170	169	40	+	+	NOUN
aji-170	169	41	)	)	PUNCT
aji-170	169	42	cells	cell	NOUN
aji-170	169	43	.	.	PUNCT
aji-170	170	1	•	•	NUM
aji-170	170	2	the	the	DET
aji-170	170	3	dysregulation	dysregulation	NOUN
aji-170	170	4	of	of	ADP
aji-170	170	5	the	the	DET
aji-170	170	6	maternal	maternal	ADJ
aji-170	170	7	immune	immune	ADJ
aji-170	170	8	system	system	NOUN
aji-170	170	9	in	in	ADP
aji-170	170	10	rsa	rsa	PROPN
aji-170	170	11	is	be	AUX
aji-170	170	12	characterised	characterise	VERB
aji-170	170	13	by	by	ADP
aji-170	170	14	a	a	DET
aji-170	170	15	shift	shift	NOUN
aji-170	170	16	towards	towards	ADP
aji-170	170	17	a	a	DET
aji-170	170	18	th1	th1	NOUN
aji-170	170	19	cytokine	cytokine	NOUN
aji-170	170	20	profile	profile	NOUN
aji-170	170	21	and	and	CCONJ
aji-170	170	22	increased	increase	VERB
aji-170	170	23	cytotoxicity	cytotoxicity	NOUN
aji-170	170	24	,	,	PUNCT
aji-170	170	25	which	which	PRON
aji-170	170	26	may	may	AUX
aji-170	170	27	contribute	contribute	VERB
aji-170	170	28	to	to	ADP
aji-170	170	29	pregnancy	pregnancy	NOUN
aji-170	170	30	loss	loss	NOUN
aji-170	170	31	.	.	PUNCT
aji-170	171	1	(	(	PUNCT
aji-170	171	2	liu	liu	PROPN
aji-170	171	3	et	et	PROPN
aji-170	171	4	al	al	PROPN
aji-170	171	5	.	.	PROPN
aji-170	171	6	,	,	PUNCT
aji-170	171	7	2021	2021	NUM
aji-170	171	8	)	)	PUNCT
aji-170	172	1	n	n	NOUN
aji-170	172	2	=	=	SYM
aji-170	172	3	150	150	NUM
aji-170	172	4	;	;	PUNCT
aji-170	172	5	50	50	NUM
aji-170	172	6	=	=	NOUN
aji-170	172	7	wrsa	wrsa	NOUN
aji-170	172	8	,	,	PUNCT
aji-170	172	9	50	50	NUM
aji-170	172	10	=	=	SYM
aji-170	172	11	hc	hc	PROPN
aji-170	172	12	-	-	PUNCT
aji-170	172	13	p	p	NOUN
aji-170	172	14	and	and	CCONJ
aji-170	172	15	50	50	NUM
aji-170	172	16	=	=	SYM
aji-170	172	17	hc	hc	PROPN
aji-170	172	18	-	-	PUNCT
aji-170	172	19	np	np	NOUN
aji-170	172	20	wrsa	wrsa	NOUN
aji-170	172	21	had	have	AUX
aji-170	172	22	increased	increase	VERB
aji-170	172	23	naïve	naïve	PROPN
aji-170	172	24	cd4	cd4	PROPN
aji-170	172	25	+	+	PROPN
aji-170	172	26	t	t	NOUN
aji-170	172	27	cells	cell	NOUN
aji-170	172	28	,	,	PUNCT
aji-170	172	29	central	central	ADJ
aji-170	172	30	memory	memory	NOUN
aji-170	172	31	cd4	cd4	PROPN
aji-170	172	32	+	+	PROPN
aji-170	172	33	t	t	NOUN
aji-170	172	34	cells	cell	NOUN
aji-170	172	35	,	,	PUNCT
aji-170	172	36	and	and	CCONJ
aji-170	172	37	mature	mature	VERB
aji-170	172	38	nk	nk	PROPN
aji-170	172	39	cells	cell	NOUN
aji-170	172	40	,	,	PUNCT
aji-170	172	41	while	while	SCONJ
aji-170	172	42	terminally	terminally	ADV
aji-170	172	43	differentiated	differentiate	VERB
aji-170	172	44	cd4	cd4	PROPN
aji-170	172	45	+	+	PROPN
aji-170	172	46	t	t	NOUN
aji-170	172	47	cells	cell	NOUN
aji-170	172	48	and	and	CCONJ
aji-170	172	49	effective	effective	ADJ
aji-170	172	50	memory	memory	NOUN
aji-170	172	51	cd4	cd4	PROPN
aji-170	172	52	+	+	PROPN
aji-170	172	53	t	t	NOUN
aji-170	172	54	cells	cell	NOUN
aji-170	172	55	were	be	AUX
aji-170	172	56	decreased	decrease	VERB
aji-170	172	57	.	.	PUNCT
aji-170	173	1	•	•	NUM
aji-170	173	2	higher	high	ADJ
aji-170	173	3	naïve	naïve	PROPN
aji-170	173	4	cd4	cd4	PROPN
aji-170	173	5	+	+	PROPN
aji-170	173	6	t	t	NOUN
aji-170	173	7	cells	cell	NOUN
aji-170	173	8	may	may	AUX
aji-170	173	9	weaken	weaken	VERB
aji-170	173	10	the	the	DET
aji-170	173	11	immune	immune	ADJ
aji-170	173	12	system	system	NOUN
aji-170	173	13	,	,	PUNCT
aji-170	173	14	while	while	SCONJ
aji-170	173	15	increased	increase	VERB
aji-170	173	16	central	central	ADJ
aji-170	173	17	memory	memory	NOUN
aji-170	173	18	cd4	cd4	PROPN
aji-170	173	19	+	+	PROPN
aji-170	173	20	t	t	NOUN
aji-170	173	21	cells	cell	NOUN
aji-170	173	22	suggest	suggest	VERB
aji-170	173	23	altered	alter	VERB
aji-170	173	24	immune	immune	ADJ
aji-170	173	25	responses	response	NOUN
aji-170	173	26	.	.	PUNCT
aji-170	174	1	elevated	elevated	ADJ
aji-170	174	2	mature	mature	ADJ
aji-170	174	3	nk	nk	PROPN
aji-170	174	4	cells	cell	NOUN
aji-170	174	5	can	can	AUX
aji-170	174	6	cause	cause	VERB
aji-170	174	7	cytotoxic	cytotoxic	ADJ
aji-170	174	8	effects	effect	NOUN
aji-170	174	9	,	,	PUNCT
aji-170	174	10	potentially	potentially	ADV
aji-170	174	11	leading	lead	VERB
aji-170	174	12	to	to	ADP
aji-170	174	13	pregnancy	pregnancy	NOUN
aji-170	174	14	loss	loss	NOUN
aji-170	174	15	.	.	PUNCT
aji-170	175	1	decreased	decrease	VERB
aji-170	175	2	terminally	terminally	ADV
aji-170	175	3	differentiated	differentiated	ADJ
aji-170	175	4	and	and	CCONJ
aji-170	175	5	effective	effective	ADJ
aji-170	175	6	memory	memory	NOUN
aji-170	175	7	,	,	PUNCT
aji-170	175	8	cd4	cd4	PROPN
aji-170	175	9	+	+	PROPN
aji-170	175	10	t	t	NOUN
aji-170	175	11	cells	cell	NOUN
aji-170	175	12	,	,	PUNCT
aji-170	175	13	indicate	indicate	VERB
aji-170	175	14	reduced	reduce	VERB
aji-170	175	15	walana	walana	PROPN
aji-170	175	16	et	et	PROPN
aji-170	175	17	al	al	PROPN
aji-170	175	18	.	.	PROPN
aji-170	175	19	;	;	PUNCT
aji-170	176	1	asian	asian	PROPN
aji-170	176	2	j.	j.	PROPN
aji-170	176	3	immunol	immunol	PROPN
aji-170	176	4	.	.	PROPN
aji-170	176	5	,	,	PUNCT
aji-170	176	6	vol	vol	NOUN
aji-170	176	7	.	.	PROPN
aji-170	176	8	8	8	NUM
aji-170	176	9	,	,	PUNCT
aji-170	176	10	no	no	INTJ
aji-170	176	11	.	.	NOUN
aji-170	176	12	1	1	NUM
aji-170	176	13	,	,	PUNCT
aji-170	176	14	pp	pp	ADJ
aji-170	176	15	.	.	PUNCT
aji-170	177	1	179	179	NUM
aji-170	177	2	-	-	SYM
aji-170	177	3	189	189	NUM
aji-170	177	4	,	,	PUNCT
aji-170	177	5	2025	2025	NUM
aji-170	177	6	;	;	PUNCT
aji-170	177	7	article	article	NOUN
aji-170	177	8	no.aji.139815	no.aji.139815	VERB
aji-170	177	9	183	183	NUM
aji-170	177	10	authors	author	NOUN
aji-170	177	11	;	;	PUNCT
aji-170	177	12	year	year	NOUN
aji-170	177	13	population	population	NOUN
aji-170	177	14	characteristics	characteristic	VERB
aji-170	177	15	t	t	PROPN
aji-170	177	16	-	-	PUNCT
aji-170	177	17	cells	cell	NOUN
aji-170	177	18	&	&	CCONJ
aji-170	177	19	exhaustion	exhaustion	NOUN
aji-170	177	20	markers	marker	NOUN
aji-170	177	21	practical	practical	ADJ
aji-170	177	22	implications	implication	NOUN
aji-170	177	23	immune	immune	ADJ
aji-170	177	24	protection	protection	NOUN
aji-170	177	25	and	and	CCONJ
aji-170	177	26	a	a	DET
aji-170	177	27	weaker	weak	ADJ
aji-170	177	28	response	response	NOUN
aji-170	177	29	to	to	ADP
aji-170	177	30	pregnancy	pregnancy	NOUN
aji-170	177	31	-	-	PUNCT
aji-170	177	32	related	relate	VERB
aji-170	177	33	antigens	antigen	NOUN
aji-170	177	34	.	.	PUNCT
aji-170	178	1	(	(	PUNCT
aji-170	178	2	wang	wang	PROPN
aji-170	178	3	et	et	PROPN
aji-170	178	4	al	al	PROPN
aji-170	178	5	.	.	PROPN
aji-170	178	6	,	,	PUNCT
aji-170	178	7	2020	2020	NUM
aji-170	178	8	)	)	PUNCT
aji-170	178	9	n=65	n=65	NOUN
aji-170	178	10	;	;	PUNCT
aji-170	178	11	45	45	NUM
aji-170	178	12	=	=	SYM
aji-170	178	13	wrsa	wrsa	NOUN
aji-170	178	14	;	;	PUNCT
aji-170	178	15	20	20	NUM
aji-170	178	16	=	=	SYM
aji-170	178	17	hc	hc	PROPN
aji-170	178	18	-	-	PUNCT
aji-170	178	19	p	p	NOUN
aji-170	178	20	increased	increase	VERB
aji-170	178	21	th1	th1	NOUN
aji-170	178	22	and	and	CCONJ
aji-170	178	23	th17	th17	PROPN
aji-170	178	24	cells	cell	NOUN
aji-170	178	25	,	,	PUNCT
aji-170	178	26	and	and	CCONJ
aji-170	178	27	decreased	decrease	VERB
aji-170	178	28	regulatory	regulatory	ADJ
aji-170	178	29	treg	treg	PROPN
aji-170	178	30	cells	cell	NOUN
aji-170	178	31	,	,	PUNCT
aji-170	178	32	were	be	AUX
aji-170	178	33	associated	associate	VERB
aji-170	178	34	with	with	ADP
aji-170	178	35	a	a	DET
aji-170	178	36	significant	significant	ADJ
aji-170	178	37	decrease	decrease	NOUN
aji-170	178	38	in	in	ADP
aji-170	178	39	the	the	DET
aji-170	178	40	expression	expression	NOUN
aji-170	178	41	of	of	ADP
aji-170	178	42	pd-1	pd-1	VERB
aji-170	178	43	on	on	ADP
aji-170	178	44	th1	th1	PROPN
aji-170	178	45	and	and	CCONJ
aji-170	178	46	th17	th17	PROPN
aji-170	178	47	cells	cell	NOUN
aji-170	178	48	in	in	ADP
aji-170	178	49	wrsa	wrsa	NOUN
aji-170	178	50	.	.	PUNCT
aji-170	179	1	•	•	NUM
aji-170	179	2	increased	increase	VERB
aji-170	179	3	proportions	proportion	NOUN
aji-170	179	4	of	of	ADP
aji-170	179	5	th1	th1	PROPN
aji-170	179	6	and	and	CCONJ
aji-170	179	7	th17	th17	PROPN
aji-170	179	8	cells	cell	NOUN
aji-170	179	9	are	be	AUX
aji-170	179	10	associated	associate	VERB
aji-170	179	11	with	with	ADP
aji-170	179	12	pro	pro	ADJ
aji-170	179	13	-	-	ADJ
aji-170	179	14	inflammatory	inflammatory	ADJ
aji-170	179	15	responses	response	NOUN
aji-170	179	16	and	and	CCONJ
aji-170	179	17	decreased	decrease	VERB
aji-170	179	18	immune	immune	ADJ
aji-170	179	19	regulatory	regulatory	ADJ
aji-170	179	20	function	function	NOUN
aji-170	179	21	due	due	ADP
aji-170	179	22	to	to	AUX
aji-170	179	23	altered	alter	VERB
aji-170	179	24	pd-1	pd-1	ADP
aji-170	179	25	/	/	SYM
aji-170	179	26	pd	pd	ADJ
aji-170	179	27	-	-	PUNCT
aji-170	179	28	l1	l1	PROPN
aji-170	179	29	expression	expression	NOUN
aji-170	179	30	,	,	PUNCT
aji-170	179	31	which	which	PRON
aji-170	179	32	may	may	AUX
aji-170	179	33	have	have	AUX
aji-170	179	34	led	lead	VERB
aji-170	179	35	to	to	ADP
aji-170	179	36	pregnancy	pregnancy	NOUN
aji-170	179	37	loss	loss	NOUN
aji-170	179	38	.	.	PUNCT
aji-170	180	1	(	(	PUNCT
aji-170	180	2	zhu	zhu	X
aji-170	180	3	et	et	PROPN
aji-170	180	4	al	al	PROPN
aji-170	180	5	.	.	PROPN
aji-170	180	6	,	,	PUNCT
aji-170	180	7	2019	2019	NUM
aji-170	180	8	)	)	PUNCT
aji-170	180	9	n=68	n=68	ADV
aji-170	180	10	;	;	PUNCT
aji-170	180	11	33	33	NUM
aji-170	180	12	=	=	NOUN
aji-170	180	13	wrsa	wrsa	NOUN
aji-170	180	14	;	;	PUNCT
aji-170	180	15	35	35	NUM
aji-170	180	16	=	=	NUM
aji-170	180	17	hcp	hcp	PROPN
aji-170	180	18	wrsa	wrsa	NOUN
aji-170	180	19	exhibits	exhibit	VERB
aji-170	180	20	an	an	DET
aji-170	180	21	activated	activated	ADJ
aji-170	180	22	immune	immune	ADJ
aji-170	180	23	system	system	NOUN
aji-170	180	24	,	,	PUNCT
aji-170	180	25	characterised	characterise	VERB
aji-170	180	26	by	by	ADP
aji-170	180	27	high	high	ADJ
aji-170	180	28	levels	level	NOUN
aji-170	180	29	of	of	ADP
aji-170	180	30	cytotoxic	cytotoxic	ADJ
aji-170	180	31	nk	nk	PROPN
aji-170	180	32	cells	cell	NOUN
aji-170	180	33	and	and	CCONJ
aji-170	180	34	low	low	ADJ
aji-170	180	35	levels	level	NOUN
aji-170	180	36	of	of	ADP
aji-170	180	37	immunoregulatory	immunoregulatory	ADJ
aji-170	180	38	il-10	il-10	NOUN
aji-170	180	39	+	+	CCONJ
aji-170	181	1	cd56bright	cd56bright	ADJ
aji-170	181	2	nk	nk	PROPN
aji-170	181	3	cells	cell	NOUN
aji-170	181	4	.	.	PUNCT
aji-170	182	1	nk	nk	PROPN
aji-170	182	2	cells	cell	NOUN
aji-170	182	3	also	also	ADV
aji-170	182	4	spontaneously	spontaneously	ADV
aji-170	182	5	produce	produce	VERB
aji-170	182	6	a	a	DET
aji-170	182	7	high	high	ADJ
aji-170	182	8	amount	amount	NOUN
aji-170	182	9	of	of	ADP
aji-170	182	10	tgfß1	tgfß1	PROPN
aji-170	182	11	.	.	PUNCT
aji-170	183	1	•	•	NOUN
aji-170	183	2	this	this	PRON
aji-170	183	3	indicates	indicate	VERB
aji-170	183	4	a	a	DET
aji-170	183	5	persistent	persistent	ADJ
aji-170	183	6	inflammatory	inflammatory	ADJ
aji-170	183	7	response	response	NOUN
aji-170	183	8	that	that	PRON
aji-170	183	9	can	can	AUX
aji-170	183	10	not	not	PART
aji-170	183	11	be	be	AUX
aji-170	183	12	efficiently	efficiently	ADV
aji-170	183	13	counter	counter	ADJ
aji-170	183	14	-	-	VERB
aji-170	183	15	regulated	regulated	ADJ
aji-170	183	16	.	.	PUNCT
aji-170	184	1	this	this	PRON
aji-170	184	2	suggests	suggest	VERB
aji-170	184	3	that	that	SCONJ
aji-170	184	4	down	down	ADV
aji-170	184	5	-	-	PUNCT
aji-170	184	6	regulating	regulate	VERB
aji-170	184	7	the	the	DET
aji-170	184	8	cytotoxic	cytotoxic	ADJ
aji-170	184	9	immune	immune	ADJ
aji-170	184	10	response	response	NOUN
aji-170	184	11	and	and	CCONJ
aji-170	184	12	enhancing	enhance	VERB
aji-170	184	13	immunoregulatory	immunoregulatory	ADJ
aji-170	184	14	mechanisms	mechanism	NOUN
aji-170	184	15	could	could	AUX
aji-170	184	16	be	be	AUX
aji-170	184	17	beneficial	beneficial	ADJ
aji-170	184	18	for	for	ADP
aji-170	184	19	wrsa	wrsa	ADJ
aji-170	184	20	(	(	PUNCT
aji-170	184	21	abdolmohammadi	abdolmohammadi	PROPN
aji-170	184	22	vahid	vahid	PROPN
aji-170	184	23	et	et	PROPN
aji-170	184	24	al	al	PROPN
aji-170	184	25	.	.	PROPN
aji-170	184	26	,	,	PUNCT
aji-170	184	27	2019	2019	NUM
aji-170	184	28	)	)	PUNCT
aji-170	184	29	n=	n=	ADJ
aji-170	184	30	100	100	NUM
aji-170	184	31	;	;	PUNCT
aji-170	184	32	50	50	NUM
aji-170	184	33	=	=	NOUN
aji-170	184	34	wrsa	wrsa	NOUN
aji-170	184	35	and	and	CCONJ
aji-170	184	36	50	50	NUM
aji-170	184	37	=	=	SYM
aji-170	184	38	hc	hc	PROPN
aji-170	184	39	-	-	PUNCT
aji-170	184	40	p	p	NOUN
aji-170	184	41	treg	treg	NOUN
aji-170	184	42	and	and	CCONJ
aji-170	184	43	exhausted	exhausted	ADJ
aji-170	184	44	t	t	NOUN
aji-170	184	45	cells	cell	NOUN
aji-170	184	46	were	be	AUX
aji-170	184	47	decreased	decrease	VERB
aji-170	184	48	,	,	PUNCT
aji-170	184	49	while	while	SCONJ
aji-170	184	50	th17	th17	PROPN
aji-170	184	51	and	and	CCONJ
aji-170	184	52	exhausted	exhausted	ADJ
aji-170	184	53	treg	treg	PROPN
aji-170	184	54	cells	cell	NOUN
aji-170	184	55	were	be	AUX
aji-170	184	56	increased	increase	VERB
aji-170	184	57	in	in	ADP
aji-170	184	58	wrsa	wrsa	NOUN
aji-170	184	59	.	.	PUNCT
aji-170	185	1	•	•	NUM
aji-170	185	2	the	the	DET
aji-170	185	3	decrease	decrease	NOUN
aji-170	185	4	in	in	ADP
aji-170	185	5	treg	treg	PROPN
aji-170	185	6	cells	cell	NOUN
aji-170	185	7	and	and	CCONJ
aji-170	185	8	exhausted	exhaust	VERB
aji-170	185	9	t	t	PROPN
aji-170	185	10	-	-	PUNCT
aji-170	185	11	cells	cell	NOUN
aji-170	185	12	suggests	suggest	VERB
aji-170	185	13	a	a	DET
aji-170	185	14	failure	failure	NOUN
aji-170	185	15	in	in	ADP
aji-170	185	16	the	the	DET
aji-170	185	17	regulatory	regulatory	ADJ
aji-170	185	18	mechanisms	mechanism	NOUN
aji-170	185	19	that	that	PRON
aji-170	185	20	prevent	prevent	VERB
aji-170	185	21	the	the	DET
aji-170	185	22	maternal	maternal	ADJ
aji-170	185	23	immune	immune	ADJ
aji-170	185	24	system	system	NOUN
aji-170	185	25	from	from	ADP
aji-170	185	26	attacking	attack	VERB
aji-170	185	27	the	the	DET
aji-170	185	28	foetus	foetus	NOUN
aji-170	185	29	.	.	PUNCT
aji-170	186	1	•	•	NUM
aji-170	186	2	increase	increase	VERB
aji-170	186	3	in	in	ADP
aji-170	186	4	th17	th17	PROPN
aji-170	186	5	and	and	CCONJ
aji-170	186	6	exhausted	exhausted	ADJ
aji-170	186	7	treg	treg	PROPN
aji-170	186	8	cells	cell	NOUN
aji-170	186	9	indicates	indicate	VERB
aji-170	186	10	a	a	DET
aji-170	186	11	shift	shift	NOUN
aji-170	186	12	towards	towards	ADP
aji-170	186	13	a	a	DET
aji-170	186	14	pro	pro	ADJ
aji-170	186	15	-	-	ADJ
aji-170	186	16	inflammatory	inflammatory	ADJ
aji-170	186	17	immune	immune	ADJ
aji-170	186	18	environment	environment	NOUN
aji-170	186	19	.	.	PUNCT
aji-170	187	1	(	(	PUNCT
aji-170	187	2	qian	qian	INTJ
aji-170	187	3	et	et	PROPN
aji-170	187	4	al	al	PROPN
aji-170	187	5	.	.	PROPN
aji-170	187	6	,	,	PUNCT
aji-170	187	7	2018	2018	NUM
aji-170	187	8	)	)	PUNCT
aji-170	188	1	n	n	NOUN
aji-170	188	2	=	=	SYM
aji-170	188	3	75	75	NUM
aji-170	188	4	;	;	PUNCT
aji-170	188	5	37	37	NUM
aji-170	188	6	=	=	SYM
aji-170	188	7	wrsa	wrsa	NOUN
aji-170	188	8	,	,	PUNCT
aji-170	188	9	38	38	NUM
aji-170	188	10	=	=	SYM
aji-170	188	11	hc	hc	PROPN
aji-170	188	12	-	-	PUNCT
aji-170	188	13	p	p	NOUN
aji-170	188	14	wrsa	wrsa	NOUN
aji-170	188	15	has	have	VERB
aji-170	188	16	a	a	DET
aji-170	188	17	higher	high	ADJ
aji-170	188	18	th17	th17	NOUN
aji-170	188	19	/	/	SYM
aji-170	188	20	treg	treg	PROPN
aji-170	188	21	cell	cell	NOUN
aji-170	188	22	ratio	ratio	NOUN
aji-170	188	23	at	at	ADP
aji-170	188	24	the	the	DET
aji-170	188	25	maternal	maternal	ADJ
aji-170	188	26	-	-	PUNCT
aji-170	188	27	foetal	foetal	ADJ
aji-170	188	28	interface	interface	NOUN
aji-170	188	29	compared	compare	VERB
aji-170	188	30	to	to	ADP
aji-170	188	31	women	woman	NOUN
aji-170	188	32	with	with	ADP
aji-170	188	33	normal	normal	ADJ
aji-170	188	34	pregnancies	pregnancy	NOUN
aji-170	188	35	•	•	ADP
aji-170	188	36	wrsa	wrsa	NOUN
aji-170	188	37	exhibited	exhibit	VERB
aji-170	188	38	elevated	elevated	ADJ
aji-170	188	39	pro	pro	ADJ
aji-170	188	40	-	-	ADJ
aji-170	188	41	inflammatory	inflammatory	ADJ
aji-170	188	42	cytokine	cytokine	NOUN
aji-170	188	43	levels	level	NOUN
aji-170	188	44	due	due	ADP
aji-170	188	45	to	to	ADP
aji-170	188	46	the	the	DET
aji-170	188	47	skewed	skewed	ADJ
aji-170	188	48	th17	th17	PROPN
aji-170	188	49	/	/	SYM
aji-170	188	50	treg	treg	PROPN
aji-170	188	51	cell	cell	NOUN
aji-170	188	52	ratio	ratio	NOUN
aji-170	188	53	at	at	ADP
aji-170	188	54	the	the	DET
aji-170	188	55	maternal	maternal	ADJ
aji-170	188	56	-	-	PUNCT
aji-170	188	57	foetal	foetal	ADJ
aji-170	188	58	interface	interface	NOUN
aji-170	188	59	,	,	PUNCT
aji-170	188	60	contributing	contribute	VERB
aji-170	188	61	to	to	ADP
aji-170	188	62	immune	immune	ADJ
aji-170	188	63	tolerance	tolerance	NOUN
aji-170	188	64	failure	failure	NOUN
aji-170	188	65	in	in	ADP
aji-170	188	66	wrsa	wrsa	NOUN
aji-170	188	67	.	.	PUNCT
aji-170	189	1	(	(	PUNCT
aji-170	189	2	kuon	kuon	PROPN
aji-170	189	3	et	et	PROPN
aji-170	189	4	al	al	PROPN
aji-170	189	5	.	.	PROPN
aji-170	189	6	,	,	PUNCT
aji-170	189	7	2015	2015	NUM
aji-170	189	8	)	)	PUNCT
aji-170	190	1	n	n	NOUN
aji-170	190	2	=	=	SYM
aji-170	190	3	123	123	NUM
aji-170	190	4	;	;	PUNCT
aji-170	190	5	97	97	NUM
aji-170	190	6	=	=	SYM
aji-170	190	7	wrsa	wrsa	NOUN
aji-170	190	8	;	;	PUNCT
aji-170	190	9	26	26	NUM
aji-170	190	10	=	=	SYM
aji-170	190	11	hc	hc	PROPN
aji-170	190	12	-	-	PUNCT
aji-170	190	13	np	np	NOUN
aji-170	190	14	wrsa	wrsa	NOUN
aji-170	190	15	showed	show	VERB
aji-170	190	16	higher	high	ADJ
aji-170	190	17	levels	level	NOUN
aji-170	190	18	of	of	ADP
aji-170	190	19	activated	activate	VERB
aji-170	190	20	t	t	PROPN
aji-170	190	21	-	-	PUNCT
aji-170	190	22	cells	cell	NOUN
aji-170	190	23	(	(	PUNCT
aji-170	190	24	cd3+dr+	cd3+dr+	NOUN
aji-170	190	25	,	,	PUNCT
aji-170	190	26	cd4+dr+	cd4+dr+	NOUN
aji-170	190	27	,	,	PUNCT
aji-170	190	28	and	and	CCONJ
aji-170	190	29	cd8+dr+	cd8+dr+	PROPN
aji-170	190	30	)	)	PUNCT
aji-170	190	31	that	that	PRON
aji-170	190	32	were	be	AUX
aji-170	190	33	less	less	ADV
aji-170	190	34	responsive	responsive	ADJ
aji-170	190	35	to	to	ADP
aji-170	190	36	mitogens	mitogen	NOUN
aji-170	190	37	than	than	ADP
aji-170	190	38	the	the	DET
aji-170	190	39	controls	control	NOUN
aji-170	190	40	.	.	PUNCT
aji-170	191	1	a	a	DET
aji-170	191	2	significant	significant	ADJ
aji-170	191	3	increase	increase	NOUN
aji-170	191	4	in	in	ADP
aji-170	191	5	neopterin	neopterin	NOUN
aji-170	191	6	levels	level	NOUN
aji-170	191	7	and	and	CCONJ
aji-170	191	8	lower	low	ADJ
aji-170	191	9	levels	level	NOUN
aji-170	191	10	of	of	ADP
aji-170	191	11	cd16+cd56	cd16+cd56	PROPN
aji-170	191	12	+	+	CCONJ
aji-170	191	13	nk	nk	PROPN
aji-170	191	14	cells	cell	NOUN
aji-170	191	15	and	and	CCONJ
aji-170	191	16	cd19	cd19	PROPN
aji-170	191	17	+	+	CCONJ
aji-170	191	18	b	b	NOUN
aji-170	191	19	lymphocytes	lymphocyte	NOUN
aji-170	191	20	•	•	VERB
aji-170	191	21	the	the	DET
aji-170	191	22	chronic	chronic	ADJ
aji-170	191	23	activation	activation	NOUN
aji-170	191	24	of	of	ADP
aji-170	191	25	t	t	PROPN
aji-170	191	26	-	-	PUNCT
aji-170	191	27	cells	cell	NOUN
aji-170	191	28	and	and	CCONJ
aji-170	191	29	the	the	DET
aji-170	191	30	deficiency	deficiency	NOUN
aji-170	191	31	in	in	ADP
aji-170	191	32	nk	nk	PROPN
aji-170	191	33	and	and	CCONJ
aji-170	191	34	b	b	X
aji-170	191	35	-	-	PUNCT
aji-170	191	36	cells	cell	NOUN
aji-170	191	37	in	in	ADP
aji-170	191	38	wrsa	wrsa	NOUN
aji-170	191	39	may	may	AUX
aji-170	191	40	contribute	contribute	VERB
aji-170	191	41	to	to	ADP
aji-170	191	42	the	the	DET
aji-170	191	43	inability	inability	NOUN
aji-170	191	44	of	of	ADP
aji-170	191	45	the	the	DET
aji-170	191	46	maternal	maternal	ADJ
aji-170	191	47	immune	immune	ADJ
aji-170	191	48	system	system	NOUN
aji-170	191	49	to	to	PART
aji-170	191	50	tolerate	tolerate	VERB
aji-170	191	51	the	the	DET
aji-170	191	52	developing	develop	VERB
aji-170	191	53	foetus	foetus	NOUN
aji-170	191	54	,	,	PUNCT
aji-170	191	55	leading	lead	VERB
aji-170	191	56	to	to	ADP
aji-170	191	57	miscarriage	miscarriage	NOUN
aji-170	191	58	.	.	PUNCT
aji-170	192	1	walana	walana	PROPN
aji-170	192	2	et	et	PROPN
aji-170	192	3	al	al	PROPN
aji-170	192	4	.	.	PROPN
aji-170	192	5	;	;	PUNCT
aji-170	192	6	asian	asian	PROPN
aji-170	192	7	j.	j.	PROPN
aji-170	192	8	immunol	immunol	PROPN
aji-170	192	9	.	.	PROPN
aji-170	192	10	,	,	PUNCT
aji-170	192	11	vol	vol	NOUN
aji-170	192	12	.	.	PROPN
aji-170	192	13	8	8	NUM
aji-170	192	14	,	,	PUNCT
aji-170	192	15	no	no	INTJ
aji-170	192	16	.	.	NOUN
aji-170	192	17	1	1	NUM
aji-170	192	18	,	,	PUNCT
aji-170	192	19	pp	pp	ADJ
aji-170	192	20	.	.	PUNCT
aji-170	193	1	179	179	NUM
aji-170	193	2	-	-	SYM
aji-170	193	3	189	189	NUM
aji-170	193	4	,	,	PUNCT
aji-170	193	5	2025	2025	NUM
aji-170	193	6	;	;	PUNCT
aji-170	193	7	article	article	NOUN
aji-170	193	8	no.aji.139815	no.aji.139815	VERB
aji-170	193	9	184	184	NUM
aji-170	193	10	authors	author	NOUN
aji-170	193	11	;	;	PUNCT
aji-170	193	12	year	year	NOUN
aji-170	193	13	population	population	NOUN
aji-170	193	14	characteristics	characteristic	VERB
aji-170	193	15	t	t	PROPN
aji-170	193	16	-	-	PUNCT
aji-170	193	17	cells	cell	NOUN
aji-170	193	18	&	&	CCONJ
aji-170	193	19	exhaustion	exhaustion	NOUN
aji-170	193	20	markers	marker	NOUN
aji-170	193	21	practical	practical	ADJ
aji-170	193	22	implications	implication	NOUN
aji-170	193	23	were	be	AUX
aji-170	193	24	observed	observe	VERB
aji-170	193	25	in	in	ADP
aji-170	193	26	wrsa	wrsa	NOUN
aji-170	193	27	.	.	PUNCT
aji-170	194	1	experimental	experimental	ADJ
aji-170	194	2	(	(	PUNCT
aji-170	194	3	li	li	PROPN
aji-170	194	4	et	et	PROPN
aji-170	194	5	al	al	PROPN
aji-170	194	6	.	.	PROPN
aji-170	194	7	,	,	PUNCT
aji-170	194	8	2022	2022	NUM
aji-170	194	9	)	)	PUNCT
aji-170	194	10	n	n	NOUN
aji-170	194	11	=	=	SYM
aji-170	194	12	135	135	NUM
aji-170	194	13	,	,	PUNCT
aji-170	194	14	40	40	NUM
aji-170	194	15	=	=	SYM
aji-170	194	16	wrsa	wrsa	NOUN
aji-170	194	17	,	,	PUNCT
aji-170	194	18	86	86	NUM
aji-170	194	19	hcp	hcp	NOUN
aji-170	194	20	,	,	PUNCT
aji-170	194	21	9	9	NUM
aji-170	194	22	hc	hc	PROPN
aji-170	194	23	-	-	PUNCT
aji-170	194	24	np	np	NOUN
aji-170	194	25	tim-3	tim-3	NUM
aji-170	194	26	expression	expression	NOUN
aji-170	194	27	is	be	AUX
aji-170	194	28	significantly	significantly	ADV
aji-170	194	29	decreased	decrease	VERB
aji-170	194	30	in	in	ADP
aji-170	194	31	wrsa	wrsa	NOUN
aji-170	194	32	,	,	PUNCT
aji-170	194	33	while	while	SCONJ
aji-170	194	34	it	it	PRON
aji-170	194	35	is	be	AUX
aji-170	194	36	increased	increase	VERB
aji-170	194	37	in	in	ADP
aji-170	194	38	normal	normal	ADJ
aji-170	194	39	pregnancies	pregnancy	NOUN
aji-170	194	40	.	.	PUNCT
aji-170	195	1	•	•	NUM
aji-170	195	2	decreased	decrease	VERB
aji-170	195	3	tim-3	tim-3	PUNCT
aji-170	195	4	results	result	NOUN
aji-170	195	5	in	in	ADP
aji-170	195	6	the	the	DET
aji-170	195	7	dysfunction	dysfunction	NOUN
aji-170	195	8	of	of	ADP
aji-170	195	9	dmφs	dmφs	NOUN
aji-170	195	10	,	,	PUNCT
aji-170	195	11	which	which	PRON
aji-170	195	12	leads	lead	VERB
aji-170	195	13	to	to	ADP
aji-170	195	14	an	an	DET
aji-170	195	15	increase	increase	NOUN
aji-170	195	16	in	in	ADP
aji-170	195	17	pro	pro	ADJ
aji-170	195	18	-	-	ADJ
aji-170	195	19	inflammatory	inflammatory	ADJ
aji-170	195	20	cytokines	cytokine	NOUN
aji-170	195	21	and	and	CCONJ
aji-170	195	22	a	a	DET
aji-170	195	23	decrease	decrease	NOUN
aji-170	195	24	in	in	ADP
aji-170	195	25	anti	anti	ADJ
aji-170	195	26	-	-	ADJ
aji-170	195	27	inflammatory	inflammatory	ADJ
aji-170	195	28	cytokines	cytokine	NOUN
aji-170	195	29	,	,	PUNCT
aji-170	195	30	subsequently	subsequently	ADV
aji-170	195	31	increasing	increase	VERB
aji-170	195	32	foetal	foetal	ADJ
aji-170	195	33	loss	loss	NOUN
aji-170	195	34	.	.	PUNCT
aji-170	196	1	(	(	PUNCT
aji-170	196	2	huang	huang	PROPN
aji-170	196	3	et	et	PROPN
aji-170	196	4	al	al	PROPN
aji-170	196	5	.	.	PROPN
aji-170	196	6	,	,	PUNCT
aji-170	196	7	2020	2020	NUM
aji-170	196	8	)	)	PUNCT
aji-170	197	1	n	n	PROPN
aji-170	197	2	=	=	SYM
aji-170	197	3	43	43	NUM
aji-170	197	4	;	;	PUNCT
aji-170	197	5	8	8	NUM
aji-170	197	6	=	=	SYM
aji-170	197	7	wrsa	wrsa	NOUN
aji-170	197	8	,	,	PUNCT
aji-170	197	9	35	35	NUM
aji-170	197	10	=	=	SYM
aji-170	197	11	hcp	hcp	VERB
aji-170	197	12	the	the	DET
aji-170	197	13	proportion	proportion	NOUN
aji-170	197	14	of	of	ADP
aji-170	197	15	cd69+cd103	cd69+cd103	NOUN
aji-170	197	16	+	+	X
aji-170	197	17	resident	resident	NOUN
aji-170	197	18	and	and	CCONJ
aji-170	197	19	memory	memory	NOUN
aji-170	197	20	t	t	PROPN
aji-170	197	21	-	-	PUNCT
aji-170	197	22	cells	cell	NOUN
aji-170	197	23	is	be	AUX
aji-170	197	24	significantly	significantly	ADV
aji-170	197	25	higher	high	ADJ
aji-170	197	26	in	in	ADP
aji-170	197	27	women	woman	NOUN
aji-170	197	28	with	with	ADP
aji-170	197	29	rsa	rsa	PROPN
aji-170	197	30	than	than	ADP
aji-170	197	31	in	in	ADP
aji-170	197	32	hc	hc	PROPN
aji-170	197	33	-	-	PROPN
aji-170	197	34	p.	p.	NOUN
aji-170	197	35	•	•	NOUN
aji-170	197	36	the	the	DET
aji-170	197	37	resident	resident	NOUN
aji-170	197	38	memory	memory	NOUN
aji-170	197	39	t	t	PROPN
aji-170	197	40	-	-	PUNCT
aji-170	197	41	cells	cell	NOUN
aji-170	197	42	expressed	express	VERB
aji-170	197	43	high	high	ADJ
aji-170	197	44	levels	level	NOUN
aji-170	197	45	of	of	ADP
aji-170	197	46	chemokine	chemokine	ADJ
aji-170	197	47	receptors	receptor	NOUN
aji-170	197	48	such	such	ADJ
aji-170	197	49	as	as	ADP
aji-170	197	50	cxcr3	cxcr3	NOUN
aji-170	197	51	and	and	CCONJ
aji-170	197	52	cxcr6	cxcr6	NOUN
aji-170	197	53	.	.	PUNCT
aji-170	198	1	they	they	PRON
aji-170	198	2	had	have	VERB
aji-170	198	3	an	an	DET
aji-170	198	4	enhanced	enhance	VERB
aji-170	198	5	capacity	capacity	NOUN
aji-170	198	6	to	to	PART
aji-170	198	7	produce	produce	VERB
aji-170	198	8	both	both	DET
aji-170	198	9	effector	effector	NOUN
aji-170	198	10	cytokines	cytokine	NOUN
aji-170	198	11	,	,	PUNCT
aji-170	198	12	tnf	tnf	PROPN
aji-170	198	13	-	-	PUNCT
aji-170	198	14	α	α	PROPN
aji-170	198	15	and	and	CCONJ
aji-170	198	16	ifn	ifn	PROPN
aji-170	198	17	-	-	PUNCT
aji-170	198	18	γ	γ	NOUN
aji-170	198	19	,	,	PUNCT
aji-170	198	20	which	which	PRON
aji-170	198	21	may	may	AUX
aji-170	198	22	have	have	AUX
aji-170	198	23	led	lead	VERB
aji-170	198	24	to	to	ADP
aji-170	198	25	pregnancy	pregnancy	NOUN
aji-170	198	26	loss	loss	NOUN
aji-170	198	27	.	.	PUNCT
aji-170	199	1	(	(	PUNCT
aji-170	199	2	liu	liu	PROPN
aji-170	199	3	et	et	PROPN
aji-170	199	4	al	al	PROPN
aji-170	199	5	.	.	PROPN
aji-170	199	6	,	,	PUNCT
aji-170	199	7	2020	2020	NUM
aji-170	199	8	)	)	PUNCT
aji-170	199	9	200	200	NUM
aji-170	199	10	specific	specific	ADJ
aji-170	199	11	pathogen	pathogen	NOUN
aji-170	199	12	-	-	PUNCT
aji-170	199	13	free	free	ADJ
aji-170	199	14	female	female	ADJ
aji-170	199	15	cba	cba	PROPN
aji-170	199	16	/	/	SYM
aji-170	199	17	j	j	PROPN
aji-170	199	18	mice	mouse	NOUN
aji-170	199	19	decreased	decrease	VERB
aji-170	199	20	pd-1	pd-1	ADP
aji-170	199	21	and	and	CCONJ
aji-170	199	22	pd	pd	PROPN
aji-170	199	23	-	-	PROPN
aji-170	199	24	l1	l1	PROPN
aji-170	199	25	expression	expression	NOUN
aji-170	199	26	in	in	ADP
aji-170	199	27	the	the	DET
aji-170	199	28	placenta	placenta	NOUN
aji-170	199	29	and	and	CCONJ
aji-170	199	30	spleen	spleen	NOUN
aji-170	199	31	•	•	ADJ
aji-170	199	32	thyroiditis	thyroiditis	NOUN
aji-170	199	33	in	in	ADP
aji-170	199	34	mice	mouse	NOUN
aji-170	199	35	led	lead	VERB
aji-170	199	36	to	to	ADP
aji-170	199	37	reduced	reduce	VERB
aji-170	199	38	pd-1	pd-1	ADP
aji-170	199	39	and	and	CCONJ
aji-170	199	40	pd	pd	PROPN
aji-170	199	41	-	-	PROPN
aji-170	199	42	l1	l1	PROPN
aji-170	199	43	expression	expression	NOUN
aji-170	199	44	in	in	ADP
aji-170	199	45	the	the	DET
aji-170	199	46	placenta	placenta	NOUN
aji-170	199	47	and	and	CCONJ
aji-170	199	48	spleen	spleen	NOUN
aji-170	199	49	,	,	PUNCT
aji-170	199	50	resulting	result	VERB
aji-170	199	51	in	in	ADP
aji-170	199	52	a	a	DET
aji-170	199	53	decrease	decrease	NOUN
aji-170	199	54	in	in	ADP
aji-170	199	55	treg	treg	PROPN
aji-170	199	56	cells	cell	NOUN
aji-170	199	57	and	and	CCONJ
aji-170	199	58	an	an	DET
aji-170	199	59	increase	increase	NOUN
aji-170	199	60	in	in	ADP
aji-170	199	61	th17	th17	NOUN
aji-170	199	62	cells	cell	NOUN
aji-170	199	63	at	at	ADP
aji-170	199	64	the	the	DET
aji-170	199	65	maternal	maternal	ADJ
aji-170	199	66	-	-	PUNCT
aji-170	199	67	foetal	foetal	ADJ
aji-170	199	68	interface	interface	NOUN
aji-170	199	69	,	,	PUNCT
aji-170	199	70	resulting	result	VERB
aji-170	199	71	in	in	ADP
aji-170	199	72	miscarriage	miscarriage	NOUN
aji-170	199	73	.	.	PUNCT
aji-170	200	1	(	(	PUNCT
aji-170	200	2	luo	luo	PROPN
aji-170	200	3	et	et	PROPN
aji-170	200	4	al	al	PROPN
aji-170	200	5	.	.	PROPN
aji-170	200	6	,	,	PUNCT
aji-170	200	7	2020	2020	NUM
aji-170	200	8	)	)	PUNCT
aji-170	200	9	n	n	NOUN
aji-170	200	10	=	=	NUM
aji-170	200	11	12	12	NUM
aji-170	200	12	;	;	PUNCT
aji-170	200	13	60	60	NUM
aji-170	200	14	wrsa	wrsa	NOUN
aji-170	200	15	and	and	CCONJ
aji-170	200	16	60	60	NUM
aji-170	200	17	hc	hc	ADV
aji-170	200	18	-	-	PUNCT
aji-170	200	19	p	p	NOUN
aji-170	200	20	decreased	decrease	VERB
aji-170	200	21	expression	expression	NOUN
aji-170	200	22	of	of	ADP
aji-170	200	23	foxp3	foxp3	NOUN
aji-170	200	24	both	both	CCONJ
aji-170	200	25	at	at	ADP
aji-170	200	26	the	the	DET
aji-170	200	27	protein	protein	NOUN
aji-170	200	28	and	and	CCONJ
aji-170	200	29	mrna	mrna	PROPN
aji-170	200	30	levels	level	NOUN
aji-170	200	31	and	and	CCONJ
aji-170	200	32	reduced	reduced	ADJ
aji-170	200	33	frequency	frequency	NOUN
aji-170	200	34	of	of	ADP
aji-170	200	35	cd4+cd25highcd127low/−	cd4+cd25highcd127low/−	PROPN
aji-170	200	36	regulatory	regulatory	ADJ
aji-170	200	37	t	t	NOUN
aji-170	200	38	cells	cell	NOUN
aji-170	200	39	in	in	ADP
aji-170	200	40	patients	patient	NOUN
aji-170	200	41	with	with	ADP
aji-170	200	42	rsa	rsa	PROPN
aji-170	200	43	•	•	NUM
aji-170	200	44	in	in	ADP
aji-170	200	45	wrsa	wrsa	NOUN
aji-170	200	46	,	,	PUNCT
aji-170	200	47	there	there	PRON
aji-170	200	48	is	be	VERB
aji-170	200	49	a	a	DET
aji-170	200	50	reduction	reduction	NOUN
aji-170	200	51	in	in	ADP
aji-170	200	52	the	the	DET
aji-170	200	53	number	number	NOUN
aji-170	200	54	and	and	CCONJ
aji-170	200	55	function	function	NOUN
aji-170	200	56	of	of	ADP
aji-170	200	57	tregs	treg	NOUN
aji-170	200	58	,	,	PUNCT
aji-170	200	59	which	which	PRON
aji-170	200	60	may	may	AUX
aji-170	200	61	lead	lead	VERB
aji-170	200	62	to	to	ADP
aji-170	200	63	the	the	DET
aji-170	200	64	immune	immune	ADJ
aji-170	200	65	system	system	NOUN
aji-170	200	66	attacking	attack	VERB
aji-170	200	67	the	the	DET
aji-170	200	68	foetus	foetus	NOUN
aji-170	200	69	,	,	PUNCT
aji-170	200	70	resulting	result	VERB
aji-170	200	71	in	in	ADP
aji-170	200	72	miscarriage	miscarriage	NOUN
aji-170	200	73	.	.	PUNCT
aji-170	201	1	(	(	PUNCT
aji-170	201	2	yu	yu	PROPN
aji-170	201	3	et	et	PROPN
aji-170	201	4	al	al	PROPN
aji-170	201	5	.	.	PROPN
aji-170	201	6	,	,	PUNCT
aji-170	201	7	2021	2021	NUM
aji-170	201	8	)	)	PUNCT
aji-170	202	1	n	n	PROPN
aji-170	202	2	=	=	SYM
aji-170	202	3	42	42	NUM
aji-170	202	4	;	;	PUNCT
aji-170	202	5	10	10	NUM
aji-170	202	6	=	=	NOUN
aji-170	202	7	wrsa	wrsa	NOUN
aji-170	202	8	-	-	PUNCT
aji-170	202	9	p	p	X
aji-170	202	10	;	;	PUNCT
aji-170	202	11	11	11	NUM
aji-170	202	12	=	=	SYM
aji-170	202	13	rsa	rsa	NOUN
aji-170	202	14	-	-	PUNCT
aji-170	202	15	up	up	NOUN
aji-170	202	16	;	;	PUNCT
aji-170	202	17	11	11	NUM
aji-170	202	18	=	=	SYM
aji-170	202	19	hc	hc	PROPN
aji-170	202	20	-	-	PUNCT
aji-170	202	21	p	p	NOUN
aji-170	202	22	;	;	PUNCT
aji-170	202	23	10	10	NUM
aji-170	202	24	=	=	SYM
aji-170	202	25	hc	hc	PROPN
aji-170	202	26	up	up	NOUN
aji-170	202	27	rsa	rsa	PROPN
aji-170	202	28	patients	patient	NOUN
aji-170	202	29	exhibit	exhibit	VERB
aji-170	202	30	increased	increase	VERB
aji-170	202	31	cd107a	cd107a	PROPN
aji-170	202	32	expression	expression	NOUN
aji-170	202	33	on	on	ADP
aji-170	202	34	gdt	gdt	PROPN
aji-170	202	35	cells	cell	NOUN
aji-170	202	36	,	,	PUNCT
aji-170	202	37	a	a	DET
aji-170	202	38	higher	high	ADJ
aji-170	202	39	frequency	frequency	NOUN
aji-170	202	40	of	of	ADP
aji-170	202	41	il-17asecreting	il-17asecrete	VERB
aji-170	202	42	vδ2	vδ2	PROPN
aji-170	202	43	+	+	CCONJ
aji-170	202	44	gdt	gdt	NOUN
aji-170	202	45	cells	cell	NOUN
aji-170	202	46	,	,	PUNCT
aji-170	202	47	upregulated	upregulate	VERB
aji-170	202	48	ccl8	ccl8	NOUN
aji-170	202	49	expression	expression	NOUN
aji-170	202	50	,	,	PUNCT
aji-170	202	51	and	and	CCONJ
aji-170	202	52	enhanced	enhanced	ADJ
aji-170	202	53	infiltration	infiltration	NOUN
aji-170	202	54	of	of	ADP
aji-170	202	55	cd8	cd8	PROPN
aji-170	202	56	+	+	PROPN
aji-170	202	57	t	t	PROPN
aji-170	202	58	cells	cell	NOUN
aji-170	202	59	and	and	CCONJ
aji-170	202	60	m2	m2	PROPN
aji-170	202	61	macrophages	macrophage	NOUN
aji-170	202	62	.	.	PUNCT
aji-170	203	1	additionally	additionally	ADV
aji-170	203	2	,	,	PUNCT
aji-170	203	3	pd1	pd1	VERB
aji-170	203	4	expressions	expression	NOUN
aji-170	203	5	on	on	ADP
aji-170	203	6	vd2	vd2	NOUN
aji-170	203	7	+	+	CCONJ
aji-170	203	8	gdt	gdt	NOUN
aji-170	203	9	cells	cell	NOUN
aji-170	203	10	are	be	AUX
aji-170	203	11	elevated	elevate	VERB
aji-170	203	12	in	in	ADP
aji-170	203	13	these	these	DET
aji-170	203	14	patients	patient	NOUN
aji-170	203	15	.	.	PUNCT
aji-170	204	1	•	•	NUM
aji-170	204	2	activated	activate	VERB
aji-170	204	3	gdt	gdt	NOUN
aji-170	204	4	cells	cell	NOUN
aji-170	204	5	,	,	PUNCT
aji-170	204	6	particularly	particularly	ADV
aji-170	204	7	those	those	PRON
aji-170	204	8	expressing	express	VERB
aji-170	204	9	cd107a	cd107a	PROPN
aji-170	204	10	and	and	CCONJ
aji-170	204	11	il-17a	il-17a	PROPN
aji-170	204	12	,	,	PUNCT
aji-170	204	13	may	may	AUX
aji-170	204	14	contribute	contribute	VERB
aji-170	204	15	to	to	ADP
aji-170	204	16	inflammation	inflammation	NOUN
aji-170	204	17	at	at	ADP
aji-170	204	18	the	the	DET
aji-170	204	19	maternal	maternal	ADJ
aji-170	204	20	-	-	PUNCT
aji-170	204	21	foetal	foetal	ADJ
aji-170	204	22	interface	interface	NOUN
aji-170	204	23	;	;	PUNCT
aji-170	204	24	these	these	DET
aji-170	204	25	cells	cell	NOUN
aji-170	204	26	have	have	VERB
aji-170	204	27	an	an	DET
aji-170	204	28	enhanced	enhanced	ADJ
aji-170	204	29	ability	ability	NOUN
aji-170	204	30	to	to	PART
aji-170	204	31	kill	kill	VERB
aji-170	204	32	other	other	ADJ
aji-170	204	33	cells	cell	NOUN
aji-170	204	34	,	,	PUNCT
aji-170	204	35	potentially	potentially	ADV
aji-170	204	36	leading	lead	VERB
aji-170	204	37	to	to	ADP
aji-170	204	38	rsa	rsa	PROPN
aji-170	204	39	.	.	PUNCT
aji-170	205	1	(	(	PUNCT
aji-170	205	2	wang	wang	PROPN
aji-170	205	3	et	et	PROPN
aji-170	205	4	al	al	PROPN
aji-170	205	5	.	.	PROPN
aji-170	205	6	,	,	PUNCT
aji-170	205	7	2019	2019	NUM
aji-170	205	8	)	)	PUNCT
aji-170	205	9	n	n	NOUN
aji-170	205	10	=	=	SYM
aji-170	205	11	37	37	NUM
aji-170	205	12	18	18	NUM
aji-170	205	13	normal	normal	ADJ
aji-170	205	14	pregnancies	pregnancy	NOUN
aji-170	205	15	19	19	NUM
aji-170	205	16	abortion	abortion	NOUN
aji-170	205	17	-	-	PUNCT
aji-170	205	18	prone	prone	ADJ
aji-170	205	19	model	model	NOUN
aji-170	205	20	decreased	decrease	VERB
aji-170	205	21	frequency	frequency	NOUN
aji-170	205	22	of	of	ADP
aji-170	205	23	splenic	splenic	PROPN
aji-170	205	24	t	t	PROPN
aji-170	205	25	cells	cell	NOUN
aji-170	205	26	co	co	VERB
aji-170	205	27	-	-	VERB
aji-170	205	28	expressing	express	VERB
aji-170	205	29	ctla-4	ctla-4	NOUN
aji-170	205	30	and	and	CCONJ
aji-170	205	31	tim-3	tim-3	VERB
aji-170	205	32	in	in	ADP
aji-170	205	33	miscarriage	miscarriage	NOUN
aji-170	205	34	models	model	NOUN
aji-170	205	35	•	•	ADV
aji-170	205	36	in	in	ADP
aji-170	205	37	the	the	DET
aji-170	205	38	abortion	abortion	NOUN
aji-170	205	39	prone	prone	ADJ
aji-170	205	40	model	model	NOUN
aji-170	205	41	,	,	PUNCT
aji-170	205	42	there	there	PRON
aji-170	205	43	is	be	VERB
aji-170	205	44	a	a	DET
aji-170	205	45	decrease	decrease	NOUN
aji-170	205	46	in	in	ADP
aji-170	205	47	splenic	splenic	PROPN
aji-170	205	48	t	t	PROPN
aji-170	205	49	cells	cell	NOUN
aji-170	205	50	co	co	VERB
aji-170	205	51	-	-	VERB
aji-170	205	52	expressing	express	VERB
aji-170	205	53	ctla-4	ctla-4	NOUN
aji-170	205	54	and	and	CCONJ
aji-170	205	55	tim-3	tim-3	NUM
aji-170	205	56	,	,	PUNCT
aji-170	205	57	which	which	PRON
aji-170	205	58	is	be	AUX
aji-170	205	59	linked	link	VERB
aji-170	205	60	to	to	ADP
aji-170	205	61	changes	change	NOUN
aji-170	205	62	in	in	ADP
aji-170	205	63	cytokine	cytokine	NOUN
aji-170	205	64	;	;	PUNCT
aji-170	205	65	there	there	PRON
aji-170	205	66	is	be	VERB
aji-170	205	67	an	an	DET
aji-170	205	68	increase	increase	NOUN
aji-170	205	69	in	in	ADP
aji-170	205	70	walana	walana	PROPN
aji-170	205	71	et	et	PROPN
aji-170	205	72	al	al	PROPN
aji-170	205	73	.	.	PROPN
aji-170	205	74	;	;	PUNCT
aji-170	205	75	asian	asian	PROPN
aji-170	205	76	j.	j.	PROPN
aji-170	205	77	immunol	immunol	PROPN
aji-170	205	78	.	.	PROPN
aji-170	205	79	,	,	PUNCT
aji-170	205	80	vol	vol	NOUN
aji-170	205	81	.	.	PROPN
aji-170	205	82	8	8	NUM
aji-170	205	83	,	,	PUNCT
aji-170	205	84	no	no	INTJ
aji-170	205	85	.	.	NOUN
aji-170	205	86	1	1	NUM
aji-170	205	87	,	,	PUNCT
aji-170	205	88	pp	pp	ADJ
aji-170	205	89	.	.	PUNCT
aji-170	206	1	179	179	NUM
aji-170	206	2	-	-	SYM
aji-170	206	3	189	189	NUM
aji-170	206	4	,	,	PUNCT
aji-170	206	5	2025	2025	NUM
aji-170	206	6	;	;	PUNCT
aji-170	206	7	article	article	NOUN
aji-170	206	8	no.aji.139815	no.aji.139815	VERB
aji-170	206	9	185	185	NUM
aji-170	206	10	authors	author	NOUN
aji-170	206	11	;	;	PUNCT
aji-170	206	12	year	year	NOUN
aji-170	206	13	population	population	NOUN
aji-170	206	14	characteristics	characteristic	VERB
aji-170	206	15	t	t	PROPN
aji-170	206	16	-	-	PUNCT
aji-170	206	17	cells	cell	NOUN
aji-170	206	18	&	&	CCONJ
aji-170	206	19	exhaustion	exhaustion	NOUN
aji-170	206	20	markers	marker	NOUN
aji-170	206	21	practical	practical	ADJ
aji-170	206	22	implications	implication	NOUN
aji-170	206	23	pro	pro	ADJ
aji-170	206	24	-	-	ADJ
aji-170	206	25	inflammatory	inflammatory	ADJ
aji-170	206	26	cytokines	cytokine	NOUN
aji-170	206	27	(	(	PUNCT
aji-170	206	28	e.g.	e.g.	ADV
aji-170	206	29	,	,	PUNCT
aji-170	206	30	tnf	tnf	PROPN
aji-170	206	31	-	-	PUNCT
aji-170	206	32	α	α	NOUN
aji-170	206	33	)	)	PUNCT
aji-170	206	34	and	and	CCONJ
aji-170	206	35	a	a	DET
aji-170	206	36	decrease	decrease	NOUN
aji-170	206	37	in	in	ADP
aji-170	206	38	anti	anti	ADJ
aji-170	206	39	-	-	ADJ
aji-170	206	40	inflammatory	inflammatory	ADJ
aji-170	206	41	cytokines	cytokine	NOUN
aji-170	206	42	(	(	PUNCT
aji-170	206	43	e.g.	e.g.	ADV
aji-170	206	44	,	,	PUNCT
aji-170	206	45	il-4	il-4	PRON
aji-170	206	46	,	,	PUNCT
aji-170	206	47	il10	il10	PROPN
aji-170	206	48	)	)	PUNCT
aji-170	206	49	.	.	PUNCT
aji-170	207	1	(	(	PUNCT
aji-170	207	2	li	li	PROPN
aji-170	207	3	et	et	PROPN
aji-170	207	4	al	al	PROPN
aji-170	207	5	.	.	PROPN
aji-170	207	6	,	,	PUNCT
aji-170	207	7	2017	2017	NUM
aji-170	207	8	)	)	PUNCT
aji-170	208	1	n	n	NOUN
aji-170	208	2	=	=	SYM
aji-170	208	3	18	18	NUM
aji-170	208	4	;	;	PUNCT
aji-170	208	5	10	10	NUM
aji-170	208	6	=	=	SYM
aji-170	208	7	wrsa	wrsa	NOUN
aji-170	208	8	,	,	PUNCT
aji-170	208	9	hc	hc	PROPN
aji-170	208	10	-	-	PUNCT
aji-170	208	11	p	p	NOUN
aji-170	208	12	=	=	NOUN
aji-170	208	13	8	8	NUM
aji-170	208	14	tim-3	tim-3	NUM
aji-170	208	15	+	+	NOUN
aji-170	208	16	nk	nk	PROPN
aji-170	208	17	cells	cell	NOUN
aji-170	208	18	from	from	ADP
aji-170	208	19	wrsa	wrsa	NOUN
aji-170	208	20	produce	produce	VERB
aji-170	208	21	fewer	few	ADJ
aji-170	208	22	anti	anti	ADJ
aji-170	208	23	-	-	ADJ
aji-170	208	24	inflammatory	inflammatory	ADJ
aji-170	208	25	cytokines	cytokine	NOUN
aji-170	208	26	and	and	CCONJ
aji-170	208	27	have	have	AUX
aji-170	208	28	increased	increase	VERB
aji-170	208	29	cytotoxicity	cytotoxicity	NOUN
aji-170	208	30	compared	compare	VERB
aji-170	208	31	to	to	ADP
aji-170	208	32	those	those	PRON
aji-170	208	33	from	from	ADP
aji-170	208	34	normal	normal	ADJ
aji-170	208	35	pregnancies	pregnancy	NOUN
aji-170	208	36	•	•	ADP
aji-170	208	37	tim-3	tim-3	NUM
aji-170	208	38	+	+	CCONJ
aji-170	208	39	nk	nk	PROPN
aji-170	208	40	produces	produce	VERB
aji-170	208	41	more	more	ADJ
aji-170	208	42	anti	anti	ADJ
aji-170	208	43	-	-	ADJ
aji-170	208	44	inflammatory	inflammatory	ADJ
aji-170	208	45	cytokines	cytokine	NOUN
aji-170	208	46	(	(	PUNCT
aji-170	208	47	tgf	tgf	NOUN
aji-170	208	48	-	-	PUNCT
aji-170	208	49	β1	β1	PROPN
aji-170	208	50	,	,	PUNCT
aji-170	208	51	il-10	il-10	PRON
aji-170	208	52	,	,	PUNCT
aji-170	208	53	il-4	il-4	PRON
aji-170	208	54	)	)	PUNCT
aji-170	208	55	and	and	CCONJ
aji-170	208	56	fewer	few	ADJ
aji-170	208	57	pro	pro	ADJ
aji-170	208	58	-	-	ADJ
aji-170	208	59	inflammatory	inflammatory	ADJ
aji-170	208	60	cytokines	cytokine	NOUN
aji-170	208	61	(	(	PUNCT
aji-170	208	62	tnf	tnf	PROPN
aji-170	208	63	-	-	PUNCT
aji-170	208	64	α	α	NOUN
aji-170	208	65	)	)	PUNCT
aji-170	208	66	,	,	PUNCT
aji-170	208	67	fostering	foster	VERB
aji-170	208	68	immune	immune	ADJ
aji-170	208	69	tolerance	tolerance	NOUN
aji-170	208	70	,	,	PUNCT
aji-170	208	71	and	and	CCONJ
aji-170	208	72	wrsa	wrsa	NOUN
aji-170	208	73	produces	produce	VERB
aji-170	208	74	fewer	few	ADJ
aji-170	208	75	anti	anti	ADJ
aji-170	208	76	-	-	ADJ
aji-170	208	77	inflammatory	inflammatory	ADJ
aji-170	208	78	cytokines	cytokine	NOUN
aji-170	208	79	,	,	PUNCT
aji-170	208	80	resulting	result	VERB
aji-170	208	81	in	in	ADP
aji-170	208	82	pregnancy	pregnancy	NOUN
aji-170	208	83	loss	loss	NOUN
aji-170	208	84	(	(	PUNCT
aji-170	208	85	xu	xu	INTJ
aji-170	208	86	et	et	PROPN
aji-170	208	87	al	al	PROPN
aji-170	208	88	.	.	PROPN
aji-170	208	89	,	,	PUNCT
aji-170	208	90	2017	2017	NUM
aji-170	208	91	)	)	PUNCT
aji-170	209	1	n=18	n=18	NOUN
aji-170	209	2	;	;	PUNCT
aji-170	209	3	9	9	NUM
aji-170	209	4	mice	mouse	NOUN
aji-170	209	5	were	be	AUX
aji-170	209	6	normal	normal	ADJ
aji-170	209	7	,	,	PUNCT
aji-170	209	8	and	and	CCONJ
aji-170	209	9	nine	nine	NUM
aji-170	209	10	were	be	AUX
aji-170	209	11	abortion	abortion	NOUN
aji-170	209	12	-	-	PUNCT
aji-170	209	13	prone	prone	ADJ
aji-170	209	14	matings	mating	NOUN
aji-170	209	15	in	in	ADP
aji-170	209	16	the	the	DET
aji-170	209	17	study	study	NOUN
aji-170	209	18	.	.	PUNCT
aji-170	210	1	tim-3	tim-3	PUNCT
aji-170	210	2	and	and	CCONJ
aji-170	210	3	pd-1	pd-1	ADV
aji-170	210	4	pathways	pathway	NOUN
aji-170	210	5	were	be	AUX
aji-170	210	6	blocked	block	VERB
aji-170	210	7	in	in	ADP
aji-170	210	8	pregnant	pregnant	ADJ
aji-170	210	9	mice	mouse	NOUN
aji-170	210	10	.	.	PUNCT
aji-170	211	1	•	•	NUM
aji-170	211	2	tim-3	tim-3	X
aji-170	211	3	and	and	CCONJ
aji-170	211	4	pd-1	pd-1	ADV
aji-170	211	5	regulate	regulate	VERB
aji-170	211	6	cd8	cd8	PROPN
aji-170	211	7	+	+	PROPN
aji-170	211	8	t	t	PROPN
aji-170	211	9	cell	cell	NOUN
aji-170	211	10	function	function	NOUN
aji-170	211	11	to	to	PART
aji-170	211	12	maintain	maintain	VERB
aji-170	211	13	early	early	ADJ
aji-170	211	14	pregnancy	pregnancy	NOUN
aji-170	211	15	in	in	ADP
aji-170	211	16	mice	mice	NOUN
aji-170	211	17	•	•	ADP
aji-170	211	18	cd8	cd8	PROPN
aji-170	211	19	+	+	PROPN
aji-170	211	20	t	t	NOUN
aji-170	211	21	cells	cell	NOUN
aji-170	211	22	that	that	PRON
aji-170	211	23	co	co	VERB
aji-170	211	24	-	-	VERB
aji-170	211	25	express	express	ADJ
aji-170	211	26	tim-3	tim-3	PUNCT
aji-170	211	27	and	and	CCONJ
aji-170	211	28	pd-1	pd-1	ADV
aji-170	211	29	were	be	AUX
aji-170	211	30	reduced	reduce	VERB
aji-170	211	31	in	in	ADP
aji-170	211	32	the	the	DET
aji-170	211	33	decidua	decidua	NOUN
aji-170	211	34	of	of	ADP
aji-170	211	35	mice	mouse	NOUN
aji-170	211	36	with	with	ADP
aji-170	211	37	abortion	abortion	NOUN
aji-170	211	38	-	-	PUNCT
aji-170	211	39	prone	prone	ADJ
aji-170	211	40	matings	mating	NOUN
aji-170	211	41	•	•	ADP
aji-170	211	42	blocking	block	VERB
aji-170	211	43	tim-3	tim-3	PUNCT
aji-170	211	44	and	and	CCONJ
aji-170	211	45	pd-1	pd-1	ADV
aji-170	211	46	in	in	ADP
aji-170	211	47	normal	normal	ADJ
aji-170	211	48	pregnant	pregnant	ADJ
aji-170	211	49	mice	mouse	NOUN
aji-170	211	50	led	lead	VERB
aji-170	211	51	to	to	ADP
aji-170	211	52	increased	increase	VERB
aji-170	211	53	foetal	foetal	ADJ
aji-170	211	54	resorption	resorption	NOUN
aji-170	211	55	(	(	PUNCT
aji-170	211	56	wang	wang	PROPN
aji-170	211	57	et	et	PROPN
aji-170	211	58	al	al	PROPN
aji-170	211	59	.	.	PROPN
aji-170	211	60	,	,	PUNCT
aji-170	211	61	2016	2016	NUM
aji-170	211	62	)	)	PUNCT
aji-170	211	63	36	36	NUM
aji-170	211	64	normal	normal	ADJ
aji-170	211	65	pregnant	pregnant	ADJ
aji-170	211	66	mice	mouse	NOUN
aji-170	211	67	45	45	NUM
aji-170	211	68	abortion	abortion	NOUN
aji-170	211	69	-	-	PUNCT
aji-170	211	70	prone	prone	ADJ
aji-170	211	71	mice	mouse	NOUN
aji-170	211	72	decreased	decrease	VERB
aji-170	211	73	pd-1	pd-1	ADP
aji-170	211	74	and	and	CCONJ
aji-170	211	75	tim-3	tim-3	NUM
aji-170	211	76	expression	expression	NOUN
aji-170	211	77	on	on	ADP
aji-170	211	78	cd4	cd4	PROPN
aji-170	211	79	+	+	PROPN
aji-170	211	80	t	t	NOUN
aji-170	211	81	cells	cell	NOUN
aji-170	211	82	in	in	ADP
aji-170	211	83	abortion	abortion	NOUN
aji-170	211	84	prone	prone	ADJ
aji-170	211	85	mice	mice	NOUN
aji-170	211	86	.	.	PUNCT
aji-170	212	1	•	•	NOUN
aji-170	212	2	blocking	block	VERB
aji-170	212	3	pd-1	pd-1	ADP
aji-170	212	4	and	and	CCONJ
aji-170	212	5	tim-3	tim-3	NUM
aji-170	212	6	pathways	pathway	NOUN
aji-170	212	7	in	in	ADP
aji-170	212	8	experimental	experimental	ADJ
aji-170	212	9	models	model	NOUN
aji-170	212	10	led	lead	VERB
aji-170	212	11	to	to	PART
aji-170	212	12	decreased	decrease	VERB
aji-170	212	13	th2	th2	PROPN
aji-170	212	14	cytokine	cytokine	ADJ
aji-170	212	15	production	production	NOUN
aji-170	212	16	and	and	CCONJ
aji-170	212	17	increased	increase	VERB
aji-170	212	18	foetal	foetal	ADJ
aji-170	212	19	resorption	resorption	NOUN
aji-170	212	20	.	.	PUNCT
aji-170	213	1	(	(	PUNCT
aji-170	213	2	sun	sun	NOUN
aji-170	213	3	et	et	PROPN
aji-170	213	4	al	al	PROPN
aji-170	213	5	.	.	PROPN
aji-170	213	6	,	,	PUNCT
aji-170	213	7	2016	2016	NUM
aji-170	213	8	)	)	PUNCT
aji-170	214	1	n	n	PROPN
aji-170	214	2	=	=	NUM
aji-170	214	3	80	80	NUM
aji-170	214	4	;	;	PUNCT
aji-170	214	5	20	20	NUM
aji-170	214	6	=	=	SYM
aji-170	214	7	wrsa	wrsa	NOUN
aji-170	214	8	,	,	PUNCT
aji-170	214	9	30	30	NUM
aji-170	214	10	=	=	SYM
aji-170	214	11	hc	hc	PROPN
aji-170	214	12	-	-	PUNCT
aji-170	214	13	np	np	NOUN
aji-170	214	14	and	and	CCONJ
aji-170	214	15	30	30	NUM
aji-170	214	16	hc	hc	PROPN
aji-170	214	17	-	-	PUNCT
aji-170	214	18	p	p	NOUN
aji-170	214	19	tim-3	tim-3	NUM
aji-170	214	20	levels	level	NOUN
aji-170	214	21	are	be	AUX
aji-170	214	22	lower	low	ADJ
aji-170	214	23	in	in	ADP
aji-170	214	24	nk	nk	PROPN
aji-170	214	25	cells	cell	NOUN
aji-170	214	26	from	from	ADP
aji-170	214	27	wrsa	wrsa	NOUN
aji-170	214	28	than	than	ADP
aji-170	214	29	in	in	ADP
aji-170	214	30	normal	normal	ADJ
aji-170	214	31	pregnancies	pregnancy	NOUN
aji-170	214	32	.	.	PUNCT
aji-170	215	1	tim-3	tim-3	PUNCT
aji-170	215	2	is	be	AUX
aji-170	215	3	more	more	ADV
aji-170	215	4	abundant	abundant	ADJ
aji-170	215	5	in	in	ADP
aji-170	215	6	dnk	dnk	NOUN
aji-170	215	7	cells	cell	NOUN
aji-170	215	8	during	during	ADP
aji-170	215	9	early	early	ADJ
aji-170	215	10	pregnancy	pregnancy	NOUN
aji-170	215	11	than	than	ADP
aji-170	215	12	pnk	pnk	NOUN
aji-170	215	13	cells	cell	NOUN
aji-170	215	14	.	.	PUNCT
aji-170	216	1	blocking	block	VERB
aji-170	216	2	tim-3	tim-3	PUNCT
aji-170	216	3	reduces	reduce	VERB
aji-170	216	4	cytokine	cytokine	ADJ
aji-170	216	5	production	production	NOUN
aji-170	216	6	in	in	ADP
aji-170	216	7	dnk	dnk	NOUN
aji-170	216	8	cells	cell	NOUN
aji-170	216	9	.	.	PUNCT
aji-170	217	1	•	•	NUM
aji-170	217	2	tim-3	tim-3	NUM
aji-170	217	3	influences	influence	VERB
aji-170	217	4	the	the	DET
aji-170	217	5	production	production	NOUN
aji-170	217	6	of	of	ADP
aji-170	217	7	cytokines	cytokine	NOUN
aji-170	217	8	like	like	ADP
aji-170	217	9	ifn	ifn	PROPN
aji-170	217	10	-	-	PUNCT
aji-170	217	11	γ	γ	X
aji-170	217	12	and	and	CCONJ
aji-170	217	13	tnf	tnf	PROPN
aji-170	217	14	-	-	PUNCT
aji-170	217	15	α	α	PROPN
aji-170	217	16	in	in	ADP
aji-170	217	17	dnk	dnk	NOUN
aji-170	217	18	cells	cell	NOUN
aji-170	217	19	,	,	PUNCT
aji-170	217	20	essential	essential	ADJ
aji-170	217	21	for	for	ADP
aji-170	217	22	immune	immune	ADJ
aji-170	217	23	tolerance	tolerance	NOUN
aji-170	217	24	and	and	CCONJ
aji-170	217	25	vascular	vascular	ADJ
aji-170	217	26	remodelling	remodelling	NOUN
aji-170	217	27	.	.	PUNCT
aji-170	218	1	•	•	NUM
aji-170	218	2	tim-3	tim-3	NOUN
aji-170	218	3	's	's	PART
aji-170	218	4	interaction	interaction	NOUN
aji-170	218	5	with	with	ADP
aji-170	218	6	galectin-9	galectin-9	PROPN
aji-170	218	7	inhibits	inhibit	VERB
aji-170	218	8	nk	nk	PROPN
aji-170	218	9	cell	cell	NOUN
aji-170	218	10	cytotoxicity	cytotoxicity	NOUN
aji-170	218	11	towards	towards	ADP
aji-170	218	12	trophoblasts	trophoblast	NOUN
aji-170	218	13	,	,	PUNCT
aji-170	218	14	preventing	prevent	VERB
aji-170	218	15	placental	placental	ADJ
aji-170	218	16	damage	damage	NOUN
aji-170	218	17	and	and	CCONJ
aji-170	218	18	supporting	support	VERB
aji-170	218	19	foetal	foetal	ADJ
aji-170	218	20	development	development	NOUN
aji-170	218	21	.	.	PUNCT
aji-170	219	1	walana	walana	PROPN
aji-170	219	2	et	et	PROPN
aji-170	219	3	al	al	PROPN
aji-170	219	4	.	.	PROPN
aji-170	219	5	;	;	PUNCT
aji-170	219	6	asian	asian	PROPN
aji-170	219	7	j.	j.	PROPN
aji-170	219	8	immunol	immunol	PROPN
aji-170	219	9	.	.	PROPN
aji-170	219	10	,	,	PUNCT
aji-170	219	11	vol	vol	NOUN
aji-170	219	12	.	.	PROPN
aji-170	219	13	8	8	NUM
aji-170	219	14	,	,	PUNCT
aji-170	219	15	no	no	INTJ
aji-170	219	16	.	.	NOUN
aji-170	219	17	1	1	NUM
aji-170	219	18	,	,	PUNCT
aji-170	219	19	pp	pp	ADJ
aji-170	219	20	.	.	PUNCT
aji-170	220	1	179	179	NUM
aji-170	220	2	-	-	SYM
aji-170	220	3	189	189	NUM
aji-170	220	4	,	,	PUNCT
aji-170	220	5	2025	2025	NUM
aji-170	220	6	;	;	PUNCT
aji-170	220	7	article	article	NOUN
aji-170	220	8	no.aji.139815	no.aji.139815	VERB
aji-170	220	9	186	186	NUM
aji-170	220	10	3	3	NUM
aji-170	220	11	.	.	PUNCT
aji-170	221	1	results	result	NOUN
aji-170	221	2	and	and	CCONJ
aji-170	221	3	discussion	discussion	NOUN
aji-170	221	4	3.1	3.1	NUM
aji-170	221	5	study	study	NOUN
aji-170	221	6	identification	identification	NOUN
aji-170	221	7	and	and	CCONJ
aji-170	221	8	retrieval	retrieval	NOUN
aji-170	221	9	fig	fig	NOUN
aji-170	221	10	.	.	PUNCT
aji-170	222	1	1	1	NUM
aji-170	222	2	illustrates	illustrate	VERB
aji-170	222	3	the	the	DET
aji-170	222	4	step	step	NOUN
aji-170	222	5	-	-	PUNCT
aji-170	222	6	by	by	ADP
aji-170	222	7	-	-	PUNCT
aji-170	222	8	step	step	NOUN
aji-170	222	9	processes	process	NOUN
aji-170	222	10	of	of	ADP
aji-170	222	11	identifying	identify	VERB
aji-170	222	12	,	,	PUNCT
aji-170	222	13	retrieving	retrieve	VERB
aji-170	222	14	,	,	PUNCT
aji-170	222	15	and	and	CCONJ
aji-170	222	16	selecting	select	VERB
aji-170	222	17	studies	study	NOUN
aji-170	222	18	for	for	ADP
aji-170	222	19	this	this	DET
aji-170	222	20	review	review	NOUN
aji-170	222	21	.	.	PUNCT
aji-170	223	1	our	our	PRON
aji-170	223	2	literature	literature	NOUN
aji-170	223	3	search	search	NOUN
aji-170	223	4	yielded	yield	VERB
aji-170	223	5	23,000	23,000	NUM
aji-170	223	6	articles	article	NOUN
aji-170	223	7	from	from	ADP
aji-170	223	8	google	google	PROPN
aji-170	223	9	scholar	scholar	NOUN
aji-170	223	10	,	,	PUNCT
aji-170	223	11	12,959	12,959	NUM
aji-170	223	12	from	from	ADP
aji-170	223	13	pubmed	pubmed	PROPN
aji-170	223	14	,	,	PUNCT
aji-170	223	15	and	and	CCONJ
aji-170	223	16	367	367	NUM
aji-170	223	17	from	from	ADP
aji-170	223	18	web	web	NOUN
aji-170	223	19	of	of	ADP
aji-170	223	20	science	science	NOUN
aji-170	223	21	.	.	PUNCT
aji-170	224	1	after	after	ADP
aji-170	224	2	filtering	filter	VERB
aji-170	224	3	to	to	PART
aji-170	224	4	remove	remove	VERB
aji-170	224	5	duplicates	duplicate	NOUN
aji-170	224	6	and	and	CCONJ
aji-170	224	7	irrelevant	irrelevant	ADJ
aji-170	224	8	studies	study	NOUN
aji-170	224	9	,	,	PUNCT
aji-170	224	10	50	50	NUM
aji-170	224	11	articles	article	NOUN
aji-170	224	12	qualified	qualify	VERB
aji-170	224	13	for	for	ADP
aji-170	224	14	a	a	DET
aji-170	224	15	thorough	thorough	ADJ
aji-170	224	16	fulltext	fulltext	NOUN
aji-170	224	17	evaluation	evaluation	NOUN
aji-170	224	18	.	.	PUNCT
aji-170	225	1	upon	upon	SCONJ
aji-170	225	2	further	further	ADJ
aji-170	225	3	assessment	assessment	NOUN
aji-170	225	4	,	,	PUNCT
aji-170	225	5	21	21	NUM
aji-170	225	6	of	of	ADP
aji-170	225	7	these	these	DET
aji-170	225	8	studies	study	NOUN
aji-170	225	9	met	meet	VERB
aji-170	225	10	the	the	DET
aji-170	225	11	predetermined	predetermine	VERB
aji-170	225	12	inclusion	inclusion	NOUN
aji-170	225	13	criteria	criterion	NOUN
aji-170	225	14	and	and	CCONJ
aji-170	225	15	were	be	AUX
aji-170	225	16	included	include	VERB
aji-170	225	17	in	in	ADP
aji-170	225	18	the	the	DET
aji-170	225	19	review	review	NOUN
aji-170	225	20	.	.	PUNCT
aji-170	226	1	4	4	X
aji-170	226	2	.	.	X
aji-170	226	3	discussion	discussion	NOUN
aji-170	226	4	recurrent	recurrent	VERB
aji-170	226	5	spontaneous	spontaneous	ADJ
aji-170	226	6	abortion	abortion	NOUN
aji-170	226	7	(	(	PUNCT
aji-170	226	8	rsa	rsa	NOUN
aji-170	226	9	)	)	PUNCT
aji-170	226	10	is	be	AUX
aji-170	226	11	a	a	DET
aji-170	226	12	multifaceted	multifaceted	ADJ
aji-170	226	13	condition	condition	NOUN
aji-170	226	14	where	where	SCONJ
aji-170	226	15	maternal	maternal	ADJ
aji-170	226	16	immune	immune	ADJ
aji-170	226	17	dysregulation	dysregulation	NOUN
aji-170	226	18	is	be	AUX
aji-170	226	19	a	a	DET
aji-170	226	20	pivotal	pivotal	ADJ
aji-170	226	21	factor	factor	NOUN
aji-170	226	22	.	.	PUNCT
aji-170	227	1	evidence	evidence	NOUN
aji-170	227	2	consistently	consistently	ADV
aji-170	227	3	highlights	highlight	VERB
aji-170	227	4	an	an	DET
aji-170	227	5	imbalance	imbalance	NOUN
aji-170	227	6	between	between	ADP
aji-170	227	7	pro	pro	ADJ
aji-170	227	8	-	-	ADJ
aji-170	227	9	inflammatory	inflammatory	ADJ
aji-170	227	10	and	and	CCONJ
aji-170	227	11	regulatory	regulatory	ADJ
aji-170	227	12	immune	immune	ADJ
aji-170	227	13	responses	response	NOUN
aji-170	227	14	central	central	ADJ
aji-170	227	15	to	to	ADP
aji-170	227	16	rsa	rsa	PROPN
aji-170	227	17	pathophysiology	pathophysiology	NOUN
aji-170	227	18	.	.	PUNCT
aji-170	228	1	for	for	ADP
aji-170	228	2	example	example	NOUN
aji-170	228	3	,	,	PUNCT
aji-170	228	4	reduced	reduced	ADJ
aji-170	228	5	expression	expression	NOUN
aji-170	228	6	of	of	ADP
aji-170	228	7	immune	immune	ADJ
aji-170	228	8	checkpoints	checkpoint	NOUN
aji-170	228	9	,	,	PUNCT
aji-170	228	10	such	such	ADJ
aji-170	228	11	as	as	ADP
aji-170	228	12	pd-1	pd-1	ADV
aji-170	228	13	and	and	CCONJ
aji-170	228	14	tim-3	tim-3	NUM
aji-170	228	15	,	,	PUNCT
aji-170	228	16	on	on	ADP
aji-170	228	17	t	t	PROPN
aji-170	228	18	cells	cell	NOUN
aji-170	228	19	—	—	PUNCT
aji-170	228	20	crucial	crucial	ADJ
aji-170	228	21	for	for	ADP
aji-170	228	22	suppressing	suppress	VERB
aji-170	228	23	inflammation	inflammation	NOUN
aji-170	228	24	—	—	PUNCT
aji-170	228	25	has	have	AUX
aji-170	228	26	been	be	AUX
aji-170	228	27	observed	observe	VERB
aji-170	228	28	in	in	ADP
aji-170	228	29	rsa	rsa	PROPN
aji-170	228	30	cases	case	NOUN
aji-170	228	31	,	,	PUNCT
aji-170	228	32	suggesting	suggest	VERB
aji-170	228	33	impaired	impair	VERB
aji-170	228	34	immune	immune	ADJ
aji-170	228	35	tolerance	tolerance	NOUN
aji-170	228	36	at	at	ADP
aji-170	228	37	the	the	DET
aji-170	228	38	maternal	maternal	ADJ
aji-170	228	39	-	-	PUNCT
aji-170	228	40	foetal	foetal	ADJ
aji-170	228	41	interface	interface	NOUN
aji-170	228	42	(	(	PUNCT
aji-170	228	43	zych	zych	NOUN
aji-170	228	44	et	et	NOUN
aji-170	228	45	al	al	PROPN
aji-170	228	46	.	.	PROPN
aji-170	228	47	,	,	PUNCT
aji-170	228	48	2021	2021	NUM
aji-170	228	49	;	;	PUNCT
aji-170	228	50	wang	wang	PROPN
aji-170	228	51	et	et	PROPN
aji-170	228	52	al	al	PROPN
aji-170	228	53	.	.	PROPN
aji-170	228	54	,	,	PUNCT
aji-170	228	55	2020	2020	NUM
aji-170	228	56	)	)	PUNCT
aji-170	228	57	.	.	PUNCT
aji-170	229	1	additionally	additionally	ADV
aji-170	229	2	,	,	PUNCT
aji-170	229	3	elevated	elevated	ADJ
aji-170	229	4	levels	level	NOUN
aji-170	229	5	of	of	ADP
aji-170	229	6	th17	th17	PROPN
aji-170	229	7	cells	cell	NOUN
aji-170	229	8	and	and	CCONJ
aji-170	229	9	a	a	DET
aji-170	229	10	reduction	reduction	NOUN
aji-170	229	11	in	in	ADP
aji-170	229	12	regulatory	regulatory	ADJ
aji-170	229	13	t	t	NOUN
aji-170	229	14	cells	cell	NOUN
aji-170	229	15	(	(	PUNCT
aji-170	229	16	tregs	treg	NOUN
aji-170	229	17	)	)	PUNCT
aji-170	229	18	further	far	ADV
aji-170	229	19	underscore	underscore	VERB
aji-170	229	20	a	a	DET
aji-170	229	21	shift	shift	NOUN
aji-170	229	22	towards	towards	ADP
aji-170	229	23	a	a	DET
aji-170	229	24	pro	pro	ADJ
aji-170	229	25	-	-	ADJ
aji-170	229	26	inflammatory	inflammatory	ADJ
aji-170	229	27	immune	immune	ADJ
aji-170	229	28	environment	environment	NOUN
aji-170	229	29	that	that	PRON
aji-170	229	30	may	may	AUX
aji-170	229	31	lead	lead	VERB
aji-170	229	32	to	to	ADP
aji-170	229	33	pregnancy	pregnancy	NOUN
aji-170	229	34	loss	loss	NOUN
aji-170	229	35	(	(	PUNCT
aji-170	229	36	vahid	vahid	PROPN
aji-170	229	37	et	et	PROPN
aji-170	229	38	al	al	PROPN
aji-170	229	39	.	.	PROPN
aji-170	229	40	,	,	PUNCT
aji-170	229	41	2018	2018	NUM
aji-170	229	42	;	;	PUNCT
aji-170	229	43	qian	qian	PROPN
aji-170	229	44	et	et	PROPN
aji-170	229	45	al	al	PROPN
aji-170	229	46	.	.	PROPN
aji-170	229	47	,	,	PUNCT
aji-170	229	48	2018	2018	NUM
aji-170	229	49	)	)	PUNCT
aji-170	229	50	.	.	PUNCT
aji-170	230	1	natural	natural	ADJ
aji-170	230	2	killer	killer	NOUN
aji-170	230	3	(	(	PUNCT
aji-170	230	4	nk	nk	PROPN
aji-170	230	5	)	)	PUNCT
aji-170	230	6	cells	cell	NOUN
aji-170	230	7	also	also	ADV
aji-170	230	8	exhibit	exhibit	VERB
aji-170	230	9	substantial	substantial	ADJ
aji-170	230	10	dysregulation	dysregulation	NOUN
aji-170	230	11	in	in	ADP
aji-170	230	12	rsa	rsa	PROPN
aji-170	230	13	.	.	PUNCT
aji-170	231	1	studies	study	NOUN
aji-170	231	2	have	have	AUX
aji-170	231	3	documented	document	VERB
aji-170	231	4	increased	increase	VERB
aji-170	231	5	cytotoxic	cytotoxic	ADJ
aji-170	231	6	nk	nk	NOUN
aji-170	231	7	cell	cell	NOUN
aji-170	231	8	activity	activity	NOUN
aji-170	231	9	alongside	alongside	ADP
aji-170	231	10	reduced	reduce	VERB
aji-170	231	11	levels	level	NOUN
aji-170	231	12	of	of	ADP
aji-170	231	13	immunoregulatory	immunoregulatory	ADJ
aji-170	231	14	subsets	subset	NOUN
aji-170	231	15	,	,	PUNCT
aji-170	231	16	a	a	DET
aji-170	231	17	combination	combination	NOUN
aji-170	231	18	that	that	PRON
aji-170	231	19	disrupts	disrupt	VERB
aji-170	231	20	the	the	DET
aji-170	231	21	immune	immune	ADJ
aji-170	231	22	balance	balance	NOUN
aji-170	231	23	essential	essential	ADJ
aji-170	231	24	for	for	ADP
aji-170	231	25	successful	successful	ADJ
aji-170	231	26	pregnancy	pregnancy	NOUN
aji-170	231	27	(	(	PUNCT
aji-170	231	28	zhu	zhu	X
aji-170	231	29	et	et	PROPN
aji-170	231	30	al	al	PROPN
aji-170	231	31	.	.	PROPN
aji-170	231	32	,	,	PUNCT
aji-170	231	33	2019	2019	NUM
aji-170	231	34	;	;	PUNCT
aji-170	231	35	li	li	PROPN
aji-170	231	36	et	et	PROPN
aji-170	231	37	al	al	PROPN
aji-170	231	38	.	.	PROPN
aji-170	231	39	,	,	PUNCT
aji-170	231	40	2017	2017	NUM
aji-170	231	41	)	)	PUNCT
aji-170	231	42	.	.	PUNCT
aji-170	232	1	gamma	gamma	NOUN
aji-170	232	2	-	-	PUNCT
aji-170	232	3	delta	delta	PROPN
aji-170	232	4	t	t	PROPN
aji-170	232	5	(	(	PUNCT
aji-170	232	6	γδt	γδt	PROPN
aji-170	232	7	)	)	PUNCT
aji-170	232	8	cells	cell	NOUN
aji-170	232	9	,	,	PUNCT
aji-170	232	10	which	which	PRON
aji-170	232	11	produce	produce	VERB
aji-170	232	12	high	high	ADJ
aji-170	232	13	levels	level	NOUN
aji-170	232	14	of	of	ADP
aji-170	232	15	il-17a	il-17a	PROPN
aji-170	232	16	and	and	CCONJ
aji-170	232	17	express	express	VERB
aji-170	232	18	cytotoxic	cytotoxic	ADJ
aji-170	232	19	markers	marker	NOUN
aji-170	232	20	,	,	PUNCT
aji-170	232	21	contribute	contribute	VERB
aji-170	232	22	to	to	ADP
aji-170	232	23	this	this	DET
aji-170	232	24	inflammatory	inflammatory	ADJ
aji-170	232	25	milieu	milieu	NOUN
aji-170	232	26	,	,	PUNCT
aji-170	232	27	further	far	ADV
aji-170	232	28	compromising	compromise	VERB
aji-170	232	29	pregnancy	pregnancy	NOUN
aji-170	232	30	outcomes	outcome	NOUN
aji-170	232	31	(	(	PUNCT
aji-170	232	32	yu	yu	X
aji-170	232	33	et	et	PROPN
aji-170	232	34	al	al	PROPN
aji-170	232	35	.	.	PROPN
aji-170	232	36	,	,	PUNCT
aji-170	232	37	2021	2021	NUM
aji-170	232	38	;	;	PUNCT
aji-170	232	39	talukdar	talukdar	NOUN
aji-170	232	40	et	et	PROPN
aji-170	232	41	al	al	PROPN
aji-170	232	42	.	.	PROPN
aji-170	232	43	,	,	PUNCT
aji-170	232	44	2018	2018	NUM
aji-170	232	45	)	)	PUNCT
aji-170	232	46	.	.	PUNCT
aji-170	233	1	dysregulation	dysregulation	NOUN
aji-170	233	2	of	of	ADP
aji-170	233	3	decidual	decidual	ADJ
aji-170	233	4	macrophages	macrophage	NOUN
aji-170	233	5	(	(	PUNCT
aji-170	233	6	dmφs	dmφs	NOUN
aji-170	233	7	)	)	PUNCT
aji-170	233	8	and	and	CCONJ
aji-170	233	9	t	t	PROPN
aji-170	233	10	cells	cell	NOUN
aji-170	233	11	is	be	AUX
aji-170	233	12	critical	critical	ADJ
aji-170	233	13	at	at	ADP
aji-170	233	14	the	the	DET
aji-170	233	15	maternal	maternal	ADJ
aji-170	233	16	-	-	PUNCT
aji-170	233	17	foetal	foetal	ADJ
aji-170	233	18	interface	interface	NOUN
aji-170	233	19	.	.	PUNCT
aji-170	234	1	reduced	reduce	VERB
aji-170	234	2	tim-3	tim-3	PUNCT
aji-170	234	3	expression	expression	NOUN
aji-170	234	4	in	in	ADP
aji-170	234	5	these	these	DET
aji-170	234	6	cells	cell	NOUN
aji-170	234	7	correlates	correlate	VERB
aji-170	234	8	with	with	ADP
aji-170	234	9	increased	increase	VERB
aji-170	234	10	production	production	NOUN
aji-170	234	11	of	of	ADP
aji-170	234	12	proinflammatory	proinflammatory	ADJ
aji-170	234	13	cytokines	cytokine	NOUN
aji-170	234	14	and	and	CCONJ
aji-170	234	15	decreased	decrease	VERB
aji-170	234	16	production	production	NOUN
aji-170	234	17	of	of	ADP
aji-170	234	18	anti	anti	ADJ
aji-170	234	19	-	-	ADJ
aji-170	234	20	inflammatory	inflammatory	ADJ
aji-170	234	21	cytokines	cytokine	NOUN
aji-170	234	22	,	,	PUNCT
aji-170	234	23	ultimately	ultimately	ADV
aji-170	234	24	contributing	contribute	VERB
aji-170	234	25	to	to	ADP
aji-170	234	26	foetal	foetal	ADJ
aji-170	234	27	loss	loss	NOUN
aji-170	234	28	(	(	PUNCT
aji-170	234	29	li	li	PROPN
aji-170	234	30	et	et	PROPN
aji-170	234	31	al	al	PROPN
aji-170	234	32	.	.	PROPN
aji-170	234	33	,	,	PUNCT
aji-170	234	34	2022	2022	NUM
aji-170	234	35	;	;	PUNCT
aji-170	234	36	xu	xu	PROPN
aji-170	234	37	et	et	PROPN
aji-170	234	38	al	al	PROPN
aji-170	234	39	.	.	PROPN
aji-170	234	40	,	,	PUNCT
aji-170	234	41	2017	2017	NUM
aji-170	234	42	)	)	PUNCT
aji-170	234	43	.	.	PUNCT
aji-170	235	1	experimental	experimental	ADJ
aji-170	235	2	models	model	NOUN
aji-170	235	3	underscore	underscore	VERB
aji-170	235	4	the	the	DET
aji-170	235	5	significance	significance	NOUN
aji-170	235	6	of	of	ADP
aji-170	235	7	immune	immune	ADJ
aji-170	235	8	checkpoints	checkpoint	NOUN
aji-170	235	9	,	,	PUNCT
aji-170	235	10	showing	show	VERB
aji-170	235	11	that	that	SCONJ
aji-170	235	12	blocking	block	VERB
aji-170	235	13	the	the	DET
aji-170	235	14	tim-3	tim-3	PUNCT
aji-170	235	15	or	or	CCONJ
aji-170	235	16	pd-1	pd-1	ADJ
aji-170	235	17	pathways	pathway	NOUN
aji-170	235	18	exacerbates	exacerbate	VERB
aji-170	235	19	pregnancy	pregnancy	NOUN
aji-170	235	20	loss	loss	NOUN
aji-170	235	21	by	by	ADP
aji-170	235	22	inducing	induce	VERB
aji-170	235	23	inflammatory	inflammatory	ADJ
aji-170	235	24	and	and	CCONJ
aji-170	235	25	cytotoxic	cytotoxic	ADJ
aji-170	235	26	responses	response	NOUN
aji-170	235	27	(	(	PUNCT
aji-170	235	28	wang	wang	PROPN
aji-170	235	29	et	et	PROPN
aji-170	235	30	al	al	PROPN
aji-170	235	31	.	.	PROPN
aji-170	235	32	,	,	PUNCT
aji-170	235	33	2016	2016	NUM
aji-170	235	34	;	;	PUNCT
aji-170	235	35	xu	xu	PROPN
aji-170	235	36	et	et	PROPN
aji-170	235	37	al	al	PROPN
aji-170	235	38	.	.	PROPN
aji-170	235	39	,	,	PUNCT
aji-170	235	40	2017	2017	NUM
aji-170	235	41	)	)	PUNCT
aji-170	235	42	.	.	PUNCT
aji-170	236	1	the	the	DET
aji-170	236	2	immunological	immunological	ADJ
aji-170	236	3	environment	environment	NOUN
aji-170	236	4	in	in	ADP
aji-170	236	5	rsa	rsa	PROPN
aji-170	236	6	is	be	AUX
aji-170	236	7	characterised	characterise	VERB
aji-170	236	8	by	by	ADP
aji-170	236	9	heightened	heighten	VERB
aji-170	236	10	inflammation	inflammation	NOUN
aji-170	236	11	and	and	CCONJ
aji-170	236	12	impaired	impaired	ADJ
aji-170	236	13	regulatory	regulatory	ADJ
aji-170	236	14	mechanisms	mechanism	NOUN
aji-170	236	15	.	.	PUNCT
aji-170	237	1	targeting	target	VERB
aji-170	237	2	immune	immune	ADJ
aji-170	237	3	checkpoints	checkpoint	NOUN
aji-170	237	4	such	such	ADJ
aji-170	237	5	as	as	ADP
aji-170	237	6	pd-1	pd-1	ADJ
aji-170	237	7	and	and	CCONJ
aji-170	237	8	tim-3	tim-3	ADV
aji-170	237	9	offers	offer	VERB
aji-170	237	10	a	a	DET
aji-170	237	11	promising	promising	ADJ
aji-170	237	12	therapeutic	therapeutic	ADJ
aji-170	237	13	approach	approach	NOUN
aji-170	237	14	to	to	PART
aji-170	237	15	restore	restore	VERB
aji-170	237	16	immune	immune	ADJ
aji-170	237	17	balance	balance	NOUN
aji-170	237	18	and	and	CCONJ
aji-170	237	19	improve	improve	VERB
aji-170	237	20	pregnancy	pregnancy	NOUN
aji-170	237	21	outcomes	outcome	NOUN
aji-170	237	22	in	in	ADP
aji-170	237	23	rsa	rsa	PROPN
aji-170	237	24	patients	patient	NOUN
aji-170	237	25	.	.	PUNCT
aji-170	238	1	5	5	X
aji-170	238	2	.	.	X
aji-170	238	3	future	future	ADJ
aji-170	238	4	perspective	perspective	NOUN
aji-170	238	5	potential	potential	ADJ
aji-170	238	6	therapeutic	therapeutic	ADJ
aji-170	238	7	strategies	strategy	NOUN
aji-170	238	8	for	for	ADP
aji-170	238	9	preventing	prevent	VERB
aji-170	238	10	spontaneous	spontaneous	ADJ
aji-170	238	11	abortion	abortion	NOUN
aji-170	238	12	include	include	VERB
aji-170	238	13	targeting	target	VERB
aji-170	238	14	t	t	PROPN
aji-170	238	15	-	-	PUNCT
aji-170	238	16	cell	cell	NOUN
aji-170	238	17	exhaustion	exhaustion	NOUN
aji-170	238	18	.	.	PUNCT
aji-170	239	1	this	this	PRON
aji-170	239	2	can	can	AUX
aji-170	239	3	be	be	AUX
aji-170	239	4	achieved	achieve	VERB
aji-170	239	5	by	by	ADP
aji-170	239	6	enhancing	enhance	VERB
aji-170	239	7	treg	treg	PROPN
aji-170	239	8	function	function	PROPN
aji-170	239	9	,	,	PUNCT
aji-170	239	10	blocking	block	VERB
aji-170	239	11	inhibitory	inhibitory	ADJ
aji-170	239	12	receptors	receptor	NOUN
aji-170	239	13	on	on	ADP
aji-170	239	14	t	t	NOUN
aji-170	239	15	cells	cell	NOUN
aji-170	239	16	,	,	PUNCT
aji-170	239	17	and	and	CCONJ
aji-170	239	18	modulating	modulate	VERB
aji-170	239	19	cytokine	cytokine	NOUN
aji-170	239	20	environments	environment	NOUN
aji-170	239	21	to	to	PART
aji-170	239	22	restore	restore	VERB
aji-170	239	23	immune	immune	ADJ
aji-170	239	24	balance	balance	NOUN
aji-170	239	25	in	in	ADP
aji-170	239	26	pregnancy	pregnancy	NOUN
aji-170	239	27	.	.	PUNCT
aji-170	240	1	diagnostic	diagnostic	ADJ
aji-170	240	2	markers	marker	NOUN
aji-170	240	3	for	for	ADP
aji-170	240	4	t	t	NOUN
aji-170	240	5	cell	cell	NOUN
aji-170	240	6	exhaustion	exhaustion	NOUN
aji-170	240	7	,	,	PUNCT
aji-170	240	8	such	such	ADJ
aji-170	240	9	as	as	ADP
aji-170	240	10	the	the	DET
aji-170	240	11	expression	expression	NOUN
aji-170	240	12	of	of	ADP
aji-170	240	13	inhibitory	inhibitory	ADJ
aji-170	240	14	receptors	receptor	NOUN
aji-170	240	15	and	and	CCONJ
aji-170	240	16	cytokine	cytokine	ADJ
aji-170	240	17	profiles	profile	NOUN
aji-170	240	18	,	,	PUNCT
aji-170	240	19	could	could	AUX
aji-170	240	20	help	help	VERB
aji-170	240	21	predict	predict	VERB
aji-170	240	22	and	and	CCONJ
aji-170	240	23	prevent	prevent	VERB
aji-170	240	24	spontaneous	spontaneous	ADJ
aji-170	240	25	abortion	abortion	NOUN
aji-170	240	26	.	.	PUNCT
aji-170	241	1	non	non	ADJ
aji-170	241	2	-	-	ADJ
aji-170	241	3	invasive	invasive	ADJ
aji-170	241	4	diagnostic	diagnostic	ADJ
aji-170	241	5	tools	tool	NOUN
aji-170	241	6	,	,	PUNCT
aji-170	241	7	such	such	ADJ
aji-170	241	8	as	as	ADP
aji-170	241	9	blood	blood	NOUN
aji-170	241	10	tests	test	NOUN
aji-170	241	11	or	or	CCONJ
aji-170	241	12	imaging	imaging	NOUN
aji-170	241	13	techniques	technique	NOUN
aji-170	241	14	,	,	PUNCT
aji-170	241	15	could	could	AUX
aji-170	241	16	be	be	AUX
aji-170	241	17	developed	develop	VERB
aji-170	241	18	to	to	PART
aji-170	241	19	monitor	monitor	VERB
aji-170	241	20	immune	immune	ADJ
aji-170	241	21	status	status	NOUN
aji-170	241	22	during	during	ADP
aji-170	241	23	pregnancy	pregnancy	NOUN
aji-170	241	24	.	.	PUNCT
aji-170	242	1	future	future	ADJ
aji-170	242	2	research	research	NOUN
aji-170	242	3	should	should	AUX
aji-170	242	4	focus	focus	VERB
aji-170	242	5	on	on	ADP
aji-170	242	6	elucidating	elucidate	VERB
aji-170	242	7	the	the	DET
aji-170	242	8	detailed	detailed	ADJ
aji-170	242	9	mechanisms	mechanism	NOUN
aji-170	242	10	of	of	ADP
aji-170	242	11	t	t	NOUN
aji-170	242	12	cell	cell	NOUN
aji-170	242	13	exhaustion	exhaustion	NOUN
aji-170	242	14	in	in	ADP
aji-170	242	15	pregnancy	pregnancy	NOUN
aji-170	242	16	,	,	PUNCT
aji-170	242	17	identifying	identify	VERB
aji-170	242	18	additional	additional	ADJ
aji-170	242	19	biomarkers	biomarker	NOUN
aji-170	242	20	,	,	PUNCT
aji-170	242	21	and	and	CCONJ
aji-170	242	22	developing	develop	VERB
aji-170	242	23	targeted	targeted	ADJ
aji-170	242	24	therapies	therapy	NOUN
aji-170	242	25	.	.	PUNCT
aji-170	243	1	collaborative	collaborative	ADJ
aji-170	243	2	efforts	effort	NOUN
aji-170	243	3	between	between	ADP
aji-170	243	4	researchers	researcher	NOUN
aji-170	243	5	,	,	PUNCT
aji-170	243	6	clinicians	clinician	NOUN
aji-170	243	7	,	,	PUNCT
aji-170	243	8	and	and	CCONJ
aji-170	243	9	pharmaceutical	pharmaceutical	NOUN
aji-170	243	10	companies	company	NOUN
aji-170	243	11	will	will	AUX
aji-170	243	12	be	be	AUX
aji-170	243	13	crucial	crucial	ADJ
aji-170	243	14	for	for	ADP
aji-170	243	15	translating	translate	VERB
aji-170	243	16	experimental	experimental	ADJ
aji-170	243	17	findings	finding	NOUN
aji-170	243	18	into	into	ADP
aji-170	243	19	clinical	clinical	ADJ
aji-170	243	20	practice	practice	NOUN
aji-170	243	21	.	.	PUNCT
aji-170	244	1	6	6	X
aji-170	244	2	.	.	X
aji-170	244	3	conclusion	conclusion	NOUN
aji-170	244	4	studies	study	NOUN
aji-170	244	5	have	have	AUX
aji-170	244	6	identified	identify	VERB
aji-170	244	7	t	t	PROPN
aji-170	244	8	-	-	PUNCT
aji-170	244	9	cell	cell	NOUN
aji-170	244	10	exhaustion	exhaustion	NOUN
aji-170	244	11	as	as	ADP
aji-170	244	12	a	a	DET
aji-170	244	13	significant	significant	ADJ
aji-170	244	14	contributor	contributor	NOUN
aji-170	244	15	to	to	ADP
aji-170	244	16	spontaneous	spontaneous	ADJ
aji-170	244	17	abortion	abortion	NOUN
aji-170	244	18	.	.	PUNCT
aji-170	245	1	this	this	DET
aji-170	245	2	phenomenon	phenomenon	NOUN
aji-170	245	3	is	be	AUX
aji-170	245	4	characterised	characterise	VERB
aji-170	245	5	by	by	ADP
aji-170	245	6	reduced	reduce	VERB
aji-170	245	7	t	t	PROPN
aji-170	245	8	cell	cell	NOUN
aji-170	245	9	functionality	functionality	NOUN
aji-170	245	10	and	and	CCONJ
aji-170	245	11	proliferation	proliferation	NOUN
aji-170	245	12	in	in	ADP
aji-170	245	13	women	woman	NOUN
aji-170	245	14	who	who	PRON
aji-170	245	15	have	have	AUX
aji-170	245	16	experienced	experience	VERB
aji-170	245	17	spontaneous	spontaneous	ADJ
aji-170	245	18	abortion	abortion	NOUN
aji-170	245	19	.	.	PUNCT
aji-170	246	1	studies	study	NOUN
aji-170	246	2	have	have	AUX
aji-170	246	3	shown	show	VERB
aji-170	246	4	that	that	SCONJ
aji-170	246	5	t	t	NOUN
aji-170	246	6	cell	cell	NOUN
aji-170	246	7	exhaustion	exhaustion	NOUN
aji-170	246	8	is	be	AUX
aji-170	246	9	characterised	characterise	VERB
aji-170	246	10	by	by	ADP
aji-170	246	11	a	a	DET
aji-170	246	12	decrease	decrease	NOUN
aji-170	246	13	in	in	ADP
aji-170	246	14	the	the	DET
aji-170	246	15	expression	expression	NOUN
aji-170	246	16	of	of	ADP
aji-170	246	17	stimulatory	stimulatory	ADJ
aji-170	246	18	receptors	receptor	NOUN
aji-170	246	19	and	and	CCONJ
aji-170	246	20	an	an	DET
aji-170	246	21	increase	increase	NOUN
aji-170	246	22	in	in	ADP
aji-170	246	23	the	the	DET
aji-170	246	24	expression	expression	NOUN
aji-170	246	25	of	of	ADP
aji-170	246	26	suppressive	suppressive	ADJ
aji-170	246	27	receptors	receptor	NOUN
aji-170	246	28	,	,	PUNCT
aji-170	246	29	making	make	VERB
aji-170	246	30	it	it	PRON
aji-170	246	31	challenging	challenge	VERB
aji-170	246	32	for	for	ADP
aji-170	246	33	t	t	PROPN
aji-170	246	34	cells	cell	NOUN
aji-170	246	35	to	to	PART
aji-170	246	36	respond	respond	VERB
aji-170	246	37	to	to	ADP
aji-170	246	38	infections	infection	NOUN
aji-170	246	39	.	.	PUNCT
aji-170	247	1	this	this	DET
aji-170	247	2	highlights	highlight	VERB
aji-170	247	3	the	the	DET
aji-170	247	4	critical	critical	ADJ
aji-170	247	5	role	role	NOUN
aji-170	247	6	of	of	ADP
aji-170	247	7	t	t	NOUN
aji-170	247	8	-	-	PUNCT
aji-170	247	9	cell	cell	NOUN
aji-170	247	10	exhaustion	exhaustion	NOUN
aji-170	247	11	in	in	ADP
aji-170	247	12	spontaneous	spontaneous	ADJ
aji-170	247	13	abortion	abortion	NOUN
aji-170	247	14	.	.	PUNCT
aji-170	248	1	regulatory	regulatory	ADJ
aji-170	248	2	t	t	PROPN
aji-170	248	3	cells	cell	NOUN
aji-170	248	4	(	(	PUNCT
aji-170	248	5	tregs	treg	NOUN
aji-170	248	6	)	)	PUNCT
aji-170	248	7	have	have	AUX
aji-170	248	8	been	be	AUX
aji-170	248	9	seen	see	VERB
aji-170	248	10	to	to	PART
aji-170	248	11	play	play	VERB
aji-170	248	12	a	a	DET
aji-170	248	13	vital	vital	ADJ
aji-170	248	14	role	role	NOUN
aji-170	248	15	in	in	ADP
aji-170	248	16	maintaining	maintain	VERB
aji-170	248	17	immune	immune	ADJ
aji-170	248	18	homeostasis	homeostasis	NOUN
aji-170	248	19	and	and	CCONJ
aji-170	248	20	preventing	prevent	VERB
aji-170	248	21	foetal	foetal	ADJ
aji-170	248	22	rejection	rejection	NOUN
aji-170	248	23	.	.	PUNCT
aji-170	249	1	however	however	ADV
aji-170	249	2	,	,	PUNCT
aji-170	249	3	women	woman	NOUN
aji-170	249	4	with	with	ADP
aji-170	249	5	a	a	DET
aji-170	249	6	history	history	NOUN
aji-170	249	7	of	of	ADP
aji-170	249	8	repeated	repeat	VERB
aji-170	249	9	unexplained	unexplained	ADJ
aji-170	249	10	pregnancy	pregnancy	NOUN
aji-170	249	11	loss	loss	NOUN
aji-170	249	12	have	have	AUX
aji-170	249	13	been	be	AUX
aji-170	249	14	found	find	VERB
aji-170	249	15	to	to	PART
aji-170	249	16	walana	walana	VERB
aji-170	249	17	et	et	PROPN
aji-170	249	18	al	al	PROPN
aji-170	249	19	.	.	PROPN
aji-170	249	20	;	;	PUNCT
aji-170	249	21	asian	asian	PROPN
aji-170	249	22	j.	j.	PROPN
aji-170	249	23	immunol	immunol	PROPN
aji-170	249	24	.	.	PROPN
aji-170	249	25	,	,	PUNCT
aji-170	249	26	vol	vol	NOUN
aji-170	249	27	.	.	PROPN
aji-170	249	28	8	8	NUM
aji-170	249	29	,	,	PUNCT
aji-170	249	30	no	no	INTJ
aji-170	249	31	.	.	NOUN
aji-170	249	32	1	1	NUM
aji-170	249	33	,	,	PUNCT
aji-170	249	34	pp	pp	ADJ
aji-170	249	35	.	.	PUNCT
aji-170	250	1	179	179	NUM
aji-170	250	2	-	-	SYM
aji-170	250	3	189	189	NUM
aji-170	250	4	,	,	PUNCT
aji-170	250	5	2025	2025	NUM
aji-170	250	6	;	;	PUNCT
aji-170	250	7	article	article	NOUN
aji-170	250	8	no.aji.139815	no.aji.139815	VERB
aji-170	250	9	187	187	NUM
aji-170	250	10	have	have	AUX
aji-170	250	11	reduced	reduce	VERB
aji-170	250	12	treg	treg	PROPN
aji-170	250	13	presence	presence	NOUN
aji-170	250	14	and	and	CCONJ
aji-170	250	15	functionality	functionality	NOUN
aji-170	250	16	,	,	PUNCT
aji-170	250	17	which	which	PRON
aji-170	250	18	may	may	AUX
aji-170	250	19	contribute	contribute	VERB
aji-170	250	20	to	to	ADP
aji-170	250	21	spontaneous	spontaneous	ADJ
aji-170	250	22	abortion	abortion	NOUN
aji-170	250	23	.	.	PUNCT
aji-170	251	1	furthermore	furthermore	ADV
aji-170	251	2	,	,	PUNCT
aji-170	251	3	t	t	NOUN
aji-170	251	4	-	-	PUNCT
aji-170	251	5	cell	cell	NOUN
aji-170	251	6	exhaustion	exhaustion	NOUN
aji-170	251	7	and	and	CCONJ
aji-170	251	8	an	an	DET
aji-170	251	9	overactive	overactive	ADJ
aji-170	251	10	immune	immune	ADJ
aji-170	251	11	response	response	NOUN
aji-170	251	12	have	have	AUX
aji-170	251	13	been	be	AUX
aji-170	251	14	linked	link	VERB
aji-170	251	15	to	to	ADP
aji-170	251	16	spontaneous	spontaneous	ADJ
aji-170	251	17	abortion	abortion	NOUN
aji-170	251	18	.	.	PUNCT
aji-170	252	1	modulating	modulate	VERB
aji-170	252	2	the	the	DET
aji-170	252	3	immune	immune	ADJ
aji-170	252	4	response	response	NOUN
aji-170	252	5	and	and	CCONJ
aji-170	252	6	preventing	prevent	VERB
aji-170	252	7	t	t	NOUN
aji-170	252	8	-	-	PUNCT
aji-170	252	9	cell	cell	NOUN
aji-170	252	10	exhaustion	exhaustion	NOUN
aji-170	252	11	may	may	AUX
aji-170	252	12	be	be	AUX
aji-170	252	13	potential	potential	ADJ
aji-170	252	14	therapeutic	therapeutic	ADJ
aji-170	252	15	strategies	strategy	NOUN
aji-170	252	16	to	to	PART
aji-170	252	17	prevent	prevent	VERB
aji-170	252	18	spontaneous	spontaneous	ADJ
aji-170	252	19	abortion	abortion	NOUN
aji-170	252	20	and	and	CCONJ
aji-170	252	21	promote	promote	VERB
aji-170	252	22	successful	successful	ADJ
aji-170	252	23	pregnancy	pregnancy	NOUN
aji-170	252	24	outcomes	outcome	NOUN
aji-170	252	25	.	.	PUNCT
aji-170	253	1	decidual	decidual	ADJ
aji-170	253	2	natural	natural	ADJ
aji-170	253	3	killer	killer	NOUN
aji-170	253	4	cells	cell	NOUN
aji-170	253	5	(	(	PUNCT
aji-170	253	6	dnk	dnk	NOUN
aji-170	253	7	)	)	PUNCT
aji-170	253	8	have	have	AUX
aji-170	253	9	been	be	AUX
aji-170	253	10	found	find	VERB
aji-170	253	11	to	to	PART
aji-170	253	12	play	play	VERB
aji-170	253	13	a	a	DET
aji-170	253	14	crucial	crucial	ADJ
aji-170	253	15	role	role	NOUN
aji-170	253	16	in	in	ADP
aji-170	253	17	maintaining	maintain	VERB
aji-170	253	18	pregnancy	pregnancy	NOUN
aji-170	253	19	and	and	CCONJ
aji-170	253	20	preventing	prevent	VERB
aji-170	253	21	spontaneous	spontaneous	ADJ
aji-170	253	22	abortion	abortion	NOUN
aji-170	253	23	.	.	PUNCT
aji-170	254	1	however	however	ADV
aji-170	254	2	,	,	PUNCT
aji-170	254	3	an	an	DET
aji-170	254	4	imbalance	imbalance	NOUN
aji-170	254	5	in	in	ADP
aji-170	254	6	dnk	dnk	NOUN
aji-170	254	7	cells	cell	NOUN
aji-170	254	8	,	,	PUNCT
aji-170	254	9	particularly	particularly	ADV
aji-170	254	10	an	an	DET
aji-170	254	11	overactivation	overactivation	NOUN
aji-170	254	12	of	of	ADP
aji-170	254	13	dnk1	dnk1	NOUN
aji-170	254	14	cells	cell	NOUN
aji-170	254	15	,	,	PUNCT
aji-170	254	16	may	may	AUX
aji-170	254	17	contribute	contribute	VERB
aji-170	254	18	to	to	ADP
aji-170	254	19	spontaneous	spontaneous	ADJ
aji-170	254	20	abortion	abortion	NOUN
aji-170	254	21	.	.	PUNCT
aji-170	255	1	in	in	ADP
aji-170	255	2	conclusion	conclusion	NOUN
aji-170	255	3	,	,	PUNCT
aji-170	255	4	t	t	NOUN
aji-170	255	5	cell	cell	NOUN
aji-170	255	6	exhaustion	exhaustion	NOUN
aji-170	255	7	and	and	CCONJ
aji-170	255	8	immune	immune	ADJ
aji-170	255	9	modulation	modulation	NOUN
aji-170	255	10	play	play	VERB
aji-170	255	11	a	a	DET
aji-170	255	12	critical	critical	ADJ
aji-170	255	13	role	role	NOUN
aji-170	255	14	in	in	ADP
aji-170	255	15	spontaneous	spontaneous	ADJ
aji-170	255	16	abortion	abortion	NOUN
aji-170	255	17	and	and	CCONJ
aji-170	255	18	recurrent	recurrent	ADJ
aji-170	255	19	pregnancy	pregnancy	NOUN
aji-170	255	20	loss	loss	NOUN
aji-170	255	21	.	.	PUNCT
aji-170	256	1	targeting	target	VERB
aji-170	256	2	these	these	DET
aji-170	256	3	cell	cell	NOUN
aji-170	256	4	populations	population	NOUN
aji-170	256	5	or	or	CCONJ
aji-170	256	6	their	their	PRON
aji-170	256	7	associated	associated	ADJ
aji-170	256	8	pathways	pathway	NOUN
aji-170	256	9	may	may	AUX
aji-170	256	10	be	be	AUX
aji-170	256	11	a	a	DET
aji-170	256	12	promising	promising	ADJ
aji-170	256	13	therapeutic	therapeutic	ADJ
aji-170	256	14	strategy	strategy	NOUN
aji-170	256	15	for	for	ADP
aji-170	256	16	preventing	prevent	VERB
aji-170	256	17	or	or	CCONJ
aji-170	256	18	treating	treat	VERB
aji-170	256	19	pregnancy	pregnancy	NOUN
aji-170	256	20	complications	complication	NOUN
aji-170	256	21	.	.	PUNCT
aji-170	257	1	further	further	ADJ
aji-170	257	2	research	research	NOUN
aji-170	257	3	is	be	AUX
aji-170	257	4	needed	need	VERB
aji-170	257	5	to	to	PART
aji-170	257	6	fully	fully	ADV
aji-170	257	7	understand	understand	VERB
aji-170	257	8	the	the	DET
aji-170	257	9	mechanisms	mechanism	NOUN
aji-170	257	10	underlying	underlie	VERB
aji-170	257	11	t	t	NOUN
aji-170	257	12	cell	cell	NOUN
aji-170	257	13	exhaustion	exhaustion	NOUN
aji-170	257	14	and	and	CCONJ
aji-170	257	15	spontaneous	spontaneous	ADJ
aji-170	257	16	abortion	abortion	NOUN
aji-170	257	17	and	and	CCONJ
aji-170	257	18	to	to	PART
aji-170	257	19	develop	develop	VERB
aji-170	257	20	practical	practical	ADJ
aji-170	257	21	therapeutic	therapeutic	ADJ
aji-170	257	22	approaches	approach	NOUN
aji-170	257	23	.	.	PUNCT
aji-170	258	1	disclaimer	disclaimer	NOUN
aji-170	258	2	(	(	PUNCT
aji-170	258	3	artificial	artificial	ADJ
aji-170	258	4	intelligence	intelligence	NOUN
aji-170	258	5	)	)	PUNCT
aji-170	258	6	author(s	author(s	NOUN
aji-170	258	7	)	)	PUNCT
aji-170	258	8	hereby	hereby	ADV
aji-170	258	9	declare	declare	VERB
aji-170	258	10	that	that	SCONJ
aji-170	258	11	no	no	DET
aji-170	258	12	generative	generative	NOUN
aji-170	258	13	ai	ai	VERB
aji-170	258	14	technologies	technology	NOUN
aji-170	258	15	such	such	ADJ
aji-170	258	16	as	as	ADP
aji-170	258	17	large	large	ADJ
aji-170	258	18	language	language	NOUN
aji-170	258	19	models	model	NOUN
aji-170	258	20	(	(	PUNCT
aji-170	258	21	chatgpt	chatgpt	NOUN
aji-170	258	22	,	,	PUNCT
aji-170	258	23	copilot	copilot	NOUN
aji-170	258	24	,	,	PUNCT
aji-170	258	25	etc	etc	X
aji-170	258	26	.	.	X
aji-170	258	27	)	)	PUNCT
aji-170	258	28	and	and	CCONJ
aji-170	258	29	text	text	NOUN
aji-170	258	30	-	-	PUNCT
aji-170	258	31	to	to	ADP
aji-170	258	32	-	-	PUNCT
aji-170	258	33	image	image	NOUN
aji-170	258	34	generators	generator	NOUN
aji-170	258	35	have	have	AUX
aji-170	258	36	been	be	AUX
aji-170	258	37	used	use	VERB
aji-170	258	38	during	during	ADP
aji-170	258	39	the	the	DET
aji-170	258	40	writing	writing	NOUN
aji-170	258	41	or	or	CCONJ
aji-170	258	42	editing	editing	NOUN
aji-170	258	43	of	of	ADP
aji-170	258	44	this	this	DET
aji-170	258	45	manuscript	manuscript	NOUN
aji-170	258	46	.	.	PUNCT
aji-170	259	1	consent	consent	NOUN
aji-170	259	2	it	it	PRON
aji-170	259	3	is	be	AUX
aji-170	259	4	not	not	PART
aji-170	259	5	applicable	applicable	ADJ
aji-170	259	6	.	.	PUNCT
aji-170	260	1	ethical	ethical	ADJ
aji-170	260	2	approval	approval	NOUN
aji-170	260	3	this	this	DET
aji-170	260	4	systematic	systematic	ADJ
aji-170	260	5	review	review	NOUN
aji-170	260	6	did	do	AUX
aji-170	260	7	not	not	PART
aji-170	260	8	necessitate	necessitate	ADJ
aji-170	260	9	ethical	ethical	ADJ
aji-170	260	10	clearance	clearance	NOUN
aji-170	260	11	,	,	PUNCT
aji-170	260	12	as	as	SCONJ
aji-170	260	13	it	it	PRON
aji-170	260	14	relied	rely	VERB
aji-170	260	15	on	on	ADP
aji-170	260	16	previously	previously	ADV
aji-170	260	17	published	publish	VERB
aji-170	260	18	studies	study	NOUN
aji-170	260	19	and	and	CCONJ
aji-170	260	20	research	research	NOUN
aji-170	260	21	works	work	VERB
aji-170	260	22	freely	freely	ADV
aji-170	260	23	accessible	accessible	ADJ
aji-170	260	24	in	in	ADP
aji-170	260	25	the	the	DET
aji-170	260	26	public	public	ADJ
aji-170	260	27	domain	domain	NOUN
aji-170	260	28	,	,	PUNCT
aji-170	260	29	eliminating	eliminate	VERB
aji-170	260	30	the	the	DET
aji-170	260	31	need	need	NOUN
aji-170	260	32	for	for	ADP
aji-170	260	33	additional	additional	ADJ
aji-170	260	34	ethical	ethical	ADJ
aji-170	260	35	oversight	oversight	NOUN
aji-170	260	36	.	.	PUNCT
aji-170	261	1	competing	compete	VERB
aji-170	261	2	interests	interest	NOUN
aji-170	261	3	authors	author	NOUN
aji-170	261	4	have	have	AUX
aji-170	261	5	declared	declare	VERB
aji-170	261	6	that	that	SCONJ
aji-170	261	7	no	no	DET
aji-170	261	8	competing	compete	VERB
aji-170	261	9	interests	interest	NOUN
aji-170	261	10	exist	exist	VERB
aji-170	261	11	.	.	PUNCT
aji-170	262	1	references	reference	NOUN
aji-170	262	2	abdolmohammadi	abdolmohammadi	NOUN
aji-170	262	3	,	,	PUNCT
aji-170	262	4	v.	v.	CCONJ
aji-170	262	5	s.	s.	PROPN
aji-170	262	6	,	,	PUNCT
aji-170	262	7	ghaebi	ghaebi	NOUN
aji-170	262	8	,	,	PUNCT
aji-170	262	9	m.	m.	NOUN
aji-170	262	10	,	,	PUNCT
aji-170	262	11	ahmadi	ahmadi	PROPN
aji-170	262	12	,	,	PUNCT
aji-170	262	13	m.	m.	NOUN
aji-170	262	14	,	,	PUNCT
aji-170	262	15	nouri	nouri	PROPN
aji-170	262	16	,	,	PUNCT
aji-170	262	17	m.	m.	NOUN
aji-170	262	18	,	,	PUNCT
aji-170	262	19	danaei	danaei	PROPN
aji-170	262	20	,	,	PUNCT
aji-170	262	21	s.	s.	PROPN
aji-170	262	22	,	,	PUNCT
aji-170	262	23	aghebati	aghebati	NOUN
aji-170	262	24	-	-	PUNCT
aji-170	262	25	maleki	maleki	NOUN
aji-170	262	26	,	,	PUNCT
aji-170	262	27	l.	l.	PROPN
aji-170	262	28	,	,	PUNCT
aji-170	262	29	mousavi	mousavi	ADJ
aji-170	262	30	ardehaie	ardehaie	NOUN
aji-170	262	31	,	,	PUNCT
aji-170	262	32	r.	r.	PROPN
aji-170	262	33	,	,	PUNCT
aji-170	262	34	yousefi	yousefi	PROPN
aji-170	262	35	,	,	PUNCT
aji-170	262	36	b.	b.	PROPN
aji-170	262	37	,	,	PUNCT
aji-170	262	38	hakimi	hakimi	PROPN
aji-170	262	39	,	,	PUNCT
aji-170	262	40	p.	p.	NOUN
aji-170	262	41	,	,	PUNCT
aji-170	262	42	hojjat	hojjat	NOUN
aji-170	262	43	-	-	PUNCT
aji-170	262	44	farsangi	farsangi	PROPN
aji-170	262	45	,	,	PUNCT
aji-170	262	46	m.	m.	NOUN
aji-170	262	47	,	,	PUNCT
aji-170	262	48	rikhtegar	rikhtegar	PROPN
aji-170	262	49	,	,	PUNCT
aji-170	262	50	r.	r.	PROPN
aji-170	262	51	,	,	PUNCT
aji-170	262	52	&	&	CCONJ
aji-170	262	53	yousefi	yousefi	PROPN
aji-170	262	54	,	,	PUNCT
aji-170	262	55	m.	m.	NOUN
aji-170	262	56	(	(	PUNCT
aji-170	262	57	2019	2019	NUM
aji-170	262	58	)	)	PUNCT
aji-170	262	59	.	.	PUNCT
aji-170	263	1	altered	alter	VERB
aji-170	263	2	t	t	PROPN
aji-170	263	3	-	-	PUNCT
aji-170	263	4	cell	cell	NOUN
aji-170	263	5	subpopulations	subpopulation	NOUN
aji-170	263	6	in	in	ADP
aji-170	263	7	recurrent	recurrent	ADJ
aji-170	263	8	pregnancy	pregnancy	NOUN
aji-170	263	9	loss	loss	NOUN
aji-170	263	10	patients	patient	NOUN
aji-170	263	11	with	with	ADP
aji-170	263	12	cellular	cellular	ADJ
aji-170	263	13	immune	immune	ADJ
aji-170	263	14	abnormalities	abnormality	NOUN
aji-170	263	15	.	.	PUNCT
aji-170	264	1	journal	journal	NOUN
aji-170	264	2	of	of	ADP
aji-170	264	3	cellular	cellular	ADJ
aji-170	264	4	physiology	physiology	NOUN
aji-170	264	5	,	,	PUNCT
aji-170	264	6	234(4	234(4	NUM
aji-170	264	7	)	)	PUNCT
aji-170	264	8	,	,	PUNCT
aji-170	264	9	4924–4933	4924–4933	NUM
aji-170	264	10	.	.	PUNCT
aji-170	265	1	https://doi.org/10.1002/jcp.27290	https://doi.org/10.1002/jcp.27290	PROPN
aji-170	265	2	hu	hu	PROPN
aji-170	265	3	,	,	PUNCT
aji-170	265	4	x.	x.	PROPN
aji-170	265	5	h.	h.	PROPN
aji-170	265	6	,	,	PUNCT
aji-170	265	7	tang	tang	PROPN
aji-170	265	8	,	,	PUNCT
aji-170	265	9	m.	m.	NOUN
aji-170	265	10	x.	x.	PROPN
aji-170	265	11	,	,	PUNCT
aji-170	265	12	mor	mor	PROPN
aji-170	265	13	,	,	PUNCT
aji-170	265	14	g.	g.	PROPN
aji-170	265	15	,	,	PUNCT
aji-170	265	16	&	&	CCONJ
aji-170	265	17	liao	liao	PROPN
aji-170	265	18	,	,	PUNCT
aji-170	265	19	a.	a.	PROPN
aji-170	265	20	h.	h.	PROPN
aji-170	265	21	(	(	PUNCT
aji-170	265	22	2016	2016	NUM
aji-170	265	23	)	)	PUNCT
aji-170	265	24	.	.	PUNCT
aji-170	266	1	tim-3	tim-3	ADV
aji-170	266	2	:	:	PUNCT
aji-170	266	3	expression	expression	NOUN
aji-170	266	4	on	on	ADP
aji-170	266	5	immune	immune	ADJ
aji-170	266	6	cells	cell	NOUN
aji-170	266	7	and	and	CCONJ
aji-170	266	8	roles	role	NOUN
aji-170	266	9	at	at	ADP
aji-170	266	10	the	the	DET
aji-170	266	11	maternal	maternal	ADJ
aji-170	266	12	-	-	PUNCT
aji-170	266	13	fetal	fetal	ADJ
aji-170	266	14	interface	interface	NOUN
aji-170	266	15	.	.	PUNCT
aji-170	267	1	journal	journal	NOUN
aji-170	267	2	of	of	ADP
aji-170	267	3	reproductive	reproductive	ADJ
aji-170	267	4	immunology	immunology	NOUN
aji-170	267	5	,	,	PUNCT
aji-170	267	6	118	118	NUM
aji-170	267	7	,	,	PUNCT
aji-170	267	8	92	92	NUM
aji-170	267	9	-	-	SYM
aji-170	267	10	99	99	NUM
aji-170	267	11	.	.	PUNCT
aji-170	268	1	https://doi.org/10.1016/j.jri.2016.10.113	https://doi.org/10.1016/j.jri.2016.10.113	PROPN
aji-170	268	2	huang	huang	PROPN
aji-170	268	3	,	,	PUNCT
aji-170	268	4	x.	x.	PROPN
aji-170	268	5	,	,	PUNCT
aji-170	268	6	liu	liu	PROPN
aji-170	268	7	,	,	PUNCT
aji-170	268	8	l.	l.	PROPN
aji-170	268	9	,	,	PUNCT
aji-170	268	10	xu	xu	PROPN
aji-170	268	11	,	,	PUNCT
aji-170	268	12	c.	c.	PROPN
aji-170	268	13	,	,	PUNCT
aji-170	268	14	peng	peng	PROPN
aji-170	268	15	,	,	PUNCT
aji-170	268	16	x.	x.	PROPN
aji-170	268	17	,	,	PUNCT
aji-170	268	18	li	li	PROPN
aji-170	268	19	,	,	PUNCT
aji-170	268	20	d.	d.	PROPN
aji-170	268	21	,	,	PUNCT
aji-170	268	22	wang	wang	PROPN
aji-170	268	23	,	,	PUNCT
aji-170	268	24	l.	l.	PROPN
aji-170	268	25	,	,	PUNCT
aji-170	268	26	&	&	CCONJ
aji-170	268	27	du	du	PROPN
aji-170	268	28	,	,	PUNCT
aji-170	268	29	m.	m.	NOUN
aji-170	268	30	(	(	PUNCT
aji-170	268	31	2020	2020	NUM
aji-170	268	32	)	)	PUNCT
aji-170	268	33	.	.	PUNCT
aji-170	269	1	tissue	tissue	NOUN
aji-170	269	2	-	-	PUNCT
aji-170	269	3	resident	resident	NOUN
aji-170	269	4	cd8+t	cd8+t	NOUN
aji-170	269	5	memory	memory	NOUN
aji-170	269	6	cells	cell	NOUN
aji-170	269	7	with	with	ADP
aji-170	269	8	unique	unique	ADJ
aji-170	269	9	properties	property	NOUN
aji-170	269	10	are	be	AUX
aji-170	269	11	present	present	ADJ
aji-170	269	12	in	in	ADP
aji-170	269	13	human	human	ADJ
aji-170	269	14	decidua	decidua	NOUN
aji-170	269	15	during	during	ADP
aji-170	269	16	early	early	ADJ
aji-170	269	17	pregnancy	pregnancy	NOUN
aji-170	269	18	—	—	PUNCT
aji-170	269	19	american	american	ADJ
aji-170	269	20	journal	journal	PROPN
aji-170	269	21	of	of	ADP
aji-170	269	22	reproductive	reproductive	ADJ
aji-170	269	23	immunology	immunology	NOUN
aji-170	269	24	,	,	PUNCT
aji-170	269	25	84(1	84(1	NUM
aji-170	269	26	)	)	PUNCT
aji-170	269	27	.	.	PUNCT
aji-170	270	1	https://doi.org/10.1111/aji.13254	https://doi.org/10.1111/aji.13254	PROPN
aji-170	270	2	kuon	kuon	PROPN
aji-170	270	3	,	,	PUNCT
aji-170	270	4	r.	r.	PROPN
aji-170	270	5	j.	j.	PROPN
aji-170	270	6	,	,	PUNCT
aji-170	270	7	schaumann	schaumann	PROPN
aji-170	270	8	,	,	PUNCT
aji-170	270	9	j.	j.	PROPN
aji-170	270	10	,	,	PUNCT
aji-170	270	11	goeggl	goeggl	PROPN
aji-170	270	12	,	,	PUNCT
aji-170	270	13	t.	t.	NOUN
aji-170	270	14	,	,	PUNCT
aji-170	270	15	strowitzki	strowitzki	NOUN
aji-170	270	16	,	,	PUNCT
aji-170	270	17	t.	t.	PROPN
aji-170	270	18	,	,	PUNCT
aji-170	270	19	sadeghi	sadeghi	PROPN
aji-170	270	20	,	,	PUNCT
aji-170	270	21	m.	m.	NOUN
aji-170	270	22	,	,	PUNCT
aji-170	270	23	opelz	opelz	PROPN
aji-170	270	24	,	,	PUNCT
aji-170	270	25	g.	g.	PROPN
aji-170	270	26	,	,	PUNCT
aji-170	270	27	daniel	daniel	PROPN
aji-170	270	28	,	,	PUNCT
aji-170	270	29	v.	v.	PROPN
aji-170	270	30	,	,	PUNCT
aji-170	270	31	&	&	CCONJ
aji-170	270	32	toth	toth	PROPN
aji-170	270	33	,	,	PUNCT
aji-170	270	34	b.	b.	PROPN
aji-170	270	35	(	(	PUNCT
aji-170	270	36	2015	2015	NUM
aji-170	270	37	)	)	PUNCT
aji-170	270	38	.	.	PUNCT
aji-170	271	1	patients	patient	NOUN
aji-170	271	2	with	with	ADP
aji-170	271	3	idiopathic	idiopathic	ADJ
aji-170	271	4	recurrent	recurrent	ADJ
aji-170	271	5	miscarriage	miscarriage	NOUN
aji-170	271	6	show	show	VERB
aji-170	271	7	higher	high	ADJ
aji-170	271	8	levels	level	NOUN
aji-170	271	9	of	of	ADP
aji-170	271	10	dr+	dr+	NOUN
aji-170	271	11	activated	activate	VERB
aji-170	271	12	t	t	NOUN
aji-170	271	13	-	-	PUNCT
aji-170	271	14	cells	cell	NOUN
aji-170	271	15	that	that	PRON
aji-170	271	16	are	be	AUX
aji-170	271	17	less	less	ADV
aji-170	271	18	responsive	responsive	ADJ
aji-170	271	19	to	to	ADP
aji-170	271	20	mitogens	mitogens	PROPN
aji-170	271	21	.	.	PUNCT
aji-170	272	1	journal	journal	PROPN
aji-170	272	2	of	of	ADP
aji-170	272	3	reproductive	reproductive	ADJ
aji-170	272	4	immunology	immunology	NOUN
aji-170	272	5	,	,	PUNCT
aji-170	272	6	112	112	NUM
aji-170	272	7	,	,	PUNCT
aji-170	272	8	82–87	82–87	NUM
aji-170	272	9	.	.	PUNCT
aji-170	272	10	https://doi.org/10.1016/j.jri.2015.08.006	https://doi.org/10.1016/j.jri.2015.08.006	NOUN
aji-170	272	11	li	li	PROPN
aji-170	272	12	,	,	PUNCT
aji-170	272	13	m.	m.	NOUN
aji-170	272	14	,	,	PUNCT
aji-170	272	15	sun	sun	PROPN
aji-170	272	16	,	,	PUNCT
aji-170	272	17	f.	f.	PROPN
aji-170	272	18	,	,	PUNCT
aji-170	272	19	xu	xu	PROPN
aji-170	272	20	,	,	PUNCT
aji-170	272	21	y.	y.	PROPN
aji-170	272	22	,	,	PUNCT
aji-170	272	23	chen	chen	PROPN
aji-170	272	24	,	,	PUNCT
aji-170	272	25	l.	l.	PROPN
aji-170	272	26	,	,	PUNCT
aji-170	272	27	chen	chen	PROPN
aji-170	272	28	,	,	PUNCT
aji-170	272	29	c.	c.	PROPN
aji-170	272	30	,	,	PUNCT
aji-170	272	31	cui	cui	PROPN
aji-170	272	32	,	,	PUNCT
aji-170	272	33	l.	l.	PROPN
aji-170	272	34	,	,	PUNCT
aji-170	272	35	qian	qian	PROPN
aji-170	272	36	,	,	PUNCT
aji-170	272	37	j.	j.	PROPN
aji-170	272	38	,	,	PUNCT
aji-170	272	39	li	li	PROPN
aji-170	272	40	,	,	PUNCT
aji-170	272	41	d.	d.	PROPN
aji-170	272	42	,	,	PUNCT
aji-170	272	43	wang	wang	PROPN
aji-170	272	44	,	,	PUNCT
aji-170	272	45	s.	s.	PROPN
aji-170	272	46	,	,	PUNCT
aji-170	272	47	&	&	CCONJ
aji-170	272	48	du	du	PROPN
aji-170	272	49	,	,	PUNCT
aji-170	272	50	m.	m.	NOUN
aji-170	272	51	(	(	PUNCT
aji-170	272	52	2022	2022	NUM
aji-170	272	53	)	)	PUNCT
aji-170	272	54	.	.	PUNCT
aji-170	273	1	tim-3	tim-3	VERB
aji-170	273	2	+	+	ADJ
aji-170	273	3	decidual	decidual	ADJ
aji-170	273	4	mφs	mφs	NOUN
aji-170	273	5	induced	induce	VERB
aji-170	273	6	th2	th2	PROPN
aji-170	273	7	and	and	CCONJ
aji-170	273	8	treg	treg	PROPN
aji-170	273	9	bias	bias	PROPN
aji-170	273	10	in	in	ADP
aji-170	273	11	decidual	decidual	ADJ
aji-170	273	12	cd4+t	cd4+t	ADJ
aji-170	273	13	cells	cell	NOUN
aji-170	273	14	and	and	CCONJ
aji-170	273	15	promoted	promote	VERB
aji-170	273	16	pregnancy	pregnancy	NOUN
aji-170	273	17	maintenance	maintenance	NOUN
aji-170	273	18	via	via	ADP
aji-170	273	19	cd132	cd132	PROPN
aji-170	273	20	.	.	PUNCT
aji-170	273	21	cell	cell	NOUN
aji-170	273	22	death	death	NOUN
aji-170	273	23	and	and	CCONJ
aji-170	273	24	disease	disease	NOUN
aji-170	273	25	,	,	PUNCT
aji-170	273	26	13(5	13(5	NUM
aji-170	273	27	)	)	PUNCT
aji-170	273	28	.	.	PUNCT
aji-170	274	1	https://doi.org/10.1038/s41419-022-048992	https://doi.org/10.1038/s41419-022-048992	PROPN
aji-170	274	2	li	li	PROPN
aji-170	274	3	,	,	PUNCT
aji-170	274	4	x.	x.	PROPN
aji-170	274	5	,	,	PUNCT
aji-170	274	6	zhou	zhou	PROPN
aji-170	274	7	,	,	PUNCT
aji-170	274	8	j.	j.	PROPN
aji-170	274	9	,	,	PUNCT
aji-170	274	10	fang	fang	PROPN
aji-170	274	11	,	,	PUNCT
aji-170	274	12	m.	m.	NOUN
aji-170	274	13	,	,	PUNCT
aji-170	274	14	&	&	CCONJ
aji-170	274	15	yu	yu	PROPN
aji-170	274	16	,	,	PUNCT
aji-170	274	17	b.	b.	PROPN
aji-170	274	18	(	(	PUNCT
aji-170	274	19	2020	2020	NUM
aji-170	274	20	)	)	PUNCT
aji-170	274	21	.	.	PUNCT
aji-170	275	1	pregnancy	pregnancy	NOUN
aji-170	275	2	immune	immune	ADJ
aji-170	275	3	tolerance	tolerance	NOUN
aji-170	275	4	at	at	ADP
aji-170	275	5	the	the	DET
aji-170	275	6	maternal	maternal	ADJ
aji-170	275	7	-	-	PUNCT
aji-170	275	8	fetal	fetal	ADJ
aji-170	275	9	interface	interface	NOUN
aji-170	275	10	.	.	PUNCT
aji-170	276	1	in	in	ADP
aji-170	276	2	international	international	ADJ
aji-170	276	3	reviews	review	NOUN
aji-170	276	4	of	of	ADP
aji-170	276	5	immunology	immunology	NOUN
aji-170	276	6	(	(	PUNCT
aji-170	276	7	vol	vol	NOUN
aji-170	276	8	.	.	PROPN
aji-170	276	9	39	39	NUM
aji-170	276	10	,	,	PUNCT
aji-170	276	11	issue	issue	NOUN
aji-170	276	12	6	6	NUM
aji-170	276	13	,	,	PUNCT
aji-170	276	14	pp	pp	ADJ
aji-170	276	15	.	.	PUNCT
aji-170	276	16	247–263	247–263	NUM
aji-170	276	17	)	)	PUNCT
aji-170	276	18	.	.	PUNCT
aji-170	277	1	taylor	taylor	PROPN
aji-170	277	2	and	and	CCONJ
aji-170	277	3	francis	francis	PROPN
aji-170	277	4	ltd	ltd	PROPN
aji-170	277	5	.	.	PUNCT
aji-170	278	1	https://doi.org/10.1080/08830185.2020.177	https://doi.org/10.1080/08830185.2020.177	PROPN
aji-170	279	1	7292	7292	NUM
aji-170	279	2	li	li	PROPN
aji-170	279	3	,	,	PUNCT
aji-170	279	4	y.	y.	PROPN
aji-170	279	5	,	,	PUNCT
aji-170	279	6	zhang	zhang	PROPN
aji-170	279	7	,	,	PUNCT
aji-170	279	8	j.	j.	PROPN
aji-170	279	9	,	,	PUNCT
aji-170	279	10	zhang	zhang	PROPN
aji-170	279	11	,	,	PUNCT
aji-170	279	12	d.	d.	PROPN
aji-170	279	13	,	,	PUNCT
aji-170	279	14	hong	hong	PROPN
aji-170	279	15	,	,	PUNCT
aji-170	279	16	x.	x.	PROPN
aji-170	279	17	,	,	PUNCT
aji-170	279	18	tao	tao	PROPN
aji-170	279	19	,	,	PUNCT
aji-170	279	20	y.	y.	PROPN
aji-170	279	21	,	,	PUNCT
aji-170	279	22	wang	wang	PROPN
aji-170	279	23	,	,	PUNCT
aji-170	279	24	s.	s.	PROPN
aji-170	279	25	,	,	PUNCT
aji-170	279	26	xu	xu	PROPN
aji-170	279	27	,	,	PUNCT
aji-170	279	28	y.	y.	PROPN
aji-170	279	29	,	,	PUNCT
aji-170	279	30	piao	piao	PROPN
aji-170	279	31	,	,	PUNCT
aji-170	279	32	h.	h.	PROPN
aji-170	279	33	,	,	PUNCT
aji-170	279	34	yin	yin	PROPN
aji-170	279	35	,	,	PUNCT
aji-170	279	36	w.	w.	PROPN
aji-170	279	37	,	,	PUNCT
aji-170	279	38	yu	yu	PROPN
aji-170	279	39	,	,	PUNCT
aji-170	279	40	m.	m.	NOUN
aji-170	279	41	,	,	PUNCT
aji-170	279	42	zhang	zhang	PROPN
aji-170	279	43	,	,	PUNCT
aji-170	279	44	y.	y.	PROPN
aji-170	279	45	,	,	PUNCT
aji-170	279	46	fu	fu	PROPN
aji-170	279	47	,	,	PUNCT
aji-170	279	48	q.	q.	PROPN
aji-170	279	49	,	,	PUNCT
aji-170	279	50	li	li	PROPN
aji-170	279	51	,	,	PUNCT
aji-170	279	52	d.	d.	PROPN
aji-170	279	53	,	,	PUNCT
aji-170	279	54	chang	chang	PROPN
aji-170	279	55	,	,	PUNCT
aji-170	279	56	x.	x.	PROPN
aji-170	279	57	,	,	PUNCT
aji-170	279	58	&	&	CCONJ
aji-170	279	59	meirong	meirong	PROPN
aji-170	279	60	du	du	PROPN
aji-170	279	61	,	,	PUNCT
aji-170	279	62	†.	†.	PUNCT
aji-170	279	63	(	(	PUNCT
aji-170	279	64	2017	2017	NUM
aji-170	279	65	)	)	PUNCT
aji-170	279	66	.	.	PUNCT
aji-170	280	1	tim-3	tim-3	VERB
aji-170	280	2	signaling	signal	VERB
aji-170	280	3	in	in	ADP
aji-170	280	4	peripheral	peripheral	ADJ
aji-170	280	5	nk	nk	PROPN
aji-170	280	6	cells	cell	NOUN
aji-170	280	7	promotes	promote	VERB
aji-170	280	8	maternalfetal	maternalfetal	ADJ
aji-170	280	9	immune	immune	ADJ
aji-170	280	10	tolerance	tolerance	NOUN
aji-170	280	11	and	and	CCONJ
aji-170	280	12	alleviates	alleviate	VERB
aji-170	280	13	pregnancy	pregnancy	NOUN
aji-170	280	14	loss	loss	NOUN
aji-170	280	15	.	.	PUNCT
aji-170	281	1	http://stke.sciencemag.org/	http://stke.sciencemag.org/	PROPN
aji-170	281	2	liu	liu	PROPN
aji-170	281	3	,	,	PUNCT
aji-170	281	4	h.	h.	PROPN
aji-170	281	5	,	,	PUNCT
aji-170	281	6	chen	chen	PROPN
aji-170	281	7	,	,	PUNCT
aji-170	281	8	m.	m.	NOUN
aji-170	281	9	,	,	PUNCT
aji-170	281	10	shan	shan	PROPN
aji-170	281	11	,	,	PUNCT
aji-170	281	12	z.	z.	PROPN
aji-170	281	13	,	,	PUNCT
aji-170	281	14	&	&	CCONJ
aji-170	281	15	teng	teng	PROPN
aji-170	281	16	,	,	PUNCT
aji-170	281	17	w.	w.	PROPN
aji-170	281	18	(	(	PUNCT
aji-170	281	19	2020	2020	NUM
aji-170	281	20	)	)	PUNCT
aji-170	281	21	.	.	PUNCT
aji-170	282	1	immunoregulation	immunoregulation	NOUN
aji-170	282	2	of	of	ADP
aji-170	282	3	pd-1	pd-1	ADP
aji-170	282	4	/	/	SYM
aji-170	282	5	pd	pd	ADJ
aji-170	282	6	-	-	PROPN
aji-170	282	7	l1	l1	PROPN
aji-170	282	8	inhibitory	inhibitory	ADJ
aji-170	282	9	pathway	pathway	NOUN
aji-170	282	10	on	on	ADP
aji-170	282	11	fetomaternal	fetomaternal	ADJ
aji-170	282	12	tolerance	tolerance	NOUN
aji-170	282	13	in	in	ADP
aji-170	282	14	abortion	abortion	NOUN
aji-170	282	15	triggered	trigger	VERB
aji-170	282	16	by	by	ADP
aji-170	282	17	thyroid	thyroid	NOUN
aji-170	282	18	autoimmunity	autoimmunity	NOUN
aji-170	282	19	.	.	PUNCT
aji-170	283	1	https://doi.org/10.21203/rs.3.rs-16978/v1	https://doi.org/10.21203/rs.3.rs-16978/v1	PROPN
aji-170	284	1	https://doi.org/10.1002/jcp.27290	https://doi.org/10.1002/jcp.27290	PROPN
aji-170	284	2	https://doi.org/10.1111/aji.13254	https://doi.org/10.1111/aji.13254	PROPN
aji-170	284	3	https://doi.org/10.1016/j.jri.2015.08.006	https://doi.org/10.1016/j.jri.2015.08.006	PROPN
aji-170	284	4	https://doi.org/10.1038/s41419-022-04899-2	https://doi.org/10.1038/s41419-022-04899-2	PROPN
aji-170	284	5	https://doi.org/10.1038/s41419-022-04899-2	https://doi.org/10.1038/s41419-022-04899-2	NUM
aji-170	284	6	http://stke.sciencemag.org/	http://stke.sciencemag.org/	NOUN
aji-170	285	1	https://doi.org/10.21203/rs.3.rs-16978/v1	https://doi.org/10.21203/rs.3.rs-16978/v1	PROPN
aji-170	286	1	walana	walana	PROPN
aji-170	286	2	et	et	PROPN
aji-170	286	3	al	al	PROPN
aji-170	286	4	.	.	PROPN
aji-170	286	5	;	;	PUNCT
aji-170	287	1	asian	asian	PROPN
aji-170	287	2	j.	j.	PROPN
aji-170	287	3	immunol	immunol	PROPN
aji-170	287	4	.	.	PROPN
aji-170	287	5	,	,	PUNCT
aji-170	287	6	vol	vol	NOUN
aji-170	287	7	.	.	PROPN
aji-170	287	8	8	8	NUM
aji-170	287	9	,	,	PUNCT
aji-170	287	10	no	no	INTJ
aji-170	287	11	.	.	NOUN
aji-170	287	12	1	1	NUM
aji-170	287	13	,	,	PUNCT
aji-170	287	14	pp	pp	ADJ
aji-170	287	15	.	.	PUNCT
aji-170	288	1	179	179	NUM
aji-170	288	2	-	-	SYM
aji-170	288	3	189	189	NUM
aji-170	288	4	,	,	PUNCT
aji-170	288	5	2025	2025	NUM
aji-170	288	6	;	;	PUNCT
aji-170	288	7	article	article	NOUN
aji-170	288	8	no.aji.139815	no.aji.139815	VERB
aji-170	288	9	188	188	NUM
aji-170	288	10	liu	liu	PROPN
aji-170	288	11	,	,	PUNCT
aji-170	288	12	h.	h.	PROPN
aji-170	288	13	,	,	PUNCT
aji-170	288	14	lin	lin	PROPN
aji-170	288	15	,	,	PUNCT
aji-170	288	16	x.	x.	PROPN
aji-170	288	17	x.	x.	PROPN
aji-170	288	18	,	,	PUNCT
aji-170	288	19	huang	huang	PROPN
aji-170	288	20	,	,	PUNCT
aji-170	288	21	x.	x.	PROPN
aji-170	288	22	b.	b.	PROPN
aji-170	288	23	,	,	PUNCT
aji-170	288	24	huang	huang	PROPN
aji-170	288	25	,	,	PUNCT
aji-170	288	26	d.	d.	PROPN
aji-170	288	27	h.	h.	PROPN
aji-170	288	28	,	,	PUNCT
aji-170	288	29	song	song	PROPN
aji-170	288	30	,	,	PUNCT
aji-170	288	31	s.	s.	PROPN
aji-170	288	32	,	,	PUNCT
aji-170	288	33	chen	chen	PROPN
aji-170	288	34	,	,	PUNCT
aji-170	288	35	y.	y.	PROPN
aji-170	288	36	j.	j.	PROPN
aji-170	288	37	,	,	PUNCT
aji-170	288	38	tang	tang	PROPN
aji-170	288	39	,	,	PUNCT
aji-170	288	40	j.	j.	PROPN
aji-170	288	41	,	,	PUNCT
aji-170	288	42	tao	tao	PROPN
aji-170	288	43	,	,	PUNCT
aji-170	288	44	d.	d.	PROPN
aji-170	288	45	,	,	PUNCT
aji-170	288	46	yin	yin	PROPN
aji-170	288	47	,	,	PUNCT
aji-170	288	48	z.	z.	PROPN
aji-170	288	49	n.	n.	PROPN
aji-170	288	50	,	,	PUNCT
aji-170	288	51	mor	mor	PROPN
aji-170	288	52	,	,	PUNCT
aji-170	288	53	g.	g.	PROPN
aji-170	288	54	,	,	PUNCT
aji-170	288	55	&	&	CCONJ
aji-170	288	56	liao	liao	PROPN
aji-170	288	57	,	,	PUNCT
aji-170	288	58	a.	a.	PROPN
aji-170	288	59	h.	h.	PROPN
aji-170	288	60	(	(	PUNCT
aji-170	288	61	2021	2021	NUM
aji-170	288	62	)	)	PUNCT
aji-170	288	63	.	.	PUNCT
aji-170	289	1	systemic	systemic	ADJ
aji-170	289	2	characterization	characterization	NOUN
aji-170	289	3	of	of	ADP
aji-170	289	4	novel	novel	ADJ
aji-170	289	5	immune	immune	ADJ
aji-170	289	6	cell	cell	NOUN
aji-170	289	7	phenotypes	phenotype	NOUN
aji-170	289	8	in	in	ADP
aji-170	289	9	recurrent	recurrent	ADJ
aji-170	289	10	pregnancy	pregnancy	NOUN
aji-170	289	11	loss	loss	NOUN
aji-170	289	12	.	.	PUNCT
aji-170	290	1	frontiers	frontier	NOUN
aji-170	290	2	in	in	ADP
aji-170	290	3	immunology	immunology	NOUN
aji-170	290	4	,	,	PUNCT
aji-170	290	5	12	12	NUM
aji-170	290	6	.	.	PUNCT
aji-170	291	1	https://doi.org/10.3389/fimmu.2021.657552	https://doi.org/10.3389/fimmu.2021.657552	PROPN
aji-170	291	2	luo	luo	PROPN
aji-170	291	3	,	,	PUNCT
aji-170	291	4	l.	l.	PROPN
aji-170	291	5	,	,	PUNCT
aji-170	291	6	luo	luo	PROPN
aji-170	291	7	,	,	PUNCT
aji-170	291	8	l.	l.	PROPN
aji-170	291	9	,	,	PUNCT
aji-170	291	10	zeng	zeng	PROPN
aji-170	291	11	,	,	PUNCT
aji-170	291	12	x.	x.	PROPN
aji-170	291	13	,	,	PUNCT
aji-170	291	14	zeng	zeng	PROPN
aji-170	291	15	,	,	PUNCT
aji-170	291	16	x.	x.	PROPN
aji-170	291	17	,	,	PUNCT
aji-170	291	18	huang	huang	PROPN
aji-170	291	19	,	,	PUNCT
aji-170	291	20	z.	z.	PROPN
aji-170	291	21	,	,	PUNCT
aji-170	291	22	huang	huang	PROPN
aji-170	291	23	,	,	PUNCT
aji-170	291	24	z.	z.	PROPN
aji-170	291	25	,	,	PUNCT
aji-170	291	26	luo	luo	PROPN
aji-170	291	27	,	,	PUNCT
aji-170	291	28	s.	s.	PROPN
aji-170	291	29	,	,	PUNCT
aji-170	291	30	luo	luo	PROPN
aji-170	291	31	,	,	PUNCT
aji-170	291	32	s.	s.	PROPN
aji-170	291	33	,	,	PUNCT
aji-170	291	34	qin	qin	PROPN
aji-170	291	35	,	,	PUNCT
aji-170	291	36	l.	l.	PROPN
aji-170	291	37	,	,	PUNCT
aji-170	291	38	qin	qin	PROPN
aji-170	291	39	,	,	PUNCT
aji-170	291	40	l.	l.	PROPN
aji-170	291	41	,	,	PUNCT
aji-170	291	42	li	li	PROPN
aji-170	291	43	,	,	PUNCT
aji-170	291	44	s.	s.	PROPN
aji-170	291	45	,	,	PUNCT
aji-170	291	46	&	&	CCONJ
aji-170	291	47	li	li	PROPN
aji-170	291	48	,	,	PUNCT
aji-170	291	49	s.	s.	PROPN
aji-170	291	50	(	(	PUNCT
aji-170	291	51	2020	2020	NUM
aji-170	291	52	)	)	PUNCT
aji-170	291	53	.	.	PUNCT
aji-170	292	1	reduced	reduce	VERB
aji-170	292	2	frequency	frequency	NOUN
aji-170	292	3	and	and	CCONJ
aji-170	292	4	functional	functional	ADJ
aji-170	292	5	defects	defect	NOUN
aji-170	292	6	of	of	ADP
aji-170	292	7	cd4+cd25highcd127low	cd4+cd25highcd127low	ADJ
aji-170	292	8	/	/	SYM
aji-170	292	9	regulatory	regulatory	ADJ
aji-170	292	10	t	t	NOUN
aji-170	292	11	cells	cell	NOUN
aji-170	292	12	in	in	ADP
aji-170	292	13	patients	patient	NOUN
aji-170	292	14	with	with	ADP
aji-170	292	15	unexplained	unexplained	ADJ
aji-170	292	16	recurrent	recurrent	ADJ
aji-170	292	17	spontaneous	spontaneous	ADJ
aji-170	292	18	abortion	abortion	NOUN
aji-170	292	19	.	.	PUNCT
aji-170	293	1	reproductive	reproductive	ADJ
aji-170	293	2	biology	biology	NOUN
aji-170	293	3	and	and	CCONJ
aji-170	293	4	endocrinology	endocrinology	NOUN
aji-170	293	5	,	,	PUNCT
aji-170	293	6	18(1	18(1	NUM
aji-170	293	7	)	)	PUNCT
aji-170	293	8	.	.	PUNCT
aji-170	294	1	https://doi.org/10.1186/s12958-020-006197	https://doi.org/10.1186/s12958-020-006197	PROPN
aji-170	294	2	miller	miller	PROPN
aji-170	294	3	,	,	PUNCT
aji-170	294	4	d.	d.	PROPN
aji-170	294	5	,	,	PUNCT
aji-170	294	6	gershater	gershater	NOUN
aji-170	294	7	,	,	PUNCT
aji-170	294	8	m.	m.	NOUN
aji-170	294	9	,	,	PUNCT
aji-170	294	10	slutsky	slutsky	PROPN
aji-170	294	11	,	,	PUNCT
aji-170	294	12	r.	r.	PROPN
aji-170	294	13	,	,	PUNCT
aji-170	294	14	romero	romero	PROPN
aji-170	294	15	,	,	PUNCT
aji-170	294	16	r.	r.	PROPN
aji-170	294	17	,	,	PUNCT
aji-170	294	18	&	&	CCONJ
aji-170	294	19	gomez	gomez	PROPN
aji-170	294	20	-	-	PUNCT
aji-170	294	21	lopez	lopez	NOUN
aji-170	294	22	,	,	PUNCT
aji-170	294	23	n.	n.	NOUN
aji-170	294	24	(	(	PUNCT
aji-170	294	25	2020	2020	NUM
aji-170	294	26	)	)	PUNCT
aji-170	294	27	.	.	PUNCT
aji-170	295	1	maternal	maternal	ADJ
aji-170	295	2	and	and	CCONJ
aji-170	295	3	fetal	fetal	ADJ
aji-170	295	4	t	t	NOUN
aji-170	295	5	cells	cell	NOUN
aji-170	295	6	in	in	ADP
aji-170	295	7	term	term	NOUN
aji-170	295	8	pregnancy	pregnancy	NOUN
aji-170	295	9	and	and	CCONJ
aji-170	295	10	preterm	preterm	ADJ
aji-170	295	11	labor	labor	NOUN
aji-170	295	12	.	.	PUNCT
aji-170	296	1	in	in	ADP
aji-170	296	2	cellular	cellular	ADJ
aji-170	296	3	and	and	CCONJ
aji-170	296	4	molecular	molecular	ADJ
aji-170	296	5	immunology	immunology	NOUN
aji-170	296	6	(	(	PUNCT
aji-170	296	7	vol	vol	NOUN
aji-170	296	8	.	.	PROPN
aji-170	296	9	17	17	NUM
aji-170	296	10	,	,	PUNCT
aji-170	296	11	issue	issue	NOUN
aji-170	296	12	7	7	NUM
aji-170	296	13	,	,	PUNCT
aji-170	296	14	pp	pp	ADJ
aji-170	296	15	.	.	PUNCT
aji-170	297	1	693	693	NUM
aji-170	297	2	–	–	PUNCT
aji-170	297	3	704	704	NUM
aji-170	297	4	)	)	PUNCT
aji-170	297	5	.	.	PUNCT
aji-170	298	1	springer	springer	NOUN
aji-170	298	2	nature	nature	NOUN
aji-170	298	3	.	.	PUNCT
aji-170	299	1	https://doi.org/10.1038/s41423-020-0471-2	https://doi.org/10.1038/s41423-020-0471-2	NUM
aji-170	299	2	qian	qian	PROPN
aji-170	299	3	,	,	PUNCT
aji-170	299	4	j.	j.	PROPN
aji-170	299	5	,	,	PUNCT
aji-170	299	6	zhang	zhang	PROPN
aji-170	299	7	,	,	PUNCT
aji-170	299	8	n.	n.	PROPN
aji-170	299	9	,	,	PUNCT
aji-170	299	10	lin	lin	PROPN
aji-170	299	11	,	,	PUNCT
aji-170	299	12	j.	j.	PROPN
aji-170	299	13	,	,	PUNCT
aji-170	299	14	wang	wang	PROPN
aji-170	299	15	,	,	PUNCT
aji-170	299	16	c.	c.	PROPN
aji-170	299	17	,	,	PUNCT
aji-170	299	18	pan	pan	PROPN
aji-170	299	19	,	,	PUNCT
aji-170	299	20	x.	x.	PROPN
aji-170	299	21	,	,	PUNCT
aji-170	299	22	chen	chen	PROPN
aji-170	299	23	,	,	PUNCT
aji-170	299	24	l.	l.	PROPN
aji-170	299	25	,	,	PUNCT
aji-170	299	26	li	li	PROPN
aji-170	299	27	,	,	PUNCT
aji-170	299	28	d.	d.	PROPN
aji-170	299	29	,	,	PUNCT
aji-170	299	30	&	&	CCONJ
aji-170	299	31	wang	wang	PROPN
aji-170	299	32	,	,	PUNCT
aji-170	299	33	l.	l.	PROPN
aji-170	299	34	(	(	PUNCT
aji-170	299	35	2018	2018	NUM
aji-170	299	36	)	)	PUNCT
aji-170	299	37	.	.	PUNCT
aji-170	300	1	distinct	distinct	ADJ
aji-170	300	2	pattern	pattern	NOUN
aji-170	300	3	of	of	ADP
aji-170	300	4	th17	th17	PROPN
aji-170	300	5	/	/	SYM
aji-170	300	6	treg	treg	PROPN
aji-170	300	7	cells	cell	NOUN
aji-170	300	8	in	in	ADP
aji-170	300	9	pregnant	pregnant	ADJ
aji-170	300	10	women	woman	NOUN
aji-170	300	11	with	with	ADP
aji-170	300	12	a	a	DET
aji-170	300	13	history	history	NOUN
aji-170	300	14	of	of	ADP
aji-170	300	15	unexplained	unexplained	ADJ
aji-170	300	16	recurrent	recurrent	ADJ
aji-170	300	17	spontaneous	spontaneous	ADJ
aji-170	300	18	abortion	abortion	NOUN
aji-170	300	19	.	.	PUNCT
aji-170	301	1	bioscience	bioscience	NOUN
aji-170	301	2	trends	trend	NOUN
aji-170	301	3	,	,	PUNCT
aji-170	301	4	12(2	12(2	NUM
aji-170	301	5	)	)	PUNCT
aji-170	301	6	,	,	PUNCT
aji-170	301	7	157	157	NUM
aji-170	301	8	–	–	SYM
aji-170	301	9	167	167	NUM
aji-170	301	10	.	.	PUNCT
aji-170	302	1	https://doi.org/10.5582/bst.2018.01012	https://doi.org/10.5582/bst.2018.01012	PROPN
aji-170	302	2	sun	sun	PROPN
aji-170	302	3	,	,	PUNCT
aji-170	302	4	j.	j.	PROPN
aji-170	302	5	,	,	PUNCT
aji-170	302	6	yang	yang	PROPN
aji-170	302	7	,	,	PUNCT
aji-170	302	8	m.	m.	NOUN
aji-170	302	9	,	,	PUNCT
aji-170	302	10	ban	ban	NOUN
aji-170	302	11	,	,	PUNCT
aji-170	302	12	y.	y.	PROPN
aji-170	302	13	,	,	PUNCT
aji-170	302	14	gao	gao	PROPN
aji-170	302	15	,	,	PUNCT
aji-170	302	16	w.	w.	PROPN
aji-170	302	17	,	,	PUNCT
aji-170	302	18	song	song	PROPN
aji-170	302	19	,	,	PUNCT
aji-170	302	20	b.	b.	PROPN
aji-170	302	21	,	,	PUNCT
aji-170	302	22	wang	wang	PROPN
aji-170	302	23	,	,	PUNCT
aji-170	302	24	y.	y.	PROPN
aji-170	302	25	,	,	PUNCT
aji-170	302	26	zhang	zhang	PROPN
aji-170	302	27	,	,	PUNCT
aji-170	302	28	y.	y.	PROPN
aji-170	302	29	,	,	PUNCT
aji-170	302	30	shao	shao	PROPN
aji-170	302	31	,	,	PUNCT
aji-170	302	32	q.	q.	PROPN
aji-170	302	33	,	,	PUNCT
aji-170	302	34	kong	kong	PROPN
aji-170	302	35	,	,	PUNCT
aji-170	302	36	b.	b.	PROPN
aji-170	302	37	,	,	PUNCT
aji-170	302	38	&	&	CCONJ
aji-170	302	39	qu	qu	PROPN
aji-170	302	40	,	,	PUNCT
aji-170	302	41	x.	x.	PROPN
aji-170	302	42	(	(	PUNCT
aji-170	302	43	2016	2016	NUM
aji-170	302	44	)	)	PUNCT
aji-170	302	45	.	.	PUNCT
aji-170	303	1	tim-3	tim-3	PUNCT
aji-170	303	2	is	be	AUX
aji-170	303	3	upregulated	upregulate	VERB
aji-170	303	4	in	in	ADP
aji-170	303	5	nk	nk	PROPN
aji-170	303	6	cells	cell	NOUN
aji-170	303	7	during	during	ADP
aji-170	303	8	early	early	ADJ
aji-170	303	9	pregnancy	pregnancy	NOUN
aji-170	303	10	and	and	CCONJ
aji-170	303	11	inhibits	inhibit	VERB
aji-170	303	12	nk	nk	PROPN
aji-170	303	13	cytotoxicity	cytotoxicity	NOUN
aji-170	303	14	toward	toward	ADP
aji-170	303	15	trophoblast	trophoblast	NOUN
aji-170	303	16	in	in	ADP
aji-170	303	17	galectin-9	galectin-9	PROPN
aji-170	303	18	dependent	dependent	ADJ
aji-170	303	19	pathway	pathway	NOUN
aji-170	303	20	.	.	PUNCT
aji-170	304	1	plos	plos	PROPN
aji-170	304	2	one	one	NUM
aji-170	304	3	,	,	PUNCT
aji-170	304	4	11(1	11(1	NUM
aji-170	304	5	)	)	PUNCT
aji-170	304	6	.	.	PUNCT
aji-170	305	1	https://doi.org/10.1371/journal.pone.01471	https://doi.org/10.1371/journal.pone.01471	NOUN
aji-170	305	2	86	86	NUM
aji-170	305	3	talukdar	talukdar	NOUN
aji-170	305	4	,	,	PUNCT
aji-170	305	5	a.	a.	PROPN
aji-170	305	6	,	,	PUNCT
aji-170	305	7	rai	rai	PROPN
aji-170	305	8	,	,	PUNCT
aji-170	305	9	r.	r.	PROPN
aji-170	305	10	,	,	PUNCT
aji-170	305	11	sharma	sharma	PROPN
aji-170	305	12	,	,	PUNCT
aji-170	305	13	k.	k.	PROPN
aji-170	305	14	a.	a.	PROPN
aji-170	305	15	,	,	PUNCT
aji-170	305	16	rao	rao	PROPN
aji-170	305	17	,	,	PUNCT
aji-170	305	18	d.	d.	PROPN
aji-170	305	19	n.	n.	PROPN
aji-170	305	20	,	,	PUNCT
aji-170	305	21	&	&	CCONJ
aji-170	305	22	sharma	sharma	PROPN
aji-170	305	23	,	,	PUNCT
aji-170	305	24	a.	a.	NOUN
aji-170	305	25	(	(	PUNCT
aji-170	305	26	2018	2018	NUM
aji-170	305	27	)	)	PUNCT
aji-170	305	28	.	.	PUNCT
aji-170	306	1	peripheral	peripheral	ADJ
aji-170	306	2	gamma	gamma	PROPN
aji-170	306	3	delta	delta	PROPN
aji-170	306	4	t	t	PROPN
aji-170	306	5	cells	cell	NOUN
aji-170	306	6	secrete	secrete	VERB
aji-170	306	7	inflammatory	inflammatory	ADJ
aji-170	306	8	cytokines	cytokine	NOUN
aji-170	306	9	in	in	ADP
aji-170	306	10	women	woman	NOUN
aji-170	306	11	with	with	ADP
aji-170	306	12	idiopathic	idiopathic	ADJ
aji-170	306	13	recurrent	recurrent	ADJ
aji-170	306	14	pregnancy	pregnancy	NOUN
aji-170	306	15	loss	loss	NOUN
aji-170	306	16	.	.	PUNCT
aji-170	307	1	cytokine	cytokine	NOUN
aji-170	307	2	,	,	PUNCT
aji-170	307	3	102	102	NUM
aji-170	307	4	,	,	PUNCT
aji-170	307	5	117–122	117–122	NUM
aji-170	307	6	.	.	PUNCT
aji-170	308	1	https://doi.org/10.1016/j.cyto.2017.07.018	https://doi.org/10.1016/j.cyto.2017.07.018	PROPN
aji-170	308	2	wang	wang	PROPN
aji-170	308	3	,	,	PUNCT
aji-170	308	4	s.	s.	PROPN
aji-170	308	5	c.	c.	PROPN
aji-170	308	6	,	,	PUNCT
aji-170	308	7	zhu	zhu	PROPN
aji-170	308	8	,	,	PUNCT
aji-170	308	9	x.	x.	PROPN
aji-170	308	10	y.	y.	PROPN
aji-170	308	11	,	,	PUNCT
aji-170	308	12	xu	xu	PROPN
aji-170	308	13	,	,	PUNCT
aji-170	308	14	y.	y.	PROPN
aji-170	308	15	y.	y.	PROPN
aji-170	308	16	,	,	PUNCT
aji-170	308	17	zhang	zhang	PROPN
aji-170	308	18	,	,	PUNCT
aji-170	308	19	d.	d.	PROPN
aji-170	308	20	,	,	PUNCT
aji-170	308	21	li	li	PROPN
aji-170	308	22	,	,	PUNCT
aji-170	308	23	y.	y.	PROPN
aji-170	308	24	h.	h.	PROPN
aji-170	308	25	,	,	PUNCT
aji-170	308	26	tao	tao	PROPN
aji-170	308	27	,	,	PUNCT
aji-170	308	28	y.	y.	PROPN
aji-170	308	29	,	,	PUNCT
aji-170	308	30	piao	piao	PROPN
aji-170	308	31	,	,	PUNCT
aji-170	308	32	h.	h.	PROPN
aji-170	308	33	l.	l.	PROPN
aji-170	308	34	,	,	PUNCT
aji-170	308	35	li	li	PROPN
aji-170	308	36	,	,	PUNCT
aji-170	308	37	d.	d.	PROPN
aji-170	308	38	j.	j.	PROPN
aji-170	308	39	,	,	PUNCT
aji-170	308	40	&	&	CCONJ
aji-170	308	41	du	du	PROPN
aji-170	308	42	,	,	PUNCT
aji-170	308	43	m.	m.	PROPN
aji-170	308	44	r.	r.	PROPN
aji-170	308	45	(	(	PUNCT
aji-170	308	46	2016	2016	NUM
aji-170	308	47	)	)	PUNCT
aji-170	308	48	.	.	PUNCT
aji-170	309	1	programmed	program	VERB
aji-170	309	2	cell	cell	NOUN
aji-170	309	3	death-1	death-1	NUM
aji-170	309	4	(	(	PUNCT
aji-170	309	5	pd-1	pd-1	ADV
aji-170	309	6	)	)	PUNCT
aji-170	309	7	and	and	CCONJ
aji-170	309	8	t	t	PROPN
aji-170	309	9	-	-	PUNCT
aji-170	309	10	cell	cell	NOUN
aji-170	309	11	immunoglobulin	immunoglobulin	NOUN
aji-170	309	12	mucin-3	mucin-3	PRON
aji-170	309	13	(	(	PUNCT
aji-170	309	14	tim-3	tim-3	NUM
aji-170	309	15	)	)	PUNCT
aji-170	309	16	regulate	regulate	VERB
aji-170	309	17	cd4	cd4	PROPN
aji-170	309	18	+	+	PROPN
aji-170	309	19	t	t	NOUN
aji-170	309	20	cells	cell	NOUN
aji-170	309	21	to	to	PART
aji-170	309	22	induce	induce	VERB
aji-170	309	23	type	type	NOUN
aji-170	309	24	2	2	NUM
aji-170	309	25	helper	helper	NOUN
aji-170	309	26	t	t	NOUN
aji-170	309	27	cell	cell	NOUN
aji-170	309	28	(	(	PUNCT
aji-170	309	29	th2	th2	PROPN
aji-170	309	30	)	)	PUNCT
aji-170	309	31	bias	bias	NOUN
aji-170	309	32	at	at	ADP
aji-170	309	33	the	the	DET
aji-170	309	34	maternal	maternal	ADJ
aji-170	309	35	-	-	PUNCT
aji-170	309	36	fetal	fetal	ADJ
aji-170	309	37	interface	interface	NOUN
aji-170	309	38	.	.	PUNCT
aji-170	310	1	human	human	ADJ
aji-170	310	2	reproduction	reproduction	NOUN
aji-170	310	3	,	,	PUNCT
aji-170	310	4	31(4	31(4	NUM
aji-170	310	5	)	)	PUNCT
aji-170	310	6	,	,	PUNCT
aji-170	310	7	700–711	700–711	NUM
aji-170	310	8	.	.	PUNCT
aji-170	311	1	https://doi.org/10.1093/humrep/dew019	https://doi.org/10.1093/humrep/dew019	PROPN
aji-170	311	2	wang	wang	PROPN
aji-170	311	3	,	,	PUNCT
aji-170	311	4	s.	s.	PROPN
aji-170	311	5	,	,	PUNCT
aji-170	311	6	li	li	PROPN
aji-170	311	7	,	,	PUNCT
aji-170	311	8	m.	m.	NOUN
aji-170	311	9	,	,	PUNCT
aji-170	311	10	sun	sun	PROPN
aji-170	311	11	,	,	PUNCT
aji-170	311	12	f.	f.	PROPN
aji-170	311	13	,	,	PUNCT
aji-170	311	14	chen	chen	PROPN
aji-170	311	15	,	,	PUNCT
aji-170	311	16	c.	c.	PROPN
aji-170	311	17	,	,	PUNCT
aji-170	311	18	ye	ye	PROPN
aji-170	311	19	,	,	PUNCT
aji-170	311	20	j.	j.	PROPN
aji-170	311	21	,	,	PUNCT
aji-170	311	22	li	li	PROPN
aji-170	311	23	,	,	PUNCT
aji-170	311	24	d.	d.	PROPN
aji-170	311	25	,	,	PUNCT
aji-170	311	26	qian	qian	PROPN
aji-170	311	27	,	,	PUNCT
aji-170	311	28	j.	j.	PROPN
aji-170	311	29	,	,	PUNCT
aji-170	311	30	&	&	CCONJ
aji-170	311	31	du	du	PROPN
aji-170	311	32	,	,	PUNCT
aji-170	311	33	m.	m.	NOUN
aji-170	311	34	(	(	PUNCT
aji-170	311	35	2016	2016	NUM
aji-170	311	36	)	)	PUNCT
aji-170	311	37	.	.	PUNCT
aji-170	312	1	th17	th17	NOUN
aji-170	312	2	/	/	SYM
aji-170	312	3	treg	treg	PROPN
aji-170	312	4	cell	cell	NOUN
aji-170	312	5	balance	balance	NOUN
aji-170	312	6	in	in	ADP
aji-170	312	7	the	the	DET
aji-170	312	8	peripheral	peripheral	ADJ
aji-170	312	9	blood	blood	NOUN
aji-170	312	10	of	of	ADP
aji-170	312	11	pregnant	pregnant	ADJ
aji-170	312	12	females	female	NOUN
aji-170	312	13	with	with	ADP
aji-170	312	14	a	a	DET
aji-170	312	15	history	history	NOUN
aji-170	312	16	of	of	ADP
aji-170	312	17	recurrent	recurrent	ADJ
aji-170	312	18	spontaneous	spontaneous	ADJ
aji-170	312	19	abortion	abortion	NOUN
aji-170	312	20	receiving	receive	VERB
aji-170	312	21	progesterone	progesterone	NOUN
aji-170	312	22	or	or	CCONJ
aji-170	312	23	cyclosporine	cyclosporine	ADJ
aji-170	312	24	a.	a.	NOUN
aji-170	312	25	experimental	experimental	ADJ
aji-170	312	26	and	and	CCONJ
aji-170	312	27	therapeutic	therapeutic	ADJ
aji-170	312	28	medicine	medicine	NOUN
aji-170	312	29	,	,	PUNCT
aji-170	312	30	21(1	21(1	NUM
aji-170	312	31	)	)	PUNCT
aji-170	312	32	.	.	PUNCT
aji-170	313	1	https://doi.org/10.3892/etm.2020.9469	https://doi.org/10.3892/etm.2020.9469	PROPN
aji-170	313	2	wang	wang	PROPN
aji-170	313	3	,	,	PUNCT
aji-170	313	4	w.	w.	PROPN
aji-170	313	5	j.	j.	PROPN
aji-170	313	6	,	,	PUNCT
aji-170	313	7	salazar	salazar	PROPN
aji-170	313	8	garcia	garcia	PROPN
aji-170	313	9	,	,	PUNCT
aji-170	313	10	m.	m.	PROPN
aji-170	313	11	d.	d.	PROPN
aji-170	313	12	,	,	PUNCT
aji-170	313	13	deutsch	deutsch	PROPN
aji-170	313	14	,	,	PUNCT
aji-170	313	15	g.	g.	PROPN
aji-170	313	16	,	,	PUNCT
aji-170	313	17	sung	sung	PROPN
aji-170	313	18	,	,	PUNCT
aji-170	313	19	n.	n.	PROPN
aji-170	313	20	,	,	PUNCT
aji-170	313	21	yang	yang	PROPN
aji-170	313	22	,	,	PUNCT
aji-170	313	23	x.	x.	PROPN
aji-170	313	24	,	,	PUNCT
aji-170	313	25	he	he	PRON
aji-170	313	26	,	,	PUNCT
aji-170	313	27	q.	q.	PROPN
aji-170	313	28	,	,	PUNCT
aji-170	313	29	jubiz	jubiz	NOUN
aji-170	313	30	,	,	PUNCT
aji-170	313	31	g.	g.	PROPN
aji-170	313	32	,	,	PUNCT
aji-170	313	33	bilal	bilal	PROPN
aji-170	313	34	,	,	PUNCT
aji-170	313	35	m.	m.	NOUN
aji-170	313	36	,	,	PUNCT
aji-170	313	37	dambaeva	dambaeva	PROPN
aji-170	313	38	,	,	PUNCT
aji-170	313	39	s.	s.	PROPN
aji-170	313	40	,	,	PUNCT
aji-170	313	41	gilman	gilman	PROPN
aji-170	313	42	-	-	PUNCT
aji-170	313	43	sachs	sachs	PROPN
aji-170	313	44	,	,	PUNCT
aji-170	313	45	a.	a.	PROPN
aji-170	313	46	,	,	PUNCT
aji-170	313	47	beaman	beaman	PROPN
aji-170	313	48	,	,	PUNCT
aji-170	313	49	k.	k.	PROPN
aji-170	313	50	,	,	PUNCT
aji-170	313	51	&	&	CCONJ
aji-170	313	52	kwak	kwak	PROPN
aji-170	313	53	-	-	PUNCT
aji-170	313	54	kim	kim	PROPN
aji-170	313	55	,	,	PUNCT
aji-170	313	56	j.	j.	PROPN
aji-170	313	57	(	(	PUNCT
aji-170	313	58	2019	2019	NUM
aji-170	313	59	)	)	PUNCT
aji-170	313	60	.	.	PUNCT
aji-170	314	1	pd-1	pd-1	ADJ
aji-170	314	2	and	and	CCONJ
aji-170	314	3	pd	pd	PROPN
aji-170	314	4	-	-	PROPN
aji-170	314	5	l1	l1	PROPN
aji-170	314	6	expression	expression	NOUN
aji-170	314	7	on	on	ADP
aji-170	314	8	t	t	NOUN
aji-170	314	9	-	-	PUNCT
aji-170	314	10	cell	cell	NOUN
aji-170	314	11	subsets	subset	NOUN
aji-170	314	12	in	in	ADP
aji-170	314	13	women	woman	NOUN
aji-170	314	14	with	with	ADP
aji-170	314	15	unexplained	unexplained	ADJ
aji-170	314	16	recurrent	recurrent	ADJ
aji-170	314	17	pregnancy	pregnancy	NOUN
aji-170	314	18	losses	loss	NOUN
aji-170	314	19	.	.	PUNCT
aji-170	315	1	american	american	ADJ
aji-170	315	2	journal	journal	PROPN
aji-170	315	3	of	of	ADP
aji-170	315	4	reproductive	reproductive	ADJ
aji-170	315	5	immunology	immunology	NOUN
aji-170	315	6	,	,	PUNCT
aji-170	315	7	83(5	83(5	NUM
aji-170	315	8	)	)	PUNCT
aji-170	315	9	.	.	PUNCT
aji-170	316	1	https://doi.org/10.1111/aji.13230	https://doi.org/10.1111/aji.13230	PROPN
aji-170	316	2	wang	wang	PROPN
aji-170	316	3	,	,	PUNCT
aji-170	316	4	w.	w.	PROPN
aji-170	316	5	,	,	PUNCT
aji-170	316	6	sung	sung	PROPN
aji-170	316	7	,	,	PUNCT
aji-170	316	8	n.	n.	PROPN
aji-170	316	9	,	,	PUNCT
aji-170	316	10	gilman	gilman	PROPN
aji-170	316	11	-	-	PUNCT
aji-170	316	12	sachs	sachs	PROPN
aji-170	316	13	,	,	PUNCT
aji-170	316	14	a.	a.	NOUN
aji-170	316	15	,	,	PUNCT
aji-170	316	16	&	&	CCONJ
aji-170	316	17	kwakkim	kwakkim	PROPN
aji-170	316	18	,	,	PUNCT
aji-170	316	19	j.	j.	PROPN
aji-170	316	20	(	(	PUNCT
aji-170	316	21	2020	2020	NUM
aji-170	316	22	)	)	PUNCT
aji-170	316	23	.	.	PUNCT
aji-170	317	1	t	t	PROPN
aji-170	317	2	helper	helper	NOUN
aji-170	317	3	(	(	PUNCT
aji-170	317	4	th	th	NOUN
aji-170	317	5	)	)	PUNCT
aji-170	317	6	cell	cell	NOUN
aji-170	317	7	profiles	profile	NOUN
aji-170	317	8	in	in	ADP
aji-170	317	9	pregnancy	pregnancy	NOUN
aji-170	317	10	and	and	CCONJ
aji-170	317	11	recurrent	recurrent	ADJ
aji-170	317	12	pregnancy	pregnancy	NOUN
aji-170	317	13	losses	loss	NOUN
aji-170	317	14	:	:	PUNCT
aji-170	317	15	th1	th1	PROPN
aji-170	317	16	/	/	SYM
aji-170	317	17	th2	th2	PROPN
aji-170	317	18	/	/	SYM
aji-170	317	19	th9	th9	PROPN
aji-170	317	20	/	/	SYM
aji-170	317	21	th17	th17	NOUN
aji-170	317	22	/	/	SYM
aji-170	317	23	th22	th22	PROPN
aji-170	317	24	/	/	SYM
aji-170	317	25	tfh	tfh	NOUN
aji-170	317	26	cells	cell	NOUN
aji-170	317	27	.	.	PUNCT
aji-170	318	1	frontiers	frontier	NOUN
aji-170	318	2	in	in	ADP
aji-170	318	3	immunology	immunology	NOUN
aji-170	318	4	,	,	PUNCT
aji-170	318	5	11	11	NUM
aji-170	318	6	.	.	PUNCT
aji-170	319	1	https://doi.org/10.3389/fimmu.2020.02025	https://doi.org/10.3389/fimmu.2020.02025	PROPN
aji-170	319	2	xu	xu	PROPN
aji-170	319	3	,	,	PUNCT
aji-170	319	4	y.-y	y.-y	PROPN
aji-170	319	5	.	.	PROPN
aji-170	319	6	,	,	PUNCT
aji-170	319	7	wang	wang	PROPN
aji-170	319	8	,	,	PUNCT
aji-170	319	9	s.-c	s.-c	PROPN
aji-170	319	10	.	.	PROPN
aji-170	319	11	,	,	PUNCT
aji-170	320	1	lin	lin	PROPN
aji-170	320	2	,	,	PUNCT
aji-170	320	3	y.-k	y.-k	PROPN
aji-170	320	4	.	.	PUNCT
aji-170	320	5	,	,	PUNCT
aji-170	320	6	li	li	PROPN
aji-170	320	7	,	,	PUNCT
aji-170	320	8	d.-j	d.-j	PROPN
aji-170	320	9	.	.	PROPN
aji-170	320	10	,	,	PUNCT
aji-170	320	11	&	&	CCONJ
aji-170	320	12	du	du	PROPN
aji-170	320	13	,	,	PUNCT
aji-170	320	14	m.-r	m.-r	PROPN
aji-170	320	15	.	.	PUNCT
aji-170	321	1	(	(	PUNCT
aji-170	321	2	2017	2017	NUM
aji-170	321	3	)	)	PUNCT
aji-170	321	4	.	.	PUNCT
aji-170	322	1	tim-3	tim-3	NUM
aji-170	322	2	and	and	CCONJ
aji-170	322	3	pd-1	pd-1	ADV
aji-170	322	4	regulate	regulate	VERB
aji-170	322	5	cd8	cd8	PROPN
aji-170	322	6	+	+	PROPN
aji-170	322	7	t	t	PROPN
aji-170	322	8	cell	cell	NOUN
aji-170	322	9	function	function	NOUN
aji-170	322	10	to	to	PART
aji-170	322	11	maintain	maintain	VERB
aji-170	322	12	early	early	ADJ
aji-170	322	13	pregnancy	pregnancy	NOUN
aji-170	322	14	in	in	ADP
aji-170	322	15	mice	mouse	NOUN
aji-170	322	16	-	-	PUNCT
aji-170	322	17	cell	cell	NOUN
aji-170	322	18	immunoglobulin	immunoglobulin	NOUN
aji-170	322	19	mucin-3	mucin-3	PRON
aji-170	322	20	(	(	PUNCT
aji-170	322	21	tim-3	tim-3	NUM
aji-170	322	22	)	)	PUNCT
aji-170	322	23	.	.	PUNCT
aji-170	323	1	original	original	ADJ
aji-170	323	2	article	article	NOUN
aji-170	323	3	-	-	PUNCT
aji-170	323	4	reprod	reprod	PROPN
aji-170	323	5	.	.	PUNCT
aji-170	324	1	dev	dev	PROPN
aji-170	324	2	,	,	PUNCT
aji-170	324	3	63	63	NUM
aji-170	324	4	.	.	PUNCT
aji-170	324	5	yu	yu	PROPN
aji-170	324	6	,	,	PUNCT
aji-170	324	7	l.	l.	PROPN
aji-170	324	8	,	,	PUNCT
aji-170	324	9	zhang	zhang	PROPN
aji-170	324	10	,	,	PUNCT
aji-170	324	11	y.	y.	PROPN
aji-170	324	12	,	,	PUNCT
aji-170	324	13	xiong	xiong	PROPN
aji-170	324	14	,	,	PUNCT
aji-170	324	15	j.	j.	PROPN
aji-170	324	16	,	,	PUNCT
aji-170	324	17	liu	liu	PROPN
aji-170	324	18	,	,	PUNCT
aji-170	324	19	j.	j.	PROPN
aji-170	324	20	,	,	PUNCT
aji-170	324	21	zha	zha	PROPN
aji-170	324	22	,	,	PUNCT
aji-170	324	23	y.	y.	PROPN
aji-170	324	24	,	,	PUNCT
aji-170	324	25	kang	kang	PROPN
aji-170	324	26	,	,	PUNCT
aji-170	324	27	q.	q.	PROPN
aji-170	324	28	,	,	PUNCT
aji-170	324	29	zhi	zhi	PROPN
aji-170	324	30	,	,	PUNCT
aji-170	324	31	p.	p.	PROPN
aji-170	324	32	,	,	PUNCT
aji-170	324	33	wang	wang	PROPN
aji-170	324	34	,	,	PUNCT
aji-170	324	35	q.	q.	PROPN
aji-170	324	36	,	,	PUNCT
aji-170	324	37	wang	wang	PROPN
aji-170	324	38	,	,	PUNCT
aji-170	324	39	h.	h.	PROPN
aji-170	324	40	,	,	PUNCT
aji-170	324	41	zeng	zeng	PROPN
aji-170	324	42	,	,	PUNCT
aji-170	324	43	w.	w.	PROPN
aji-170	324	44	,	,	PUNCT
aji-170	324	45	&	&	CCONJ
aji-170	324	46	huang	huang	PROPN
aji-170	324	47	,	,	PUNCT
aji-170	324	48	y.	y.	PROPN
aji-170	324	49	(	(	PUNCT
aji-170	324	50	2021	2021	NUM
aji-170	324	51	)	)	PUNCT
aji-170	324	52	.	.	PUNCT
aji-170	325	1	activated	activate	VERB
aji-170	325	2	γδ	γδ	ADP
aji-170	325	3	t	t	NOUN
aji-170	325	4	cells	cell	NOUN
aji-170	325	5	with	with	ADP
aji-170	325	6	higher	high	ADJ
aji-170	325	7	cd107a	cd107a	ADJ
aji-170	325	8	expression	expression	NOUN
aji-170	325	9	and	and	CCONJ
aji-170	325	10	inflammatory	inflammatory	ADJ
aji-170	325	11	potential	potential	NOUN
aji-170	325	12	during	during	ADP
aji-170	325	13	early	early	ADJ
aji-170	325	14	pregnancy	pregnancy	NOUN
aji-170	325	15	in	in	ADP
aji-170	325	16	patients	patient	NOUN
aji-170	325	17	with	with	ADP
aji-170	325	18	recurrent	recurrent	ADJ
aji-170	325	19	spontaneous	spontaneous	ADJ
aji-170	325	20	abortion	abortion	NOUN
aji-170	325	21	.	.	PUNCT
aji-170	326	1	frontiers	frontier	NOUN
aji-170	326	2	in	in	ADP
aji-170	326	3	immunology	immunology	NOUN
aji-170	326	4	,	,	PUNCT
aji-170	326	5	12	12	NUM
aji-170	326	6	.	.	PUNCT
aji-170	327	1	https://doi.org/10.3389/fimmu.2021.724662	https://doi.org/10.3389/fimmu.2021.724662	PROPN
aji-170	327	2	zargar	zargar	NOUN
aji-170	327	3	,	,	PUNCT
aji-170	327	4	m.	m.	NOUN
aji-170	327	5	,	,	PUNCT
aji-170	327	6	ghafourian	ghafourian	NOUN
aji-170	327	7	,	,	PUNCT
aji-170	327	8	m.	m.	NOUN
aji-170	327	9	,	,	PUNCT
aji-170	327	10	behrahi	behrahi	PROPN
aji-170	327	11	,	,	PUNCT
aji-170	327	12	f.	f.	PROPN
aji-170	327	13	,	,	PUNCT
aji-170	327	14	nikbakht	nikbakht	PROPN
aji-170	327	15	,	,	PUNCT
aji-170	327	16	r.	r.	PROPN
aji-170	327	17	,	,	PUNCT
aji-170	327	18	&	&	CCONJ
aji-170	327	19	salehi	salehi	PROPN
aji-170	327	20	,	,	PUNCT
aji-170	327	21	a.	a.	NOUN
aji-170	327	22	m.	m.	NOUN
aji-170	327	23	(	(	PUNCT
aji-170	327	24	2024	2024	NUM
aji-170	327	25	)	)	PUNCT
aji-170	327	26	.	.	PUNCT
aji-170	328	1	association	association	NOUN
aji-170	328	2	of	of	ADP
aji-170	328	3	recurrent	recurrent	ADJ
aji-170	328	4	implantation	implantation	NOUN
aji-170	328	5	failure	failure	NOUN
aji-170	328	6	and	and	CCONJ
aji-170	328	7	recurrent	recurrent	ADJ
aji-170	328	8	pregnancy	pregnancy	NOUN
aji-170	328	9	loss	loss	NOUN
aji-170	328	10	with	with	ADP
aji-170	328	11	peripheral	peripheral	ADJ
aji-170	328	12	blood	blood	NOUN
aji-170	328	13	natural	natural	ADJ
aji-170	328	14	killer	killer	NOUN
aji-170	328	15	cells	cell	NOUN
aji-170	328	16	and	and	CCONJ
aji-170	328	17	interferon	interferon	ADJ
aji-170	328	18	-	-	PUNCT
aji-170	328	19	gamma	gamma	NOUN
aji-170	328	20	level	level	NOUN
aji-170	328	21	.	.	PUNCT
aji-170	329	1	obstetrics	obstetric	NOUN
aji-170	329	2	and	and	CCONJ
aji-170	329	3	gynecology	gynecology	NOUN
aji-170	329	4	science	science	NOUN
aji-170	329	5	,	,	PUNCT
aji-170	329	6	67(1	67(1	NOUN
aji-170	329	7	)	)	PUNCT
aji-170	329	8	,	,	PUNCT
aji-170	329	9	112–119	112–119	NUM
aji-170	329	10	.	.	PUNCT
aji-170	330	1	https://doi.org/10.5468/ogs.23120	https://doi.org/10.5468/ogs.23120	PROPN
aji-170	330	2	zhang	zhang	PROPN
aji-170	330	3	,	,	PUNCT
aji-170	330	4	t.	t.	PROPN
aji-170	330	5	,	,	PUNCT
aji-170	330	6	zhao	zhao	PROPN
aji-170	330	7	,	,	PUNCT
aji-170	330	8	y.	y.	PROPN
aji-170	330	9	,	,	PUNCT
aji-170	330	10	cheung	cheung	PROPN
aji-170	330	11	,	,	PUNCT
aji-170	330	12	w.	w.	PROPN
aji-170	330	13	c.	c.	PROPN
aji-170	330	14	,	,	PUNCT
aji-170	330	15	gan	gan	PROPN
aji-170	330	16	,	,	PUNCT
aji-170	330	17	y.	y.	PROPN
aji-170	330	18	h.	h.	PROPN
aji-170	330	19	,	,	PUNCT
aji-170	330	20	huang	huang	PROPN
aji-170	330	21	,	,	PUNCT
aji-170	330	22	l.	l.	PROPN
aji-170	330	23	,	,	PUNCT
aji-170	330	24	li	li	PROPN
aji-170	330	25	,	,	PUNCT
aji-170	330	26	m.	m.	NOUN
aji-170	330	27	,	,	PUNCT
aji-170	330	28	leung	leung	PROPN
aji-170	330	29	,	,	PUNCT
aji-170	330	30	k.	k.	PROPN
aji-170	330	31	t.	t.	PROPN
aji-170	330	32	,	,	PUNCT
aji-170	330	33	chung	chung	PROPN
aji-170	330	34	,	,	PUNCT
aji-170	330	35	p.	p.	PROPN
aji-170	330	36	w.	w.	PROPN
aji-170	330	37	,	,	PUNCT
aji-170	330	38	wang	wang	PROPN
aji-170	330	39	,	,	PUNCT
aji-170	330	40	c.	c.	PROPN
aji-170	330	41	c.	c.	PROPN
aji-170	330	42	,	,	PUNCT
aji-170	330	43	laird	laird	PROPN
aji-170	330	44	,	,	PUNCT
aji-170	330	45	s.	s.	PROPN
aji-170	330	46	,	,	PUNCT
aji-170	330	47	chen	chen	PROPN
aji-170	330	48	,	,	PUNCT
aji-170	330	49	x.	x.	PROPN
aji-170	330	50	,	,	PUNCT
aji-170	330	51	&	&	CCONJ
aji-170	330	52	li	li	PROPN
aji-170	330	53	,	,	PUNCT
aji-170	330	54	t.	t.	PROPN
aji-170	330	55	c.	c.	PROPN
aji-170	330	56	(	(	PUNCT
aji-170	330	57	2022	2022	NUM
aji-170	330	58	)	)	PUNCT
aji-170	330	59	.	.	PUNCT
aji-170	331	1	serial	serial	ADJ
aji-170	331	2	changes	change	NOUN
aji-170	331	3	in	in	ADP
aji-170	331	4	two	two	NUM
aji-170	331	5	immune	immune	ADJ
aji-170	331	6	checkpoint	checkpoint	NOUN
aji-170	331	7	receptors	receptor	NOUN
aji-170	331	8	and	and	CCONJ
aji-170	331	9	ligands	ligand	NOUN
aji-170	331	10	,	,	PUNCT
aji-170	331	11	tim-3	tim-3	NUM
aji-170	331	12	/	/	SYM
aji-170	331	13	gal-9	gal-9	PUNCT
aji-170	331	14	and	and	CCONJ
aji-170	331	15	pd-1	pd-1	ADP
aji-170	331	16	/	/	SYM
aji-170	331	17	pd	pd	NOUN
aji-170	331	18	-	-	PROPN
aji-170	331	19	l1	l1	PROPN
aji-170	331	20	in	in	ADP
aji-170	331	21	peripheral	peripheral	ADJ
aji-170	331	22	blood	blood	NOUN
aji-170	331	23	prior	prior	ADV
aji-170	331	24	to	to	ADP
aji-170	331	25	miscarriage	miscarriage	NOUN
aji-170	331	26	:	:	PUNCT
aji-170	331	27	comparison	comparison	NOUN
aji-170	331	28	with	with	ADP
aji-170	331	29	pregnancies	pregnancy	NOUN
aji-170	331	30	resulting	result	VERB
aji-170	331	31	in	in	ADP
aji-170	331	32	a	a	DET
aji-170	331	33	live	live	ADJ
aji-170	331	34	birth	birth	NOUN
aji-170	331	35	.	.	PUNCT
aji-170	332	1	https://doi.org/10.3389/fimmu.2021.657552	https://doi.org/10.3389/fimmu.2021.657552	PROPN
aji-170	332	2	https://doi.org/10.1186/s12958-020-00619-7	https://doi.org/10.1186/s12958-020-00619-7	PROPN
aji-170	332	3	https://doi.org/10.1186/s12958-020-00619-7	https://doi.org/10.1186/s12958-020-00619-7	NUM
aji-170	332	4	https://doi.org/10.1038/s41423-020-0471-2	https://doi.org/10.1038/s41423-020-0471-2	NUM
aji-170	332	5	https://doi.org/10.5582/bst.2018.01012	https://doi.org/10.5582/bst.2018.01012	NOUN
aji-170	332	6	https://doi.org/10.1371/journal.pone.0147186	https://doi.org/10.1371/journal.pone.0147186	VERB
aji-170	332	7	https://doi.org/10.1371/journal.pone.0147186	https://doi.org/10.1371/journal.pone.0147186	VERB
aji-170	332	8	https://doi.org/10.1093/humrep/dew019	https://doi.org/10.1093/humrep/dew019	ADJ
aji-170	332	9	https://doi.org/10.3892/etm.2020.9469	https://doi.org/10.3892/etm.2020.9469	NOUN
aji-170	332	10	https://doi.org/10.1111/aji.13230	https://doi.org/10.1111/aji.13230	PROPN
aji-170	332	11	https://doi.org/10.3389/fimmu.2020.02025	https://doi.org/10.3389/fimmu.2020.02025	PROPN
aji-170	332	12	https://doi.org/10.3389/fimmu.2021.724662	https://doi.org/10.3389/fimmu.2021.724662	PROPN
aji-170	333	1	https://doi.org/10.5468/ogs.23120	https://doi.org/10.5468/ogs.23120	PROPN
aji-170	333	2	walana	walana	PROPN
aji-170	333	3	et	et	PROPN
aji-170	333	4	al	al	PROPN
aji-170	333	5	.	.	PROPN
aji-170	333	6	;	;	PUNCT
aji-170	333	7	asian	asian	PROPN
aji-170	333	8	j.	j.	PROPN
aji-170	333	9	immunol	immunol	PROPN
aji-170	333	10	.	.	PROPN
aji-170	333	11	,	,	PUNCT
aji-170	333	12	vol	vol	NOUN
aji-170	333	13	.	.	PROPN
aji-170	333	14	8	8	NUM
aji-170	333	15	,	,	PUNCT
aji-170	333	16	no	no	INTJ
aji-170	333	17	.	.	NOUN
aji-170	333	18	1	1	NUM
aji-170	333	19	,	,	PUNCT
aji-170	333	20	pp	pp	ADJ
aji-170	333	21	.	.	PUNCT
aji-170	334	1	179	179	NUM
aji-170	334	2	-	-	SYM
aji-170	334	3	189	189	NUM
aji-170	334	4	,	,	PUNCT
aji-170	334	5	2025	2025	NUM
aji-170	334	6	;	;	PUNCT
aji-170	334	7	article	article	NOUN
aji-170	334	8	no.aji.139815	no.aji.139815	VERB
aji-170	334	9	189	189	NUM
aji-170	334	10	american	american	ADJ
aji-170	334	11	journal	journal	NOUN
aji-170	334	12	of	of	ADP
aji-170	334	13	reproductive	reproductive	ADJ
aji-170	334	14	immunology	immunology	NOUN
aji-170	334	15	,	,	PUNCT
aji-170	334	16	87(5	87(5	NUM
aji-170	334	17	)	)	PUNCT
aji-170	334	18	.	.	PUNCT
aji-170	335	1	https://doi.org/10.1111/aji.13524	https://doi.org/10.1111/aji.13524	PROPN
aji-170	335	2	zhu	zhu	PROPN
aji-170	335	3	,	,	PUNCT
aji-170	335	4	l.	l.	PROPN
aji-170	335	5	,	,	PUNCT
aji-170	335	6	aly	aly	PROPN
aji-170	335	7	,	,	PUNCT
aji-170	335	8	m.	m.	NOUN
aji-170	335	9	,	,	PUNCT
aji-170	335	10	kuon	kuon	PROPN
aji-170	335	11	,	,	PUNCT
aji-170	335	12	r.	r.	PROPN
aji-170	335	13	j.	j.	PROPN
aji-170	335	14	,	,	PUNCT
aji-170	335	15	toth	toth	PROPN
aji-170	335	16	,	,	PUNCT
aji-170	335	17	b.	b.	PROPN
aji-170	335	18	,	,	PUNCT
aji-170	335	19	wang	wang	PROPN
aji-170	335	20	,	,	PUNCT
aji-170	335	21	h.	h.	PROPN
aji-170	335	22	,	,	PUNCT
aji-170	335	23	karakizlis	karakizlis	PROPN
aji-170	335	24	,	,	PUNCT
aji-170	335	25	h.	h.	PROPN
aji-170	335	26	,	,	PUNCT
aji-170	335	27	weimer	weimer	PROPN
aji-170	335	28	,	,	PUNCT
aji-170	335	29	r.	r.	PROPN
aji-170	335	30	,	,	PUNCT
aji-170	335	31	morath	morath	NOUN
aji-170	335	32	,	,	PUNCT
aji-170	335	33	c.	c.	PROPN
aji-170	335	34	,	,	PUNCT
aji-170	335	35	ibrahim	ibrahim	PROPN
aji-170	335	36	,	,	PUNCT
aji-170	335	37	e.	e.	PROPN
aji-170	335	38	,	,	PUNCT
aji-170	335	39	ekpoom	ekpoom	NOUN
aji-170	335	40	,	,	PUNCT
aji-170	335	41	n.	n.	NOUN
aji-170	335	42	,	,	PUNCT
aji-170	335	43	opelz	opelz	PROPN
aji-170	335	44	,	,	PUNCT
aji-170	335	45	g.	g.	PROPN
aji-170	335	46	,	,	PUNCT
aji-170	335	47	&	&	CCONJ
aji-170	335	48	daniel	daniel	PROPN
aji-170	335	49	,	,	PUNCT
aji-170	335	50	v.	v.	PROPN
aji-170	335	51	(	(	PUNCT
aji-170	335	52	2019	2019	NUM
aji-170	335	53	)	)	PUNCT
aji-170	335	54	.	.	PUNCT
aji-170	336	1	patients	patient	NOUN
aji-170	336	2	with	with	ADP
aji-170	336	3	idiopathic	idiopathic	ADJ
aji-170	336	4	recurrent	recurrent	ADJ
aji-170	336	5	miscarriage	miscarriage	NOUN
aji-170	336	6	have	have	AUX
aji-170	336	7	abnormally	abnormally	ADV
aji-170	336	8	high	high	ADJ
aji-170	336	9	tgfß+	tgfß+	ADP
aji-170	336	10	blood	blood	NOUN
aji-170	336	11	nk	nk	PROPN
aji-170	336	12	,	,	PUNCT
aji-170	336	13	nkt	nkt	PROPN
aji-170	336	14	and	and	CCONJ
aji-170	336	15	t	t	NOUN
aji-170	336	16	cells	cell	NOUN
aji-170	336	17	in	in	ADP
aji-170	336	18	the	the	DET
aji-170	336	19	presence	presence	NOUN
aji-170	336	20	of	of	ADP
aji-170	336	21	abnormally	abnormally	ADV
aji-170	336	22	low	low	ADJ
aji-170	336	23	tgfß	tgfß	NOUN
aji-170	336	24	plasma	plasma	NOUN
aji-170	336	25	levels	level	NOUN
aji-170	336	26	.	.	PUNCT
aji-170	337	1	bmc	bmc	ADJ
aji-170	337	2	immunology	immunology	NOUN
aji-170	337	3	,	,	PUNCT
aji-170	337	4	20(1	20(1	NUM
aji-170	337	5	)	)	PUNCT
aji-170	337	6	.	.	PUNCT
aji-170	338	1	https://doi.org/10.1186/s12865-019-0290-3	https://doi.org/10.1186/s12865-019-0290-3	NUM
aji-170	338	2	zych	zych	NOUN
aji-170	338	3	,	,	PUNCT
aji-170	338	4	m.	m.	NOUN
aji-170	338	5	,	,	PUNCT
aji-170	338	6	kniotek	kniotek	PROPN
aji-170	338	7	,	,	PUNCT
aji-170	338	8	m.	m.	NOUN
aji-170	338	9	,	,	PUNCT
aji-170	338	10	roszczyk	roszczyk	PROPN
aji-170	338	11	,	,	PUNCT
aji-170	338	12	a.	a.	NOUN
aji-170	338	13	,	,	PUNCT
aji-170	338	14	dąbrowski	dąbrowski	PROPN
aji-170	338	15	,	,	PUNCT
aji-170	338	16	f.	f.	PROPN
aji-170	338	17	,	,	PUNCT
aji-170	338	18	jędra	jędra	PROPN
aji-170	338	19	,	,	PUNCT
aji-170	338	20	r.	r.	PROPN
aji-170	338	21	,	,	PUNCT
aji-170	338	22	&	&	CCONJ
aji-170	338	23	zagożdżon	zagożdżon	PROPN
aji-170	338	24	,	,	PUNCT
aji-170	338	25	r.	r.	PROPN
aji-170	338	26	(	(	PUNCT
aji-170	338	27	2024	2024	NUM
aji-170	338	28	)	)	PUNCT
aji-170	338	29	.	.	PUNCT
aji-170	339	1	surface	surface	NOUN
aji-170	339	2	immune	immune	ADJ
aji-170	339	3	checkpoints	checkpoint	NOUN
aji-170	339	4	as	as	ADP
aji-170	339	5	potential	potential	ADJ
aji-170	339	6	biomarkers	biomarker	NOUN
aji-170	339	7	in	in	ADP
aji-170	339	8	physiological	physiological	ADJ
aji-170	339	9	pregnancy	pregnancy	NOUN
aji-170	339	10	and	and	CCONJ
aji-170	339	11	recurrent	recurrent	ADJ
aji-170	339	12	pregnancy	pregnancy	NOUN
aji-170	339	13	loss	loss	NOUN
aji-170	339	14	.	.	PUNCT
aji-170	340	1	international	international	ADJ
aji-170	340	2	journal	journal	NOUN
aji-170	340	3	of	of	ADP
aji-170	340	4	molecular	molecular	ADJ
aji-170	340	5	sciences	science	NOUN
aji-170	340	6	,	,	PUNCT
aji-170	340	7	25(17	25(17	NUM
aji-170	340	8	)	)	PUNCT
aji-170	340	9	,	,	PUNCT
aji-170	340	10	9378	9378	NUM
aji-170	340	11	.	.	PUNCT
aji-170	341	1	https://doi.org/10.3390/ijms25179378	https://doi.org/10.3390/ijms25179378	PROPN
aji-170	341	2	zych	zych	NOUN
aji-170	341	3	,	,	PUNCT
aji-170	341	4	m.	m.	NOUN
aji-170	341	5	,	,	PUNCT
aji-170	341	6	roszczyk	roszczyk	PROPN
aji-170	341	7	,	,	PUNCT
aji-170	341	8	a.	a.	NOUN
aji-170	341	9	,	,	PUNCT
aji-170	341	10	kniotek	kniotek	PROPN
aji-170	341	11	,	,	PUNCT
aji-170	341	12	m.	m.	NOUN
aji-170	341	13	,	,	PUNCT
aji-170	341	14	dabrowski	dabrowski	NOUN
aji-170	341	15	,	,	PUNCT
aji-170	341	16	f.	f.	PROPN
aji-170	341	17	,	,	PUNCT
aji-170	341	18	&	&	CCONJ
aji-170	341	19	zagożdżon	zagożdżon	PROPN
aji-170	341	20	,	,	PUNCT
aji-170	341	21	r.	r.	PROPN
aji-170	341	22	(	(	PUNCT
aji-170	341	23	2021	2021	NUM
aji-170	341	24	)	)	PUNCT
aji-170	341	25	.	.	PUNCT
aji-170	342	1	differences	difference	NOUN
aji-170	342	2	in	in	ADP
aji-170	342	3	immune	immune	ADJ
aji-170	342	4	checkpoints	checkpoint	NOUN
aji-170	342	5	expression	expression	NOUN
aji-170	342	6	(	(	PUNCT
aji-170	342	7	tim-3	tim-3	NUM
aji-170	342	8	and	and	CCONJ
aji-170	342	9	pd-1	pd-1	ADP
aji-170	342	10	)	)	PUNCT
aji-170	342	11	on	on	ADP
aji-170	342	12	t	t	PROPN
aji-170	342	13	cells	cell	NOUN
aji-170	342	14	in	in	ADP
aji-170	342	15	women	woman	NOUN
aji-170	342	16	with	with	ADP
aji-170	342	17	recurrent	recurrent	ADJ
aji-170	342	18	miscarriages	miscarriage	NOUN
aji-170	342	19	—	—	PUNCT
aji-170	342	20	preliminary	preliminary	ADJ
aji-170	342	21	studies	study	NOUN
aji-170	342	22	.	.	PUNCT
aji-170	343	1	journal	journal	PROPN
aji-170	343	2	of	of	ADP
aji-170	343	3	clinical	clinical	ADJ
aji-170	343	4	medicine	medicine	NOUN
aji-170	343	5	,	,	PUNCT
aji-170	343	6	10(18	10(18	NUM
aji-170	343	7	)	)	PUNCT
aji-170	343	8	.	.	PUNCT
aji-170	344	1	https://doi.org/10.3390/jcm10184182	https://doi.org/10.3390/jcm10184182	PROPN
aji-170	344	2	disclaimer	disclaimer	ADJ
aji-170	344	3	/	/	SYM
aji-170	344	4	publisher	publisher	NOUN
aji-170	344	5	’s	’s	PART
aji-170	344	6	note	note	NOUN
aji-170	344	7	:	:	PUNCT
aji-170	344	8	the	the	DET
aji-170	344	9	statements	statement	NOUN
aji-170	344	10	,	,	PUNCT
aji-170	344	11	opinions	opinion	NOUN
aji-170	344	12	and	and	CCONJ
aji-170	344	13	data	datum	NOUN
aji-170	344	14	contained	contain	VERB
aji-170	344	15	in	in	ADP
aji-170	344	16	all	all	DET
aji-170	344	17	publications	publication	NOUN
aji-170	344	18	are	be	AUX
aji-170	344	19	solely	solely	ADV
aji-170	344	20	those	those	PRON
aji-170	344	21	of	of	ADP
aji-170	344	22	the	the	DET
aji-170	344	23	individual	individual	ADJ
aji-170	344	24	author(s	author(s	PROPN
aji-170	344	25	)	)	PUNCT
aji-170	344	26	and	and	CCONJ
aji-170	344	27	contributor(s	contributor(s	NOUN
aji-170	344	28	)	)	PUNCT
aji-170	344	29	and	and	CCONJ
aji-170	344	30	not	not	PART
aji-170	344	31	of	of	ADP
aji-170	344	32	the	the	DET
aji-170	344	33	publisher	publisher	NOUN
aji-170	344	34	and/or	and/or	CCONJ
aji-170	344	35	the	the	DET
aji-170	344	36	editor(s	editor(s	NOUN
aji-170	344	37	)	)	PUNCT
aji-170	344	38	.	.	PUNCT
aji-170	345	1	this	this	DET
aji-170	345	2	publisher	publisher	NOUN
aji-170	345	3	and/or	and/or	CCONJ
aji-170	345	4	the	the	DET
aji-170	345	5	editor(s	editor(s	NOUN
aji-170	345	6	)	)	PUNCT
aji-170	345	7	disclaim	disclaim	VERB
aji-170	345	8	responsibility	responsibility	NOUN
aji-170	345	9	for	for	ADP
aji-170	345	10	any	any	DET
aji-170	345	11	injury	injury	NOUN
aji-170	345	12	to	to	ADP
aji-170	345	13	people	people	NOUN
aji-170	345	14	or	or	CCONJ
aji-170	345	15	property	property	NOUN
aji-170	345	16	resulting	result	VERB
aji-170	345	17	from	from	ADP
aji-170	345	18	any	any	DET
aji-170	345	19	ideas	idea	NOUN
aji-170	345	20	,	,	PUNCT
aji-170	345	21	methods	method	NOUN
aji-170	345	22	,	,	PUNCT
aji-170	345	23	instructions	instruction	NOUN
aji-170	345	24	or	or	CCONJ
aji-170	345	25	products	product	NOUN
aji-170	345	26	referred	refer	VERB
aji-170	345	27	to	to	ADP
aji-170	345	28	in	in	ADP
aji-170	345	29	the	the	DET
aji-170	345	30	content	content	NOUN
aji-170	345	31	.	.	PUNCT
aji-170	346	1	_	_	PUNCT
aji-170	347	1	_	_	PUNCT
aji-170	348	1	_	_	PUNCT
aji-170	349	1	_	_	PUNCT
aji-170	350	1	_	_	PUNCT
aji-170	351	1	_	_	PUNCT
aji-170	352	1	_	_	PUNCT
aji-170	353	1	_	_	PUNCT
aji-170	354	1	_	_	PUNCT
aji-170	355	1	_	_	PUNCT
aji-170	356	1	_	_	PUNCT
aji-170	357	1	_	_	PUNCT
aji-170	358	1	_	_	PUNCT
aji-170	359	1	_	_	PUNCT
aji-170	360	1	_	_	PUNCT
aji-170	361	1	_	_	PUNCT
aji-170	362	1	_	_	PUNCT
aji-170	363	1	_	_	PUNCT
aji-170	364	1	_	_	PUNCT
aji-170	365	1	_	_	PUNCT
aji-170	366	1	_	_	PUNCT
aji-170	367	1	_	_	PUNCT
aji-170	368	1	_	_	PUNCT
aji-170	369	1	_	_	PUNCT
aji-170	370	1	_	_	PUNCT
aji-170	371	1	_	_	PUNCT
aji-170	372	1	_	_	PUNCT
aji-170	373	1	_	_	PUNCT
aji-170	374	1	_	_	PUNCT
aji-170	375	1	_	_	PUNCT
aji-170	376	1	_	_	PUNCT
aji-170	377	1	_	_	PUNCT
aji-170	378	1	_	_	PUNCT
aji-170	379	1	_	_	PUNCT
aji-170	380	1	_	_	PUNCT
aji-170	381	1	_	_	PUNCT
aji-170	382	1	_	_	PUNCT
aji-170	383	1	_	_	PUNCT
aji-170	384	1	_	_	PUNCT
aji-170	385	1	_	_	PUNCT
aji-170	386	1	_	_	PUNCT
aji-170	387	1	_	_	PUNCT
aji-170	388	1	_	_	PUNCT
aji-170	389	1	_	_	PUNCT
aji-170	390	1	_	_	PUNCT
aji-170	391	1	_	_	PUNCT
aji-170	392	1	_	_	PUNCT
aji-170	393	1	_	_	PUNCT
aji-170	394	1	_	_	PUNCT
aji-170	395	1	_	_	PUNCT
aji-170	396	1	_	_	PUNCT
aji-170	397	1	_	_	PUNCT
aji-170	398	1	_	_	PUNCT
aji-170	399	1	_	_	PUNCT
aji-170	400	1	_	_	PUNCT
aji-170	401	1	_	_	PUNCT
aji-170	402	1	_	_	PUNCT
aji-170	403	1	_	_	PUNCT
aji-170	404	1	_	_	PUNCT
aji-170	405	1	_	_	PUNCT
aji-170	406	1	_	_	PUNCT
aji-170	407	1	_	_	PUNCT
aji-170	408	1	_	_	PUNCT
aji-170	409	1	_	_	PUNCT
aji-170	410	1	_	_	PUNCT
aji-170	411	1	_	_	PUNCT
aji-170	412	1	_	_	PUNCT
aji-170	413	1	_	_	PUNCT
aji-170	414	1	_	_	PUNCT
aji-170	415	1	_	_	PUNCT
aji-170	416	1	_	_	PUNCT
aji-170	417	1	_	_	PUNCT
aji-170	418	1	_	_	PUNCT
aji-170	419	1	_	_	PUNCT
aji-170	420	1	_	_	PUNCT
aji-170	421	1	_	_	PUNCT
aji-170	422	1	_	_	PUNCT
aji-170	423	1	_	_	PUNCT
aji-170	424	1	_	_	PUNCT
aji-170	425	1	_	_	PUNCT
aji-170	426	1	_	_	PUNCT
aji-170	427	1	©	©	PRON
aji-170	427	2	copyright	copyright	NOUN
aji-170	427	3	(	(	PUNCT
aji-170	427	4	2025	2025	NUM
aji-170	427	5	):	):	PUNCT
aji-170	427	6	author(s	author(s	NOUN
aji-170	427	7	)	)	PUNCT
aji-170	427	8	.	.	PUNCT
aji-170	428	1	the	the	DET
aji-170	428	2	licensee	licensee	NOUN
aji-170	428	3	is	be	AUX
aji-170	428	4	the	the	DET
aji-170	428	5	journal	journal	PROPN
aji-170	428	6	publisher	publisher	NOUN
aji-170	428	7	.	.	PUNCT
aji-170	429	1	this	this	PRON
aji-170	429	2	is	be	AUX
aji-170	429	3	an	an	DET
aji-170	429	4	open	open	ADJ
aji-170	429	5	access	access	NOUN
aji-170	429	6	article	article	NOUN
aji-170	429	7	distributed	distribute	VERB
aji-170	429	8	under	under	ADP
aji-170	429	9	the	the	DET
aji-170	429	10	terms	term	NOUN
aji-170	429	11	of	of	ADP
aji-170	429	12	the	the	DET
aji-170	429	13	creative	creative	ADJ
aji-170	429	14	commons	common	NOUN
aji-170	429	15	attribution	attribution	NOUN
aji-170	429	16	license	license	NOUN
aji-170	429	17	(	(	PUNCT
aji-170	429	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-170	429	19	)	)	PUNCT
aji-170	429	20	,	,	PUNCT
aji-170	429	21	which	which	PRON
aji-170	429	22	permits	permit	VERB
aji-170	429	23	unrestricted	unrestricted	ADJ
aji-170	429	24	use	use	NOUN
aji-170	429	25	,	,	PUNCT
aji-170	429	26	distribution	distribution	NOUN
aji-170	429	27	,	,	PUNCT
aji-170	429	28	and	and	CCONJ
aji-170	429	29	reproduction	reproduction	NOUN
aji-170	429	30	in	in	ADP
aji-170	429	31	any	any	DET
aji-170	429	32	medium	medium	NOUN
aji-170	429	33	,	,	PUNCT
aji-170	429	34	provided	provide	VERB
aji-170	429	35	the	the	DET
aji-170	429	36	original	original	ADJ
aji-170	429	37	work	work	NOUN
aji-170	429	38	is	be	AUX
aji-170	429	39	properly	properly	ADV
aji-170	429	40	cited	cite	VERB
aji-170	429	41	.	.	PUNCT
aji-170	430	1	peer	peer	NOUN
aji-170	430	2	-	-	PUNCT
aji-170	430	3	review	review	NOUN
aji-170	430	4	history	history	NOUN
aji-170	430	5	:	:	PUNCT
aji-170	430	6	the	the	DET
aji-170	430	7	peer	peer	NOUN
aji-170	430	8	review	review	NOUN
aji-170	430	9	history	history	NOUN
aji-170	430	10	for	for	ADP
aji-170	430	11	this	this	DET
aji-170	430	12	paper	paper	NOUN
aji-170	430	13	can	can	AUX
aji-170	430	14	be	be	AUX
aji-170	430	15	accessed	access	VERB
aji-170	430	16	here	here	ADV
aji-170	430	17	:	:	PUNCT
aji-170	430	18	https://pr.sdiarticle5.com/review-history/139815	https://pr.sdiarticle5.com/review-history/139815	NOUN
aji-170	431	1	https://doi.org/10.1111/aji.13524	https://doi.org/10.1111/aji.13524	PROPN
aji-170	431	2	https://doi.org/10.1186/s12865-019-0290-3	https://doi.org/10.1186/s12865-019-0290-3	NUM
aji-170	431	3	https://doi.org/10.3390/ijms25179378	https://doi.org/10.3390/ijms25179378	ADJ
aji-170	431	4	https://doi.org/10.3390/jcm10184182	https://doi.org/10.3390/jcm10184182	NOUN
aji-170	431	5	https://pr.sdiarticle5.com/review-history/139815	https://pr.sdiarticle5.com/review-history/139815	NOUN